
<html lang="en"     class="pb-page"  data-request-id="7840e5b0-153e-4d82-99f1-c991df7aa908"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2015.58.issue-1;wgroup:string:ACHS website Group;article:article:10.1021/jm5005336;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent" /></meta><meta name="dc.Creator" content="Peter B.  Sampson" /></meta><meta name="dc.Creator" content="Yong  Liu" /></meta><meta name="dc.Creator" content="Bryan  Forrest" /></meta><meta name="dc.Creator" content="Graham  Cumming" /></meta><meta name="dc.Creator" content="Sze-Wan  Li" /></meta><meta name="dc.Creator" content="Narendra Kumar  Patel" /></meta><meta name="dc.Creator" content="Louise  Edwards" /></meta><meta name="dc.Creator" content="Radoslaw  Laufer" /></meta><meta name="dc.Creator" content="Miklos  Feher" /></meta><meta name="dc.Creator" content="Fuqiang  Ban" /></meta><meta name="dc.Creator" content="Donald E.  Awrey" /></meta><meta name="dc.Creator" content="Guodong  Mao" /></meta><meta name="dc.Creator" content="Olga  Plotnikova" /></meta><meta name="dc.Creator" content="Richard  Hodgson" /></meta><meta name="dc.Creator" content="Irina  Beletskaya" /></meta><meta name="dc.Creator" content="Jacqueline M.  Mason" /></meta><meta name="dc.Creator" content="Xunyi  Luo" /></meta><meta name="dc.Creator" content="Vincent  Nadeem" /></meta><meta name="dc.Creator" content="Xin  Wei" /></meta><meta name="dc.Creator" content="Reza  Kiarash" /></meta><meta name="dc.Creator" content="Brian  Madeira" /></meta><meta name="dc.Creator" content="Ping  Huang" /></meta><meta name="dc.Creator" content="Tak W.  Mak" /></meta><meta name="dc.Creator" content="Guohua  Pan" /></meta><meta name="dc.Creator" content="Henry W.  Pauls" /></meta><meta name="dc.Description" content="Previous publications from our laboratory have introduced novel inhibitors of Polo-like kinase 4 (PLK4), a mitotic kinase identified as a potential target for cancer therapy. The search for potent ..." /></meta><meta name="Description" content="Previous publications from our laboratory have introduced novel inhibitors of Polo-like kinase 4 (PLK4), a mitotic kinase identified as a potential target for cancer therapy. The search for potent ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 24, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5005336" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5005336" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5005336" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5005336" /></link>
        
    
    

<title>The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5005336" /></meta><meta property="og:title" content="The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0013.jpeg" /></meta><meta property="og:description" content="Previous publications from our laboratory have introduced novel inhibitors of Polo-like kinase 4 (PLK4), a mitotic kinase identified as a potential target for cancer therapy. The search for potent and selective PLK4 inhibitors yielded (E)-3-((1H-indazol-6-yl)methylene)indolin-2-ones, which were superseded by the bioisosteric 2-(1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones, e.g., 3. The later scaffold confers improved drug-like properties and incorporates two stereogenic centers. This work reports the discovery of a novel one-pot double SN2 displacement reaction for the stereoselective installation of the desired asymmetric centers and confirms the stereochemistry of the most potent stereoisomer, e.g., 44. Subsequent work keys on the optimization of the oral exposure of nanomolar PLK4 inhibitors with potent cancer cell growth inhibitory activity. A short list of compounds with superior potency and pharmacokinetic properties in rodents and dogs was studied in mouse models of tumor growth. We conclude with the identification of compound 48 (designated CFI-400945) as a novel clinical candidate for cancer therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5005336"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5005336">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5005336&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5005336&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5005336&amp;href=/doi/10.1021/jm5005336" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 147-169</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500537u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500373x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(((<i>cis</i>)-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+B.++Sampson">Peter B. Sampson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Liu">Yong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan++Forrest">Bryan Forrest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graham++Cumming">Graham Cumming</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sze-Wan++Li">Sze-Wan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Narendra+Kumar++Patel">Narendra Kumar Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Edwards">Louise Edwards</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Radoslaw++Laufer">Radoslaw Laufer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miklos++Feher">Miklos Feher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fuqiang++Ban">Fuqiang Ban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+E.++Awrey">Donald E. Awrey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guodong++Mao">Guodong Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Plotnikova">Olga Plotnikova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Hodgson">Richard Hodgson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Beletskaya">Irina Beletskaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline+M.++Mason">Jacqueline M. Mason</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xunyi++Luo">Xunyi Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Nadeem">Vincent Nadeem</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wei">Xin Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reza++Kiarash">Reza Kiarash</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Madeira">Brian Madeira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Huang">Ping Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tak+W.++Mak">Tak W. Mak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guohua++Pan">Guohua Pan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+W.++Pauls">Henry W. Pauls</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Celtic Catalysts, 1-03 Nova Centre, Belfield, Dublin 4, Ireland</span></div><div class="corresp-info"><strong>*</strong>Phone: 416-581-7620. E-mail: <a href="/cdn-cgi/l/email-protection#8fe7ffeefae3fccffae7e1fdeafceaeefdece7a1ecee"><span class="__cf_email__" data-cfemail="c6aeb6a7b3aab586b3aea8b4a3b5a3a7b4a5aee8a5a7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5005336&amp;href=/doi/10.1021%2Fjm5005336" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 147–169</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 27, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 April 2014</li><li><span class="item_label"><b>Published</b> online</span>24 June 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 January 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5005336" title="DOI URL">https://doi.org/10.1021/jm5005336</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D147%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPeter%2BB.%2BSampson%252C%2BYong%2BLiu%252C%2BBryan%2BForrest%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D1%26contentID%3Djm5005336%26title%3DThe%2BDiscovery%2Bof%2BPolo-Like%2BKinase%2B4%2BInhibitors%253A%2BIdentification%2Bof%2B%25281R%252C2S%2529-2-%25283-%2528%2528E%2529-4-%2528%2528%2528cis%2529-2%252C6-Dimethylmorpholino%2529methyl%2529styryl%2529-1H-indazol-6-yl%2529-5%25E2%2580%25B2-methoxyspiro%255Bcyclopropane-1%252C3%25E2%2580%25B2-indolin%255D-2%25E2%2580%25B2-one%2B%2528CFI-400945%2529%2Bas%2Ba%2BPotent%252C%2BOrally%2BActive%2BAntitumor%2BAgent%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D169%26publicationDate%3DJanuary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5005336"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3703</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">70</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5005336" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;B. Sampson&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;Forrest&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;Cumming&quot;},{&quot;first_name&quot;:&quot;Sze-Wan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Narendra&quot;,&quot;last_name&quot;:&quot;Kumar Patel&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;Radoslaw&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Miklos&quot;,&quot;last_name&quot;:&quot;Feher&quot;},{&quot;first_name&quot;:&quot;Fuqiang&quot;,&quot;last_name&quot;:&quot;Ban&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;E. Awrey&quot;},{&quot;first_name&quot;:&quot;Guodong&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Plotnikova&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Hodgson&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Beletskaya&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;M. Mason&quot;},{&quot;first_name&quot;:&quot;Xunyi&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Nadeem&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Reza&quot;,&quot;last_name&quot;:&quot;Kiarash&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Madeira&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Tak&quot;,&quot;last_name&quot;:&quot;W. Mak&quot;},{&quot;first_name&quot;:&quot;Guohua&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;W. Pauls&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;147-169&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5005336&quot;},&quot;abstract&quot;:&quot;Previous publications from our laboratory have introduced novel inhibitors of Polo-like kinase 4 (PLK4), a mitotic kinase identified as a potential target for cancer therapy. The search for potent and selective PLK4 inhibitors yielded (E)-3-((1H-indazol-6-yl)methylene)indolin-2-ones, which were superseded by the bioisosteric 2-(1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones, e.g., 3. The later scaffold confers improved drug-like properties and incorporates two stereogenic centers. This work reports the discovery of a novel one-pot double SN2 displacement reaction for the stereoselective installation of the desired asymmetric centers and confirms the stereochemistry of the most potent stereoisomer, e.g., 44. Subsequent work keys on the optimization of the oral exposure of nanomolar PLK4 inhibitors with potent cancer cell growth inhibitory activity. A short list of compounds with superior potency and pharmacokinetic properties in rodents and dogs was studied in mouse models of tumor growth. We conclud&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5005336&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5005336" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5005336&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5005336" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5005336&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5005336" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5005336&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5005336&amp;href=/doi/10.1021/jm5005336" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5005336" /></input><a href="/doi/pdf/10.1021/jm5005336" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5005336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5005336%26sid%3Dliteratum%253Aachs%26pmid%3D24867403%26genre%3Darticle%26aulast%3DSampson%26date%3D2015%26atitle%3DThe%2BDiscovery%2Bof%2BPolo-Like%2BKinase%2B4%2BInhibitors%253A%2BIdentification%2Bof%2B%25281R%252C2S%2529-2-%25283-%2528%2528E%2529-4-%2528%2528%2528cis%2529-2%252C6-Dimethylmorpholino%2529methyl%2529styryl%2529-1H-indazol-6-yl%2529-5%25E2%2580%25B2-methoxyspiro%255Bcyclopropane-1%252C3%25E2%2580%25B2-indolin%255D-2%25E2%2580%25B2-one%2B%2528CFI-400945%2529%2Bas%2Ba%2BPotent%252C%2BOrally%2BActive%2BAntitumor%2BAgent%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D1%26spage%3D147%26epage%3D169%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jmcmar.2015.58.issue-1/20150108/jmcmar.2015.58.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previous publications from our laboratory have introduced novel inhibitors of Polo-like kinase 4 (PLK4), a mitotic kinase identified as a potential target for cancer therapy. The search for potent and selective PLK4 inhibitors yielded (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones, which were superseded by the bioisosteric 2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones, e.g., <b>3</b>. The later scaffold confers improved drug-like properties and incorporates two stereogenic centers. This work reports the discovery of a novel one-pot double S<sub>N</sub>2 displacement reaction for the stereoselective installation of the desired asymmetric centers and confirms the stereochemistry of the most potent stereoisomer, e.g., <b>44</b>. Subsequent work keys on the optimization of the oral exposure of nanomolar PLK4 inhibitors with potent cancer cell growth inhibitory activity. A short list of compounds with superior potency and pharmacokinetic properties in rodents and dogs was studied in mouse models of tumor growth. We conclude with the identification of compound <b>48</b> (designated CFI-400945) as a novel clinical candidate for cancer therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/58/1"><issue-title>New Frontiers in Kinases</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Polo-like kinase (PLK) family of serine/threonine kinases plays a critical role in the regulation of mitosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The family derives its name from the Polo-box domains (PBD) incorporated in the proteins, which are distinct and separate from the kinase (ATP binding) pocket.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The PBDs bind phosphorylated peptide sequences, and this interaction plays a role in the localization of Polo-like kinases to subcellular structures. Of the five members described to date, PLK1, 2, 3, 4, and 5, PLK1 is the most studied member. Multiple PLK1 inhibitors have been described, and several have been taken into the clinic.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> By contrast, PLK4 has, as yet, received little attention. This enzyme is structurally the most distinct member of the family.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Unlike PLK1, 2, and 3, PLK4 has one Polo box only and an active site with high homology to the Aurora kinases. PLK4 has a restricted tissue distribution, being present only in proliferating tissues.</div><div class="NLM_p">PLK4 localizes to the centrosomes and is a critical regulator of centriole duplication.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> Deregulation of PLK4 results in loss of centrosome numerical integrity and leads to chromosome instability (CIN), a characteristic observed in many types of cancers.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> It has been shown that PLK4 is up-regulated in breast cancer, specifically in the basal-like subtype, and that high PLK4 levels are associated with poor patient outcomes.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> We have shown that treatment of breast cancer cells with PLK4 RNAi prevents centriole duplication and results in cell death while normal breast cells are unaffected.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Consistent with these observations, RNAi-mediated depletion of PLK4 in breast cancer xenografts causes growth suppression. These findings identified PLK4 as a potential target for anticancer therapy and caused us to initiate a drug discovery effort.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">The most common strategy for the inhibition of kinases is binding to the ATP site; potent inhibitors result but the potential for cross reactivity with other kinases is well documented.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> An alternative approach to inhibition is possible for the Polo-like kinase family. A priori, binding to the polo-box domain could yield specific inhibitors and overcome drug resistance often associated with ATP competitive kinase inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The PBD is unique for the family of PLKs and is essential for PLK functions and so is a potentially useful site for the development of potent inhibitors for clinical uses. Unfortunately, the known ligands for PBD sites are generally rather large phosphorylated peptide sequences.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These are unsuitable starting points for lead generation, and thus our approach was dictated by the availability of drug-like hits for the inhibition of PLK4, which turned out to be ATP competitive hinge binders.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">Our previous publication on PLK4 inhibition described the discovery of a novel series of ATP competitive kinase inhibitors, namely (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones <b>1</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Subsequent optimization of PLK4 activity by several orders of magnitude was accomplished by substituting the indolinone ring and appending an aryl vinyl moiety on the indazole, giving compound <b>2</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The preceding work<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> describes the bioisosteric replacement of the alkene linker with a cyclopropane ring to yield (2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones, for example, compound <b>3</b>. This change resulted in a substantial improvement in drug-like properties such as oral bioavailability, which were further refined by morphing the dimethyl amino moiety to a morpholine-containing compound <b>4</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Systematic Optimization of PLK4 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Besides the documented beneficial effects,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> the change from an alkene to cyclopropane linker had stereochemical consequences: the new series has two stereogenic centers. Fortuitously, the chemistry employed to install the cyclopropane ring yielded the more active diastereomer as the major product, albeit as a racemic mixture of enantiomers. It was anticipated that only one of these enantiomers was responsible for the potent PLK4 activity observed. The X-ray structure presented in the preceding paper showed that the active enantiomer was likely to have the 1<i>R</i>,2<i>S</i> stereochemistry.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In fact, our modeling studies indicated that this same enantiomer would be favored by up to 2 log units of binding energy. In addition, because development of racemic mixtures is undesirable, a chiral route to our final compounds was required.</div><div class="NLM_p">A number of strategies for the preparation of asymmetric spirocyclopropanes were contemplated. The most direct approach is to apply some chiral version of the ylide chemistry (Corey–Chaykovsky reaction) used for the racemic synthesis.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, cyclopropanations using chiral sulfoxonium ylides do not provide high levels of asymmetric induction and generally fail when applied to complex systems.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Chiral sulfonium ylides have shown greater success,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> but even simple reagents, such as dimethylsulfonium methylide, failed to react with the (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-one substrates. Our approach to the preparation of asymmetric cyclopropanes was based on the double S<sub>N</sub>2 displacement of a chiral bis-electrophile with bis-nucleophile (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). A simple racemic version of this reaction has been described by Marti and Carreira<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> using a cyclic sulfate as the bis-electrophile.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> It was envisaged that the desired reaction would proceed via an inversion of stereochemistry at the benzylic carbon, i.e., reaction of the anion of indolinone <b>6</b> with the asymmetric cyclic sulfate <b>7a</b>. Hydrophobic collapse and/or a favorable π-stacking interaction during the subsequent ring closure induce formation of the desired isomer at the quaternary center of the cyclopropane. This sets the stereochemistry as 1<i>R</i>,2<i>S</i>; removal of the benzyl protecting group gives compound <b>5a</b>, the desired isomer. Conversely, rotation of the indolinone, ring closure and benzyl deprotection would yield the undesired diastereomer <b>8a</b>.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Chiral Indazolyl-spiro[cyclopropane-indolinones] via a Double S<sub>N</sub>2 Displacement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this work, we verify the configuration of the most active stereoisomer and describe the synthetic chemistry developed to obtain the same, stereoselectively, with high enantiomeric purity. This breakthrough, preliminarily disclosed,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> set the stage for further optimization of the series, resulting in the identification of compound <b>48</b>, a potent, orally active PLK4 inhibitor as an antitumor agent for clinical development.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemical Synthesis</h3><div class="NLM_p">Our preliminary studies were performed with racemic substrate in order to test the feasibility of the double displacement chemistry. Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> outlines the preparation of the requisite starting material. Treatment of commercially available bromoindazole <b>9</b> with benzyl chloride and potassium <i>tert</i>-butoxide generated a 1:3 mixture of <i>N</i>2 and <i>N</i>1-benzylated indazoles, <b>10</b> and <b>11</b>, respectively. The mixture was isomerized exclusively to the <i>N</i>1 benzylated indazole <b>11</b> by heating to 150 °C in excess benzyl chloride. Suzuki–Miyaura coupling with vinyl boronic acid pinacol ester gave vinyl indazole <b>12</b>, in good yield, which was smoothly converted to racemic diol <b>13</b>. Unfortunately, reaction of <b>13</b> with thionyl chloride failed to yield the cyclic sulfate <b>7</b>. In contrast, treatment of diol <b>13</b> with methanesulfonyl chloride readily generated racemic <b>14</b>, an alternate version of the required bis-electrophile. To test the feasibility of the key reaction, <b>14</b> and oxindole <b>6</b> were treated with sodium hydride in THF. We observed rapid conversion to one major product, consistent with the racemate <b>15</b>. Similar to the Marti and Carreira result,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> the reaction had proceeded with high relative stereoselectivity to yield the desired diastereomer (94% de). Debenzylation, using a mixture of potassium <i>tert</i>-butoxide and an O<sub>2</sub>-saturated solution in DMSO/THF,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> gave indazole <b>5</b>, which was resolved by chiral preparative supercritical fluid chromatography<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> into the presumptive 1<i>R</i>,2<i>S</i> (<b>5a</b>) and 1<i>S</i>,2<i>R</i> (<b>5b</b>) enantiomers. Racemic <b>5</b> was smoothly iodinated to give <b>17</b>; this material was identical in all respects to a sample of racemic <b>17</b> generated by treatment of <b>1</b> with sulfoxonium ylide, as previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The racemic (1<i>R</i>,2<i>S</i>)-2-(3-iodo-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one <b>18</b> was similarly available via the cyclopropanation of alkene <b>1b</b>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis and Chiral Separation of Racemic (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BnCl, DMSO, <i>t</i>-BuOK, 4 h; (ii) BnCl, 150 °C, 8 h; (iii) 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 80 °C, 7 h; (iv) K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (0.5 mol %), NMO (1.1 equiv), citric acid (2 equiv), <i>t</i>-BuOH/H<sub>2</sub>O, rt 16 h then 50 °C; (v) SO<sub>2</sub>Cl<sub>2</sub>, TEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (vi) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (vii) NaH (60% in oil), THF; (viii) DMSO, <i>t</i>-BuOK, THF, O<sub>2</sub>; (ix) chiral preparative SFC; (x) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>; (xi) Me<sub>3</sub>S(O)I, NaH, DMF, rt; (xii) ArCH═CHBpin, 2:1 PhMe/EtOH, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mol %), microwave 120 °C, 2 h or 1 M aq Na<sub>2</sub>CO<sub>3</sub>, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub> (2.5 mol %), dioxane, reflux, 18 h. Relative and absolute stereochemistry indicated by unwedged (bold and hashed) and wedged (bold and hashed) lines, respectively.</p></p></figure><div class="NLM_p">The racemic iodoindazole <b>17</b> was resolved as above into the presumptive 1<i>R</i>,2<i>S</i> (<b>17a</b>) and 1<i>S</i>,2<i>R</i> (<b>17b</b>) enantiomers (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>); enantiomers <b>18a</b> and <b>18b</b> were similarly obtained. The tentative assignment was based on correlation of optimal activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with the co-complex X-ray structure given in our previous paper.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Subsequent conversion of <b>17a</b> and <b>17b</b> to compounds <b>3a</b> and <b>3b</b> and compounds <b>18a</b> and <b>18b</b> to compounds <b>4a</b> and <b>4b</b>, respectively, was effected by Suzuki–Miyaura reaction.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Spirocyclopropane Stereochemistry on PLK4 and Cell Growth Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>17</b></th><th class="colsep0 rowsep0" align="center"><b>17a</b></th><th class="colsep0 rowsep0" align="center"><b>17b</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>3a</b></th><th class="colsep0 rowsep0" align="center"><b>3b</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>4a</b></th><th class="colsep0 rowsep0" align="center"><b>4b</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">stereochemistry</td><td class="colsep0 rowsep0" align="left">racemic</td><td class="colsep0 rowsep0" align="left">1<i>R</i>,2<i>S</i></td><td class="colsep0 rowsep0" align="left">1<i>S</i>,2<i>R</i></td><td class="colsep0 rowsep0" align="left">racemic</td><td class="colsep0 rowsep0" align="left">1<i>R</i>,2<i>S</i></td><td class="colsep0 rowsep0" align="left">1<i>S</i>,2<i>R</i></td><td class="colsep0 rowsep0" align="left">racemic</td><td class="colsep0 rowsep0" align="left">1<i>R</i>,2<i>S</i></td><td class="colsep0 rowsep0" align="left">1<i>S</i>,2<i>R</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">PLK4 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.65</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">∼30</td><td class="colsep0 rowsep0" align="left">0.002</td><td class="colsep0 rowsep0" align="left">0.00062</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">0.0022</td><td class="colsep0 rowsep0" align="left">0.0009</td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">MDA-MB-468 GI<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.14</td></tr></tbody></table></div></div><div class="NLM_p">With these results in hand, preparation of chiral diol <b>13a</b> (<i>S</i>-enantiomer), predicted to yield the desired isomer <b>5a</b>, was initiated (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Sharpless asymmetric dihydroxylation of <b>12</b> using AD-mix-α generated diol <b>13a</b> as the <i>S</i>-enantiomer in high enantiomeric excess (>98%).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The diol was subsequently converted to the chiral dimesylate <b>14a</b> in high yield. The key reaction, i.e., double S<sub>N</sub>2 displacement of the dimesylate <b>14a</b> with the anionic oxindole <b>6</b>, proceeded cleanly to give the protected spirocyclopropane <b>15a</b> with high enantioselectivity (≥98% ee by chiral HPLC) as the presumptive 1<i>R</i>,2<i>S</i> enantiomer. Similarly, compounds <b>23</b>–<b>26</b> were prepared by treatment of <b>14a</b> with oxindoles <b>19</b>–<b>22</b>, respectively.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Stereoselective Synthesis of (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (DHQ)<sub>2</sub>PHAL, K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (0.5 mol %), K<sub>3</sub>Fe(CN)<sub>6</sub>, K<sub>2</sub>CO<sub>3</sub>, <i>t</i>-BuOH/H<sub>2</sub>O, 0 °C, 5 h; (ii) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (iii) NaH (60% in oil), THF; (iv) DMSO, <i>t</i>-BuOK, THF, O<sub>2</sub>; (v) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF; (vi) BnBr, DCM, 50% aq KOH, TBAB; (vii) ArCH=CHBpin, 2:1 PhMe/EtOH, 1 M Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mol %), microwave 120 °C, 2 h or 1 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub> (2.5 mol %), dioxane, reflux, 18 h.</p></p></figure><div class="NLM_p last">Attempted removal of the benzyl protecting groups of compound <b>15a</b>, under catalytic hydrogenation conditions, resulted in partial ring-opening of the cyclopropane. However, the benzyl groups were removed cleanly from compounds 1<b>5a</b> and <b>23</b>–<b>26</b> using the conditions developed for the racemate <b>15</b>, i.e., <i>t</i>-BuOK in an O<sub>2</sub> saturated solution of THF/DMSO. Compound <b>5a</b>, so prepared, was identical to the material obtained by preparative chiral chromatography (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Subsequent iodination of intermediates <b>5a</b>, <b>16a</b>, and <b>27</b>–<b>29</b> gave <b>17a</b>, <b>18a</b>, and <b>30</b>–<b>32</b>, respectively, in yields ranging from 45% to 95%. Enantiomeric excesses were determined at this stage of the syntheses (chiral HPLC) and were found to be uniformly ≥98%. Compounds <b>17a</b> and <b>18a</b> were identical in all respects to the materials prepared in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> via chiral prep-HPLC. At this stage, compound <b>30</b> was benzylated and the product of the reaction <b>33</b> was recrystallized; single crystal X-ray structure determination was performed on this material (vide infra). PLK4 inhibitors <b>34</b>–<b>58</b> were prepared via Suzuki–Miyaura coupling of iodoindazoles <b>17a</b>, <b>18a</b>, and <b>30</b>–<b>32</b> with the vinyl boronic acid pinacol esters in moderate yields.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cyclopropane Stereochemistry</h3><div class="NLM_p">Our initial assignments of stereochemistry at positions 1 and 2 of the cyclopropane ring were based on molecular modeling predictions, wherein the 1<i>R</i>,2<i>S</i> enantiomer scored up to 2 orders of magnitude higher than the 1<i>S</i>,2<i>R</i>. This tentative assignment was corroborated by the PLK4 co-complex X-ray structure given in the previous paper and the chemistry outlined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> which is predicted to yield the 1<i>R</i>,2<i>S</i> isomer preferentially. This assignment was confirmed by an X-ray crystallographic study of <b>33</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), which indicates that the 1<i>R</i>,2<i>S</i> stereochemistry of the cyclopropyl enantiomer is derived from the vicinal (<i>S</i>)-diol <b>13a</b> via the double S<sub>N</sub>2 displacement reaction of <b>14a</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The corresponding ORTEP diagram is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0015.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. ORTEP diagram for compound <b>33</b> X-ray structure showing the 1<i>R</i>,2<i>S</i> stereochemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 2<i>S</i> stereochemistry is set by the S<sub>N</sub>2 inversion of the benzylic mesylate as anticipated (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The induction at the spiro position of the cyclopropane to give 1<i>R</i>, virtually exclusively, was less certain. It would appear that hydrophobic collapse and/or a π-stacking interaction<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> serves to align the indolinone and indazole in such a way to ensure that ring closure yields the desired isomer, i.e., the left fork of the proposed mechanism of Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Bis-electrophiles analogous to <b>14a</b> react preferentially at the benzylic position.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> However, an alternative reaction course, in which the first displacement occurs on the primary position followed by inversion at the benzylic position, cannot be ruled out. The stereochemical consequences of this sequence would be the same as long as the latter reaction is controlled by an S<sub>N</sub>2 process, and the aforementioned π-stacking is operative.</div><div class="NLM_p last">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes the PLK4 activity for three racemates, <b>17</b>, <b>3</b>, and <b>4</b>, and their constituent enantiomers. It is clear that the 1<i>R</i>,2<i>S</i> stereoisomer 1<b>7a</b> is substantially more active against PLK4 than the 1<i>S</i>,2<i>R</i> stereoisomer <b>17b</b> (∼100 fold) and that the active isomer is 2 times more active than the racemate. This preference is also seen in the more elaborated and potent inhibitors <b>3</b> and <b>4</b> and their constituent enantiomers, <b>3a</b>,<b>b</b> and <b>4a</b>,<b>b</b>, respectively. The cell growth inhibitory activity also reflects this SAR; the PLK4 active isomers are 1–2 orders of magnitude more effective at attenuating MDA-MB-468 breast cancer cell growth. Subsequent lead optimization efforts were focused on the 1<i>R</i>,2<i>S</i> isomer.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Lead Optimization</h3><div class="NLM_p">Much of the SAR that had been developed on the (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was transferable to the racemic 2-(1<i>H</i>-indazol-6-yl)spiro[cyclo-propane-1,3′-indolin]-2′-ones<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and, as anticipated, to the optically active version as well. This is made clear by the entries of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, which indicate that excellent biochemical potency was maintained by the chiral PLK4 inhibitors. Trends previously established were recapitulated in that substitution of the indolinone with a methoxy group at the 5′ position was generally beneficial, as supported by the matched pair <b>47</b> and <b>48</b>. The objective of the work going forward was to optimize the drug-like characteristics of the compounds in hopes of identifying an orally bioavailable development candidate for the treatment of solid tumors. Our efforts were centered on maintaining the in vitro potency of the compounds while maximizing PK properties by fine-tuning the indolinone substituents R and R′ and the aromatic moiety Ar.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In vitro Activity of (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones PLK4 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0009.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0011.gif" alt="" id="GRAPHIC-d5409e1516-autogenerated" /></img><div></div></div><div class="NLM_p">Cell growth was determined by measuring total protein content by SRB assay after 5 days of treatment. In accordance with other mitotic kinase inhibitors,<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> PLK4 inhibitors require treatment times of ≥4 days for their effects to manifest.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> illustrates the effect of a representative PLK4 inhibitor, namely compound <b>47</b>, on the growth inhibition of four breast cancer cell lines (HCC1954, MCF-7, MDA-MB-231, and MDA-MB-468). The plot shows % survival (normalized to control) versus log concentration of compound <b>47</b> in molar (M) and illustrates the differential cellular responses to compound treatment. In related work, we have evaluated the effect of our PLK4 inhibitors on growth attenuation in panels of cancer cell lines, including breast. Distinct outcomes have been observed: polyploidization followed by cell death (e.g., MDA-MB-468), polyploidization followed by cell arrest (e.g., MDA-MB-231), and an intermediate effect.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> The sensitivity of the most responsive cell lines (MDA-MB468 followed by HCC1954 and MCF-7) to compound <b>47</b> is very similar, i.e., the inflection points for the dose response curves are around 10 nM in each case. It is difficult to accurately determine the sensitivity of the MDA-MB-231 cell line in that the survival is high (∼70%) and the inflection is gradual and indistinct. The GI<sub>50</sub>s, i.e., concentrations of PLK4 inhibitors required to inhibit growth of these breast cancer cell lines by 50% of the maximal response has been captured in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0016.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SRB dose–response curves for HCC1954, MCF-7, MDA-MB-231, and MDA-MB-468 cells upon treatment with compound <b>47</b> for 5 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our first publication on PLK4 inhibitors<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> had demonstrated the attributes of the 6-(4-methylpiperazin-1-yl)pyridin-3-yl aryl group vis a vis the pyridinyl aryl group (<b>34</b>), and this was recapitulated in the chiral 2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones. The basic piperazine group in this solvent accessible region of the molecule is associated with enhanced cell activity with the side benefit of increased aqueous solubility. Compounds <b>35</b> and <b>36</b> are potent against PLK4 and, excepting MDA-MB-231, are effective in attenuating breast cancer cell growth across the panel. The latter compound, by methylating the indolinone nitrogen, has the benefit of removing an H-bond donor and potentially increasing permeability. Inspection of our binding models had suggested that this substitution would be tolerated. Although <i>N</i>-methylation removes a potential H-bond with Gln-160, this interaction is solvated and has little thermodynamic value. Because of the <i>N</i>-Me/carbonyl repulsion, the molecule is pushed away from Gln-160; deeper insertion of the 5′-methoxy group into the hydrophobic pocket results, which appears to compensate somewhat for the loss of a weak H-bond. PLK4 inhibitor <b>37</b> was prepared in an effort to remove the potential liability of the pyridyl nitrogen; the latter maintains excellent cell activity and solubility. Compounds <b>34</b>, <b>35</b>, and <b>37</b> were taken forward into mouse PK studies.</div><div class="NLM_p">An alternate motif, described in the preceding work,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> is the 4-((dialkylamino)methyl)-phenyl group, found in compound <b>3a</b>. This moiety also imparts improved aqueous solubility, especially at acidic pH (p<i>K</i><sub>a</sub> = 8.8)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and is generally associated with potent inhibition of PLK4. A series of analogues were prepared in which this basic motif was retained, i.e., compounds <b>38</b>–<b>43</b>; biochemical potency ranged an order of magnitude with the best inhibitors at the subnanomolar level. The 5′-methoxy compound <b>38</b> was the most potent; in contrast, appending a methyl group at the N-1 position of the indolinone decreased potency by 2-fold, compound <b>39</b>. The potential benefits of <i>N</i>-methylation (described above for <b>36</b>) were realized in that compound <b>39</b> was the most effective cell growth inhibitor of the triplet of compounds incorporating the 4-((dialkylamino)methyl)-phenyl group.</div><div class="NLM_p">Replacement of the dimethyl amine with cyclic variants gave compounds <b>40</b>–<b>43</b>; potency against PLK4 was generally maintained as was attenuation of the growth of MDA-MB-468 cells. Curiously, the pyrrolidines (<b>40</b>, <b>41</b>) were effective against HCC-1954 cells while the piperidines (<b>42</b>, <b>43</b>) inhibited the growth of MCF-7 cell line more strongly; we have no explanation for this empirical observation. Representatives, <b>41</b> and <b>43</b>, were tested in mouse PK studies.</div><div class="NLM_p">The promise of the cyclic inhibitors was explored in additional variations on this theme, namely the morpholine analogues <b>4a</b> and <b>44</b>–<b>53</b>, the oxazepane <b>54</b>, and the piperazines <b>55</b> and <b>56</b>. The inclusion of the oxygen in this ring system reduces the p<i>K</i><sub>a</sub> of the benzylic nitrogen from 8.9 to 7.1;<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> we reasoned that modulation of the basicity could enhance permeability and result in improved cell activity and PK parameters. These inhibitors potently inhibited PLK4 and, excepting MDA-MB-231, effectively inhibited the growth of the breast cancer cells. We noted that the meso dimethyl analogues <b>47</b>–<b>49</b> were somewhat less effective against PLK4, but good activity against the cell panel was maintained. However, the 1,3-phenyl substituted analogues <b>50</b> and <b>51</b> were less active than their 1,4 substituted counterparts and were eliminated from further consideration. The methyl, bicylic, and ring expanded analogues <b>52</b>, <b>53</b>, and <b>54</b>, respectively offered no advantage over the parent compound <b>44</b>.</div><div class="NLM_p last">Inclusion of nitrogen into the ring system, i.e., piperazines <b>55</b> and <b>56</b>, shifts the most basic center to the distal nitrogen and yields compounds with relatively high p<i>K</i><sub>a</sub>s (8.4–8.8).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> These compounds inhibited PLK4 potently but weakly attenuated growth of the HCC-1954 and MCF-7 cell lines. In an effort to maintain the topology of the morpholinomethyl moiety while moving the basic center to the distal ring position, (alkylpiperidin-4-yl)oxy compounds <b>57</b> and <b>58</b> were prepared. The latter compound in particular had potent in vitro activities and was tested more extensively in eADME and in vivo assays. It should be noted that the growth inhibitory effect of compounds on human mammary epithelial cells (HMEC GI<sub>50</sub>) was measured (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The ability of the PLK4 inhibitors to inhibit the growth of these cells was poor and generally about 3 orders of magnitude less potent than the effects seen on breast cancer cell lines such as MDA-MB-468.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> eADME and Mouse Plasma Levels</h3><div class="NLM_p">Cytochrome P450, microsomal stability (<i>T</i><sub>1/2</sub>), and mouse plasma levels (PO dosing) were obtained for selected inhibitors, as given in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Compounds were routinely tested against the 1A2 and 2D6 isoforms, however, no inhibition was observed (data not shown). As seen for the alkene-linked compounds,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the CYP450 IC<sub>50</sub> values were generally lower for 2C9 and 2C19 as opposed to other isoforms. Overall, the IC<sub>50</sub>s against CYP450s were micromolar or higher, including the all-important 3A4 isoform. In some instances, values dipped significantly below the single-digit micromolar range (entries <b>49</b>, <b>52</b>, and <b>56</b>) and these compounds were not taken forward. Mouse microsomal <i>T</i><sub>1/2</sub> was often less than 30 min for the earlier entries, but the half-lives were longer for the later entries; microsomal <i>T</i><sub>1/2</sub> was also longer in the presence of human microsomes as compared to mouse. As a predictor of in vivo performance in the putative toxicology species (rat and dog), we measured mouse plasma levels obtained upon oral dosing. Mouse was used for these preliminary exposure studies being readily available, compound sparing, and the species of choice for the subsequent xenografts.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. eADME and Mouse Plasma Levels for Selected PLK4 Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">CYP<sub>450</sub> IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">microsomal <i>T</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">mouse plasma levels (PO @ 25 mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">entry</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">3A4 DBF</th><th class="colsep0 rowsep0" align="center" char=".">3A4 BFC</th><th class="colsep0 rowsep0" align="center" char=".">m</th><th class="colsep0 rowsep0" align="center" char=".">r</th><th class="colsep0 rowsep0" align="center" char=".">d</th><th class="colsep0 rowsep0" align="center" char=".">h</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μg·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">∼10</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">0.120</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">∼10</td><td class="colsep0 rowsep0" align="char" char=".">∼5</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">∼10</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td><td class="colsep0 rowsep0" align="char" char=".">>1.0</td><td class="colsep0 rowsep0" align="char" char=".">∼10</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">∼10</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">>60</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">ND: not determined.</p></div></div></div><div class="NLM_p">The first eight entries in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> attained modest plasma levels in mouse, with the highest exposure being achieved by the <i>N</i>-Me indolinone analogues <b>36</b> and <b>39</b> and the cyclic inhibitors <b>41</b> and <b>43</b>. It is possible that the increased lipophilicity of these entries enhances permeability, however, these effects are modest. In contrast, the large increase in exposure for the morpholines <b>4a</b> and <b>44</b>–<b>49</b> is unmistakable. We postulate a role for the ring oxygen in attenuating the basicity of the nitrogen (p<i>K</i><sub>a</sub> = 7.1), thus striking a balance between enhanced solubility at low pH and good permeability at physiological pH. As a group the morpholino-methyl compounds achieved exposures an order of magnitude higher than their dialkylamino-methyl comparators. The more basic piperazinyl and (alkylpiperidin-4-yl)oxy moieties, as represented by compounds <b>56</b> and <b>58</b>, respectively, showed similarly lower exposures.</div><div class="NLM_p">During the course of the mouse plasma studies, we modeled the ability of early ADME measures to predict the performance of our compounds in vivo. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> gives the correlation of logAUC (experimental) with logAUC (predicted) for PO dosing of PLK4 inhibitors in mice. QSAR analysis established that two independent variables, namely mouse microsomal <i>T</i><sub>1/2</sub> and log<i>D</i><sub>7.4</sub>, can describe predicted logAUC with an <i>R</i><sup>2</sup> of 0.43 and RMSE of 0.43. The correlation is low but not unexpected when modeling in vivo data. The level of variance observed indicates that additional factors could be important in describing exposure of our PLK4 inhibitors in mice, such as the involvement of phase II metabolism, which would not be captured by microsomal measurements. It appears that the microsomal metabolism was of some value in guiding compound optimization but of limited applicability in predicting overall in vivo performance.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0017.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Correlation of logAUC (experimental) with logAUC (predicted) for PO dosing of PLK4 inhibitors in mice. QSAR analysis established that two independent variables (mouse microsomal <i>T</i><sub>1/2</sub> and log<i>D</i><sub>7.4</sub>) describe logAUC (predicted), with an <i>R</i><sup>2</sup> of 0.43 and RMSE of 0.43 (<i>n</i> = 74).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Morpholines with a desirable combination of in vitro and in vivo properties, namely compounds <b>4a</b> and <b>44</b>–<b>48</b>, were advanced to rat and dog pharmacokinetic studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compounds <b>4a</b>, <b>44</b>, and <b>45</b> had relatively high clearance rates in rat; <b>4a</b> had a short dog <i>t</i><sub>1/2</sub> and <b>44</b> had a low oral bioavailability in dog. Compound <b>45</b> had the additional burden of being relatively difficult to make, a feature shared by all compounds with a methyl group at the 5′ position of the indolinone. Thus, a short list of three emerged from these studies as compounds of high interest: <b>46</b>, <b>47</b>, and <b>48</b>. These inhibitors were tested in an expanded cancer cell line panel including lung, colon, and ovarian cancers (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). All three compounds had very similar profiles, with responses more dependent on the cancer cell line tested as opposed to the compound per se; nonetheless, the overall rank order appeared to be in line with the inherent potency of the compounds against PLK4.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rat and Dog Pharmacokinetics for Selected PLK4 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><b>4a</b></th><th class="colsep0 rowsep0" align="center" char="."><b>44</b></th><th class="colsep0 rowsep0" align="center" char="."><b>45</b></th><th class="colsep0 rowsep0" align="center" char="."><b>46</b></th><th class="colsep0 rowsep0" align="center" char="."><b>47</b></th><th class="colsep0 rowsep0" align="center" char="."><b>48</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat IV (1 mg/kg)</td><td class="colsep0 rowsep0" align="left">Cl (L·h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">312</td><td class="colsep0 rowsep0" align="char" char=".">285</td><td class="colsep0 rowsep0" align="char" char=".">553</td><td class="colsep0 rowsep0" align="char" char=".">1234</td><td class="colsep0 rowsep0" align="char" char=".">534</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PO (5 mg/kg)</td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">272</td><td class="colsep0 rowsep0" align="char" char=".">478</td><td class="colsep0 rowsep0" align="char" char=".">410</td><td class="colsep0 rowsep0" align="char" char=".">688</td><td class="colsep0 rowsep0" align="char" char=".">2807</td><td class="colsep0 rowsep0" align="char" char=".">767</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">oral BA (%)</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog IV (1 mg/kg)</td><td class="colsep0 rowsep0" align="left">Cl (L·h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">0.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">402</td><td class="colsep0 rowsep0" align="char" char=".">515</td><td class="colsep0 rowsep0" align="char" char=".">795</td><td class="colsep0 rowsep0" align="char" char=".">648</td><td class="colsep0 rowsep0" align="char" char=".">2050</td><td class="colsep0 rowsep0" align="char" char=".">1054</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog PO (5 mg/kg)</td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">1423</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">1139</td><td class="colsep0 rowsep0" align="char" char=".">1030</td><td class="colsep0 rowsep0" align="char" char=".">4987</td><td class="colsep0 rowsep0" align="char" char=".">3460</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">oral BA (%)</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PLK4 <i>K</i><sub>i</sub> and Growth Inhibition Data for <b>46</b>, <b>47</b>, and <b>48</b> in an Expanded Panel of Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="8" align="center" char=".">cancer cell line GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">breast</th><th class="rowsep1 colsep0" align="center" char=".">lung</th><th class="rowsep1 colsep0" align="center" char=".">ovarian</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">colon</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char="±">PLK4 <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">SKBr-3</th><th class="colsep0 rowsep0" align="center" char=".">Cal-51</th><th class="colsep0 rowsep0" align="center" char=".">BT-20</th><th class="colsep0 rowsep0" align="center" char=".">A549</th><th class="colsep0 rowsep0" align="center" char=".">OVCAR-3</th><th class="colsep0 rowsep0" align="center" char=".">SW620</th><th class="colsep0 rowsep0" align="center" char=".">Colo-205</th><th class="colsep0 rowsep0" align="center" char=".">HCT116+/+</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char="±">0.10 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.055</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char="±">0.73 ± 0.28</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">0.091</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">0.057</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char="±">0.26 ± 0.10</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.058</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> PLK4 Binding Model</h3><div class="NLM_p">A model of compound <b>48</b> in the PLK4 active site is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and is representative for inhibitors of this class. Key interactions, shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A, include two H-bonds from the indazole to the hinge (Glu90 and Cys92) and two H-bonds from the indolinone carbonyl and NH to Lys41 and Gln160, respectively. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B shows a similar view with a surface representation on the protein; the morpholine is at the protein–water interface. There is extensive hydrophobic contact between the enzyme and the ligand, especially at the aromatic rings. The methoxy group nestles in a groove bounded by the protein backbone and the side chains of Leu143 and Glu96.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0018.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode for compound <b>48</b> generated by GlideXP docking in the PLK4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF">4JXF</a>) active site. (A) Top panel shows H-bonds from indolinone carbonyl and NH to Lys41 and Gln160 respectively and H-bonds from indazole to Glu90 and Cys92 of the hinge. (B) Bottom panel shows a similar view with a surface representation on the protein; morpholine is at protein–water interface; the OMe group nestles in a groove bounded by the protein backbone and side chains.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Kinase Selectivity</h3><div class="NLM_p">The short list of PLK4 inhibitors was profiled against other members of the Polo-like kinase family; none of the compounds significantly inhibited PLK1, 2, or 3 at a concentration of 50 μM. In an effort to distinguish between compounds, the short list was tested (Millipore radiometric assay) against a large panel of kinases (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Only a subset of the kinases (48 of 274) was inhibited above 50% at 0.1 μM by at least one compound. This data is represented as a heat map in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>; the PLK4 inhibitor <b>48</b> was clearly more selective than compound <b>46</b>, followed by <b>47</b>. For compound <b>48</b>, biochemical (IC<sub>50</sub>) and cellular (EC<sub>50</sub>)<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> inhibition constants were determined for those human kinases which were significantly inhibited (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). There is an order of magnitude separation between the EC<sub>50</sub>s for PLK4 (12 nM) and the off-target kinases namely AURKA, AURKB/INCENP, TIE2/TEK, TRKA, and TRKB. A kinetic analysis of compound <b>48</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) confirmed the potent (<i>K</i><sub>i</sub> = 0.26 ± 0.10 nM) and ATP competitive nature of the binding, not surprising given the X-ray structures of related compounds.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Biochemical (IC<sub>50</sub>) and Cellular (EC<sub>50</sub>) Binding Constants for Compound <b>48</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="​" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="​">EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLK4</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left">TIE2/TEK</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char="​">117</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AURKA</td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">510</td><td class="colsep0 rowsep0" align="left">TRKA</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char="​">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AURKB/INCENP</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="left">TRKB</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char="​">88</td></tr></tbody></table></div></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Heat map showing % inhibition of kinases at a screening concentration of 0.1 μM by PLK4 inhibitors <b>46</b>, <b>47</b>, and <b>48</b>. Only kinases inhibited >50% by at least one compound (46 of 274) are represented.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although inhibitory effects in cellular contexts were demonstrated for TrkA, TrkB, and Tie2/TEK, these kinases do not have expression patterns or biological activity that would account for the effects of the PLK4 inhibitor <b>48</b> on the cells tested in vitro. TrkA and TrkB are highly expressed in neuroblastomas,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> whereas Tie2/TEK is overexpressed in the microvasculature of solid tumors.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> AURKB is present in all proliferating cells and an integral component of the chromosome passenger protein complex (CPPC), thus its inhibition could explain some of the observed effects of <b>48</b> such as the accumulation of polyploid cells.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> Cellular effects of PLK4 inhibition are observed (e.g., inhibition of centriole duplication),<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> and compound <b>48</b> is 8.5-fold selective for PLK4 over AURKB in cells. However, we cannot rule out that inhibition of AURKB, or other off-target kinases, contribute to the activity of compound <b>48</b>.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Efficacy</h3><div class="NLM_p">Mouse xenograft studies were performed with the short list, chosen from three pathologies, namely, breast (MDA-MB-468), colon (SW620), and lung (A549); these clean cell lines were well established in our laboratories, demonstrating reproducible tumor growth rates in mice. The compounds were given orally at a high (9.4 mg/kg) and low (3.0 mg/kg) dose, once a day, for 21 days. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> shows the results for a representative study with compounds <b>47</b> and <b>48</b> in the breast MDA-MB-468 xenograft model. All doses were tolerated in that none of the animals were lost during the course of the experiment (21 days) and none of the mice lost more than 20% of their body weight. A dose response was seen for both compounds, and all four treatment arms reached statistically significant response vis a vis control (<i>p</i> < 0.05). Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> summarizes the results for the shortlisted compounds in the three xenograft models. Note that all three compounds were efficacious in the models tested, albeit to varying degrees; there was a robust response in the SW620 xenograft which would not have been predicted by the in vitro results (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The lone exception was compound <b>46</b> in the A549 model; the high dose was not tolerated and all animals in this arm were lost. In summary, we deemed these results supported our interest in the shortlisted compounds as potential anticancer agents but were not discriminatory.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mouse Xenograft Results for PLK4 Inhibitors <b>46</b>, <b>47</b>, and <b>48</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="​">percent tumor growth inhibition</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="​">MDA-MB-468</th><th class="rowsep1 colsep0" colspan="2" align="center" char="​">SW620</th><th class="rowsep1 colsep0" colspan="2" align="center" char="​">A549</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char="​">dose 3 mg/kg</th><th class="colsep0 rowsep0" align="center" char="​">dose 9.4 mg/kg</th><th class="colsep0 rowsep0" align="center" char="​">dose 3 mg/kg</th><th class="colsep0 rowsep0" align="center" char="​">dose 9.4 mg/kg</th><th class="colsep0 rowsep0" align="center" char="​">dose 3 mg/kg</th><th class="colsep0 rowsep0" align="center">dose 9.4 mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char="​">61<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">96<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">47<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">77<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">46<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char="​">45</td><td class="colsep0 rowsep0" align="char" char="​">90<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">57<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">80<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">44<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">79<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char="​">57<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">77<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">7</td><td class="colsep0 rowsep0" align="char" char="​">86<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">32</td><td class="colsep0 rowsep0" align="center">70<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last"><i>p</i> < 0.05.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">All animals in this arm were lost during the study.</p></div></div></div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tumor volume and average weight vs days of treatment with compounds <b>47</b> and <b>48</b> in an MDA-MB-468 mouse xenograft model (PO QD dosing).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are theoretical reasons to suppose that antimitotic agents can better exert their effects on tumor growth inhibition by employing an intermittent dosing regimen,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and some chemotherapeutic agents perform optimally on such schedules.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> Accordingly, the maximum tolerated dose (MTD) for compounds <b>46</b>, <b>47</b>, and <b>48</b> for a 1-on/3-off schedule were estimated to be 39, 36, and 39 mg/kg, respectively. Thus, we were able to increase the total compound dosed over the 21 day experiment from 197.4 mg/kg for 9.4 mg/kg (QD regimen) to 252 and 273 mg/kg for the 36 and 39 mg/kg (1-on/3-off regimen) respectively. The short list was dosed at MTD and 2/3MTD in an HCT116 xenograft model (Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A,B), with the last dose on day 21. PLK4 inhibitor <b>48</b> was the most effective followed by compounds <b>46</b> and <b>47</b>; the maximal response was seen at day 25 (98, 90, and 78% TGI, respectively, at the MTD). All dosing arms were tolerated. The experiment continued to day 35 (93% TGI for compound <b>48</b> at 39 mg/kg); at this point, the control tumors had grown to a volume such that the animals needed to be taken off study and sacrificed.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. HCT-116 mouse xenograft model. Solid arrows indicate treatment days with compounds <b>46</b>, <b>47</b>, and <b>48</b> (1 on 3 off, PO); 5-fluorouracil was given at 50 mg/kg IP for 5 days. (A) Top panel shows tumor volume vs day following treatment initiation. (B) Bottom panel shows percent mean body weight loss vs day following treatment initiation. The solid arrows indicate dosing events.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Compound <b>48</b></h3><div class="NLM_p last">Compound <b>48</b> represents an optimized structure from the (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-((dialkylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one class of PLK4 inhibitors. Although having comparable in vitro potency to many other inhibitors listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the morpholino group confers a high level of oral exposure not shared by the compounds incorporating more basic dialkylamino moieties. The two methyl substituents on the morpholine confer additional benefit in that clearance in rat and dog is significantly reduced. The methoxy substituent on the indolinone ring is associated with increased potency and selectivity as evidence by the head to head comparison of compounds <b>47</b> and <b>48</b>. The advantages of compound <b>48</b> culminate in its superior performance in mouse xenografts. On the basis of the cumulative results (vida supra) and additional preclinical data,<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> compound <b>48</b> was selected for IND enabling studies.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have verified the configuration of the most active stereoisomer of the (2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones to be 1<i>R</i>,2<i>S</i> and have described a novel synthetic method to obtain the same, with high enantiomeric and diastereomeric purity. This breakthrough set the stage for systematic optimization of this series to identify the morpholinomethyl-styryl derivatives with nanomolar activity against PLK4 and concomitant inhibitory effects against a panel of breast cancer cell lines. These compounds demonstrated high exposure upon oral dosing in mice, and a subset was taken forward into rat and dog PK studies from which a short list of three compounds was selected for detailed study.</div><div class="NLM_p last">Compounds <b>46</b>, <b>47</b>, and <b>48</b> are single-digit nanomolar PLK4 inhibitors and selective against other members of the PLK family (>10 μM). The shortlisted compounds attenuate the growth of a variety of breast, colon, and ovarian cancer cell lines and are efficacious in mouse xenograft models of tumor growth. Compound <b>48</b> is the most selective shortlisted compound as determined by a radiometric assay against a panel of 274 human kinases. Upon intermittent oral dosing, in a mouse model of colon cancer, compound <b>48</b> was an effective inhibitor of HCT116 tumor growth and was well tolerated. On the strength of the data presented herein, and additional preclinical studies,<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> compound <b>48</b> (designated CFI-400945) was selected for clinical development. IND enabling studies have been completed and this compound has entered phase I human trials in Canada and the United States.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Computational Methods</h3><div class="NLM_p last">The computational processes, model refinement, and QSAR-type analyses were performed using the MOE software.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The PLK4 co-complex X-ray structure, described in the previous paper,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> was used for the docking experiments described herein. Ligand preparation, conformer generation, and docking experiments were as previously described.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthetic Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Experimental Methods</h4><div class="NLM_p">Commercially available starting materials, reagents, and solvents were used as received. In general, anhydrous reactions were performed under an inert atmosphere such as nitrogen or argon. Microwave reactions were performed using a Biotage Initiator microwave reactor. Reaction progress was generally monitored by TLC using Merck silica gel plates with visualization by UV at 254 nm by analytical HPLC or by LCMS (Bruker Esquire 4000). Flash column chromatographic purification of intermediates or final products was performed on a Biotage Isolera One purification system using SNAP KP-sil cartridges. Crude reactions were partially purified using Waters PoraPak Rxn CX cartridges. Preparative reverse-phase HPLC purification was performed on a Varian PrepStar model SD-1 HPLC system with a Varian Monochrom 10 μ C-18 reverse-phase column. Elution was performed using a gradient of 10% MeOH/water to 90% MeOH/water (0.05% TFA) over a 40 min period at a flow rate of 40 mL/min. Fractions containing the desired material were concentrated and lyophilized to obtain the final products. All reported yields were not optimized. Proton NMRs were recorded on a Bruker 400 MHz spectrometer, and mass spectra were obtained using a Bruker Esquire 4000 spectrometer. Chiral SFC separations were performed by Lotus Separations, Princeton, NJ. Optical rotation was measured on an Optical Activity AA-55 polarimeter. Compound purity by analytical HPLC (UV detection at λ = 270 nm) was performed on a Varian Prostar HPLC or Shimadzu Prominance HPLC, using a 100 mm × 4.6 mm Phenomenex Luna 3 μ C-18 column. Elution was performed using a gradient 10% MeOH/water to 90% MeOH/water (0.05% TFA) between 1 and 10 min at a flow rate of 1 mL/min. Purity is reported as area percent; the purity of all final compounds was shown by HPLC to be ≥95%.</div><div class="NLM_p last">Low resolution mass spectra (MS ESI) were obtained using a Bruker Esquire 4000 spectrometer under electron spray ionization conditions. High resolution mass spectra (HRMS) were obtained by a Waters Acquity UPLC coupled with a Waters Synapt G2 time-of-flight mass spec, using an ESI source. Compounds in DMSO solutions (5 mg/mL) were diluted to 0.01 mg/mL; 5 uL was injected on to a Waters BEH C18 1.7 μm 2.1 mm × 100 mm column equilibrated at 10% acetonitrile in water, spiked with 0.1% formic acid at a flow rate of 0.5 mL/min. Bound analytes were eluted by a linear gradient of 10–95% acetonitrile in water, between 1 and 8 min. The mass spectrum was calibrated using formate clusters; leucine enkephalin was used as a “lock mass” for additional, real-time, accurate-mass correction.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Preparation of Indazole Intermediates</h4><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>N</i>1-Benzyl-6-bromo-1<i>H</i>-indazole (<b>11</b>)</h5><div class="NLM_p last">A solution of 6-bromo-1<i>H</i>-indazole (<b>9</b>) (300 g, 1.52 mol) in dry DMSO (1.5 L) was treated with KO<sup>t</sup>Bu (181 mL, 1.8 mol). After 10 min, BnCl (199 g, 1.8 mol) was added, and the resulting mixture left to stir at rt. After 4 h, the reaction was quenched with satd NH<sub>4</sub>Cl (3 L) and extracted with MTBE (2 × 2 L). The combined organic phases were washed with brine (2 × 1 L) and concentrated to a red oil. The oil was slurried with heptane to give a yellow solid as a 3:1 mixture of <i>N</i>1- and <i>N</i>2-benzylated indazoles (<b>11</b> and <b>10</b>). The mixture was isomerized exclusively to the <i>N</i>1 isomer by dissolving into benzyl chloride (350 mL) and heating to 150 °C for 8 h. Excess benzyl chloride was distilled off at 150 °C to give a red oil which was treated with heptane (600 mL) to give <b>11</b> as a red solid (335 g, 77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00 (d, <i>J</i> = 0.6 Hz, 1H), 7.58 (d, <i>J</i> = 8.6 Hz, 1H), 7.52 (s, 1H), 7.36–7.20 (m, 4H), 7.20–7.15 (m, 2H), 5.53 (s, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>14</sub>H<sub>11</sub>BrN<sub>2</sub> + H]<sup>+</sup> 287.0 (<sup>79</sup>Br), 289.0 (<sup>81</sup>Br); found, 287.0; 289.0.</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>N</i>1-Benzyl-6-vinyl-1<i>H</i>-indazole (<b>12</b>)</h5><div class="NLM_p last">A mixture of <b>11</b> (300 g, 1.05 mol) and K<sub>2</sub>CO<sub>3</sub> (432 g, 3.1 mol) in DME/water (3:1, 3.3 L) was purged with nitrogen. 4,4,5,5-Tetramethyl-2-vinyl-1,3,2-dioxaborolane (300 mL, 1.3 mol) was added, followed by Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (36 g, 5 mol %), and the mixture was heated to 80 °C for 7 h. The mixture was diluted with heptane (2 L) and washed with water (3 × 1 L) and brine (1 L). The organic phase was concentrated to 1 L and cooled to 0 °C. The resulting precipitate was collected and dried under high vacuum at 40 °C for 12 h to give the title compound as a yellow solid (160 g, 65%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (s, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.29–7.19 (m, 5H), 7.18–7.13 (m, 2H), 6.75 (dd, <i>J</i> = 17.6, 10.9 Hz, 1H), 5.76 (d, <i>J</i> = 17.5 Hz, 1H), 5.53 (s, 2H), 5.26 (d, <i>J</i> = 10.9 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>14</sub>N<sub>2</sub> + H]<sup>+</sup> 235.1; found, 235.0.</div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 1-(<i>N</i>1-Benzyl-1<i>H</i>-indazol-6-yl)-ethane-1,2-diol (<b>13</b>)</h5><div class="NLM_p last">Compound <b>12</b> (5.6 g, 24 mmol) was stirred in a mixture of <i>t</i>-BuOH (25 mL), water (25 mL), and citric acid (10.1 g, 48.0 mmol). <i>N</i>-Methylmorpholine-<i>N</i>-oxide (3.1 g, 26.4 mmol) and K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (44 mg, 0.12 mmol, 0.5 mol %) were added, and the resulting oily, biphasic mixture stirred overnight at rt. <sup>1</sup>H NMR of a sample showed approximately 40% conversion, and so the mixture was warmed to 50 °C (giving a single phase) for 7 h. Ethanol (50 mL) was added, and the mixture again stirred an additional 24 h at rt. The mixture was filtered through Celite, and the filtrate was concentrated in vacuo. The residue was taken up in 1.0 M aq HCl and EtOAc; the layers were separated and the aqueous phase extracted with further EtOAc. The combined organic portions were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was passed through a short silica plug, eluting with EtOAc, and concentrated to afford racemic <b>13</b> as a reddish gum (6.26 g, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (s, 1H), 7.65 (d, <i>J</i> = 8.4 Hz, 1 H), 7.38 (s, 1H), 7.27–7.18 (m, 3H), 7.16–7.09 (m, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 5.50 (s, 2H), 4.86 (d, <i>J</i> = 7.6 Hz, 1H), 3.78–3.68 (m, 1H), 3.60 (t, <i>J</i> = 9.6 Hz, 1H), 3.46 (s, 1H), 2.84 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub> + H]<sup>+</sup>, 269.1; found, 269.0.</div></div><div id="sec4_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (<i>S</i>)-1-(<i>N</i>1-Benzyl-1<i>H</i>-indazol-6-yl)-ethane-1,2-diol (<b>13a</b>)</h5><div class="NLM_p last">A 5 L clamp-top reaction vessel equipped with an overhead stirrer was treated with K<sub>3</sub>Fe(CN)<sub>6</sub> (405 g, 1.23 mol), K<sub>2</sub>CO<sub>3</sub> (170 g, 1.23 mol), (DHQ)<sub>2</sub>PHAL (3.2 g, 4.1 mmol), and K<sub>2</sub>OsO<sub>4.</sub>2H<sub>2</sub>O (1.54 g, 4.1 mmol). A mixture of <i>t</i>-BuOH and water (1:1, 4 L) was added, forming a clear, biphasic mixture on stirring. The mixture was cooled with an ice bath before addition of <i>N</i>1-benzyl-6-vinyl-1<i>H</i>-indazole (<b>12</b>) (96 g, 410 mmol). The resulting mixture was vigorously stirred at 0 °C for 4 h, and then warmed to 10 °C for 2 h. The reaction was quenched by portionwise addition of sodium metabisulfite (1 kg). The mixture was stirred for 1 h at rt and then filtered through a pad of Celite to remove precipitated OsO<sub>2</sub>. The filtrate was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 2 L), and the combined organic portions dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was recrystallized from hot toluene (10 mL/g) to afford the title compound as a white solid (74 g, 68%, 98% ee), with <sup>1</sup>H NMR and MS results identical to <b>13</b>. Chiral HPLC retention time, 16.8 min (Daicel Chiralpak IB (250 mm × 4.6 mm); isocratic 10% EtOH in <i>n</i>-heptane; 1 mL/min; ambient temperature.</div></div><div id="sec4_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 1-(1-Benzyl-1<i>H</i>-indazol-6-yl)ethane-1,2-diyl Dimethanesulfonate (<b>14</b>)</h5><div class="NLM_p last">A solution of diol <b>13</b> (0.27 g, 1.0 mmol) and TEA (0.35 mL, 2.5 mmol) in dry DCM (5 mL) was cooled in an ice bath followed by dropwise addition of MsCl (0.15 mL, 2.0 mmol) over 5 min. The resulting mixture was left to stir for 2 h and warmed to rt. The mixture was diluted with DCM and washed quickly with 1.0 M aq HCl (20 mL), satd NaHCO<sub>3</sub> (40 mL), and brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated at 25 °C to afford the crude product. The crude product was purified by silica gel chromatography (1:1 Et<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>) to give <b>14</b> as an off-white, gummy foam (0.30 g, 71%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (s, 1H), 7.81 (d, <i>J</i> = 8.3 Hz, 1H), 7.42 (s, 1H), 7.34–7.23 (m, 3H), 7.17 (dd, <i>J</i> = 18.1, 7.6 Hz, 3H), 5.89 (dd, <i>J</i> = 8.5, 3.2 Hz, 1H), 5.66 (d, <i>J</i> = 15.8 Hz, 1H), 5.60 (d, <i>J</i> = 15.8 Hz, 1H), 4.52 (dd, <i>J</i> = 11.8, 8.6 Hz, 1H), 4.40 (dd, <i>J</i> = 11.8, 3.2 Hz, 1H), 3.04 (s, 3H), 2.75 (s, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub> + H]<sup>+</sup>, 425.1; found, 425.0.</div></div><div id="sec4_2_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (<i>S</i>)-1-(1-Benzyl-1<i>H</i>-indazol-6-yl)ethane-1,2-diyl Dimethanesulfonate (<b>14a</b>)</h5><div class="NLM_p last">A solution of <b>13a</b> (134 g, 0.5 mol) and TEA (174 mL, 1.25 mol) in CH<sub>2</sub>Cl<sub>2</sub> (2.5 L) was cooled in an ice bath and treated by slow addition of MsCl (81 mL, 1.05 mol) over 1 h. The internal temperature increased to a maximum of 11 °C. The resulting mixture was left to stir for 30 min. The reaction was quenched with cold 1.0 M aq HCl (400 mL), the phases separated, and the organic phase washed with cold 1.0 M aq HCl, aq NaHCO<sub>3</sub>, and brine, then dried over MgSO<sub>4</sub>. The solution was poured onto a short silica gel pad under suction. The product was eluted using 1:1 Et<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub> (2 L). Removal of the solvents under reduced pressure gave a hard white solid, which was triturated with Et<sub>2</sub>O (800 mL) overnight. The precipitate was collected by filtration and washed with further Et<sub>2</sub>O (2 × 100 mL) to yield the title compound as a fine white powder (184 g, 87%, 99% ee) with <sup>1</sup>H NMR and MS results identical to <b>14</b>. Chiral HPLC retention time, 13.4 min (Daicel Chiralpak IB (250 mm × 4.6 mm); isocratic 30% EtOH in <i>n</i>-heptane; 1 mL/min; ambient temperature.</div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Cyclopropane Formation: General Method A</h4><div class="NLM_p">A solution of indolin-2-one (1 equiv) in dry THF (30 mL/g) was cooled in an ice bath. Sodium hydride (60 wt % in mineral oil, 2.1 equiv) was added in four portions, and the mixture was stirred at 0 °C for 15 min. A solution of 1 equiv of dimesylate (<b>14</b> or <b>14a</b>) in THF (30 mL/g) was added dropwise over 1 h and stirred for 2 h. The reaction was quenched with satd NH<sub>4</sub>Cl solution, diluted with water, and extracted with EtOAc (3 volumes). The organic layer was dried with MgSO<sub>4</sub> and concentrated to a crude product, which was further purified by trituration or silica gel chromatography.</div><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>rac</i>-(1<i>R</i>,2<i>S</i>)-1′-Benzyl-2-(1-benzyl-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>15</b>)</h5><div class="NLM_p last">Prepared according to general method A using oxindole <b>6</b> (45 mg, 0.2 mmol) and dimesylate <b>14</b> (85 mg, 0.2 mmol). The crude product was triturated with petroleum ether/EtOAc (3:1) and filtered to give the title compound <b>15</b> as a light-brown solid (75 mg, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.99 (s, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.36–7.20 (m, 8H), 7.19 (s, 1H), 7.15–7.10 (m, <i>J</i> = 6.4 Hz, 2H), 6.99 (td, <i>J</i> = 7.8, 0.9 Hz, 1H), 6.92 (d, <i>J</i> = 8.3 Hz, 1H), 6.74 (d, <i>J</i> = 7.8 Hz, 1H), 6.50 (t, <i>J</i> = 7.4 Hz, 1H), 5.76 (d, <i>J</i> = 7.3 Hz, 1H), 5.61 (d, <i>J</i> = 15.8 Hz, 1H), 5.53 (d, <i>J</i> = 15.8 Hz, 1H), 5.08 (d, <i>J</i> = 15.6 Hz, 1H), 4.97 (d, <i>J</i> = 15.7 Hz, 1H), 3.48 (t, <i>J</i> = 8.5 Hz, 1H), 2.28 (dd, <i>J</i> = 9.0, 4.5 Hz, 1H), 2.02 (dd, <i>J</i> = 8.0, 4.6 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>25</sub>N<sub>3</sub>O + H]<sup>+</sup>, 456.2; found, 456.0.</div></div><div id="sec4_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (1<i>R</i>,2<i>S</i>)-1′-Benzyl-2-(1-benzyl-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>15a</b>)</h5><div class="NLM_p last">Prepared according to general method A using oxindole <b>6</b> (57 g, 224 mmol) and dimesylate <b>14a</b> (95 g, 224 mmol). The crude product was triturated with petroleum ether/EtOAc (3:1) and filtered to give the title compound <b>15a</b> as a light-brown solid (50 g, 46%, 98% ee) with <sup>1</sup>H NMR and MS results identical to <b>15</b>. Chiral HPLC retention time, 13.3 min (Daicel Chiralpak IA, 250 mm × 4.6 mm); isocratic 10% EtOH in <i>n</i>-heptane; 1 mL/min; ambient temperature.</div></div><div id="sec4_2_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (1<i>R</i>,2<i>S</i>)-1′-Benzyl-2-(1-benzyl-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (<b>23</b>)</h5><div class="NLM_p last">Prepared according to general method A using dimethanesulfonate <b>14a</b> (95 g, 224 mmol) and 1-benzyl-5-methoxyindolin-2-one <b>19</b> (56 g, 224 mmol). The crude product was triturated with 3:1 petroleum ether/EtOAc to give <b>23</b> as a white solid (50 g, 46%, >99.9% ee, Chiralpak IA (250 mm × 4.6 mm); 1.0 mL/min; hexane/EtOH: 80/20). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (s, 1H), 7.64 (d, <i>J</i> = 8.2 Hz, 1H), 7.36–7.23 (m, 9H), 7.14 (d, <i>J</i> = 7.2 Hz, 2H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 6.63 (d, <i>J</i> = 8.3 Hz, 1H), 6.53 (d, <i>J</i> = 8.4 Hz, 1H), 5.61 (d, <i>J</i> = 15.1 Hz, 1H), 5.54 (d, <i>J</i> = 15.4 Hz, 1H), 5.37 (s, 1H), 5.07 (d, <i>J</i> = 15.4 Hz, 1H), 4.95 (d, <i>J</i> = 15.7 Hz, 1H), 3.51 (t, <i>J</i> = 8.1 Hz, 1H), 3.18 (s, 3H), 2.32–2.29 (m, 1H), 2.09–2.00 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 486.2; found, 486.3.</div></div><div id="sec4_2_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (1<i>R</i>,2<i>S</i>)-2-(1-benzyl-1<i>H</i>-indazol-6-yl)-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>24</b>)</h5><div class="NLM_p last">Prepared according to the general method A using 1-methylindolin-2-one <b>20</b> (2.33 g, 15.8 mmol) and a solution of dimesylate <b>14a</b> (6.70 g, 15.8 mmol) in dry THF (45 mL). Purification via column chromatography (silica gel, 25–50% EtOAc in hexane) yielded the title compound as a pale-orange crystalline solid (5.0 g, 84%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00 (s, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.30–7.25 (m, 3H), 7.18 (s, 1H), 7.13–7.10 (m, 3H), 6.92 (d, <i>J</i> = 8.6 Hz, 1H), 6.85 (d, <i>J</i> = 7.6 Hz, 1H), 6.55 (t, <i>J</i> = 7.0 Hz, 1H), 5.76 (d, <i>J</i> = 7.2 Hz, 1H), 5.63–5.49 (m, 2H), 3.41 (t, <i>J</i> = 8.8 Hz, 1H), 3.33 (s, 3H), 2.22–2.18 (m, 1H), 2.00–1.96 (m, 1H); LCMS (ESI) m/z calcd for [C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O + H]<sup>+</sup> 380.18; found, 380.2.</div></div><div id="sec4_2_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (1<i>R</i>,2<i>S</i>)-2-(1-Benzyl-1<i>H</i>-indazol-6-yl)-5′-methoxy-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>25</b>)</h5><div class="NLM_p last">Prepared according to the general method A using dimethanesulfonate <b>14a</b> (1.44 g, 3.4 mmol) and 5-methoxy-1-methylindolin-2-one <b>21</b> (0.60 g, 3.4 mmol). Purification using Biotage Isolera (1–50% EtOAc in hexane, SNAP 25g column) yielded the title compound as a light-brown solid (1.05 g, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (d, <i>J</i> = 0.8 Hz, 1 H), 7.66 (d, <i>J</i> = 8.3 Hz, 1 H), 7.48 (s, 1 H), 7.17–7.31 (m, 3 H), 7.06–7.15 (m, 2 H), 6.92–6.99 (m, 1 H), 6.88 (d, <i>J</i> = 8.3 Hz, 1 H), 6.67 (dd, <i>J</i> = 8.5, 2.5 Hz, 1 H), 5.51–5.68 (m, 2 H), 5.41 (d, <i>J</i> = 2.5 Hz, 1 H), 3.33–3.40 (m, 1 H), 3.28 (s, 3 H), 3.15 (s, 3 H), 2.11–2.24 (m, 2 H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 410.2; found, 410.2.</div></div><div id="sec4_2_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (1<i>R</i>,2<i>S</i>)-1′-Benzyl-2-(1-benzyl-1<i>H</i>-indazol-6-yl)-5′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>26</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general method A using dimethanesulfonate <b>14a</b> (4.24 g, 10 mmol) and 1-benzyl-5-methylindolin-2-one <b>22</b> (2.37 g, 10 mmol). Purification by Biotage Isolera (20–30% EtOAc in hexane) gave <b>26</b> as a beige solid (3.2 g, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.63 (d, <i>J</i> = 8.0 Hz, 1H), 7.36–7.20 (m, 9H), 7.14 (d, <i>J</i> = 6.0 Hz, 2H), 6.94 (d, <i>J</i> = 8.4 Hz, 1H), 6.80 (d, <i>J</i> = 8.0 Hz, 1H), 6.64 (d, <i>J</i> = 7.2 Hz, 1H), 5.62 (d, <i>J</i> = 16.8 Hz, 1H), 5.59 (s, 1H), 5.55 (d, <i>J</i> = 16.8 Hz, 1H), 5.08 (d, <i>J</i> = 16.0 Hz, 1H), 4.97 (d, <i>J</i> = 15.6 Hz, 1H), 3.48 (t, <i>J</i> = 8.4 Hz, 1H), 2.30–2.25 (m, 1H), 2.02–1.96 (m, 1H), 1.85 (s, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>27</sub>N<sub>3</sub>O + H]<sup>+</sup>, 470.2; found, 470.3.</div></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Debenzylation: General Method B</h4><div class="NLM_p">A solution of benzylated indazol-6-ylspiro[cyclopropane-1,3′-indolin]-2′-ones (1 equiv) in THF (6 mL/g) was cooled in ice before addition of <i>t</i>-BuOK (1.7 M solution in THF, 20 equiv). DMSO (19 equiv) was added, and the mixture was purged gently with oxygen in an ice bath for 3 h and then warmed to rt overnight under an atmosphere of oxygen. Mixtures were generally quenched with 20% aq NH<sub>4</sub>Cl, extracted with EtOAc, dried, and evaporated. The product was purified by silica gel chromatography or recrystallization.</div><div id="sec4_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> rac-(1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)spiro-[cyclopropane-1,3-indolin]-2′-one (<b>5</b>)</h5><div class="NLM_p last">Prepared according to general method B using a solution of <b>15</b> (6.5 g, 14 mmol) in a mixture of DMSO (20 mL) and THF (200 mL). In this instance, the combined organic portions (4 × 50 mL EtOAc) were washed with satd aq sodium thiosulfate (50 mL) and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was slurried in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and poured onto a short silica pad (2 cm depth × 5 cm diameter) under suction. The major byproduct (<i>R</i><sub>f</sub> 0.6 in 1:1 EtOAc/cyclohexane) was eluted using CH<sub>2</sub>Cl<sub>2</sub> (ca. 1 L). The product (<i>R</i><sub>f</sub> 0.25 in 1:1 EtOAc/cyclohexane) was eluted (2% then 5% MeOH/EtOAc) and concentrated to afford the title compound (2.5 g, 64%) as a pale-brown solid with a diastereomeric excess of 94%.</div></div><div id="sec4_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)spiro-[cyclopropane-1,3-indolin]-2′-one (<b>5a</b>)</h5><div class="NLM_p">Prepared according to general method B using a solution of <b>15a</b> (10 g, 22 mmol). The material was purified by dry-flash silica pad (4 cm depth × 20 cm diameter). Byproducts were eluted using solvent of increasing eluent strength (0:1, 1:9, 1:4 EtOAc/cyclohexane), and then the product was eluted using EtOAc to give the title compound as a beige solid (4.2 g, 70%, >98.5% ee). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.01 (s, 1H), 10.61 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.63 (d, <i>J</i> = 8.3 Hz, 1H), 7.44 (s, 1H), 6.99 (t, <i>J</i> = 7.5 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 6.84 (d, <i>J</i> = 8.0 Hz, 1H), 6.51 (t, <i>J</i> = 7.0 Hz, 1H), 5.98 (d, <i>J</i> = 8.0 Hz, 1H), 3.20–3.17 (m, 1H), 2.30–2.26 (m, 1H), 2.00–1.95 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>13</sub>N<sub>3</sub>O + H]<sup>+</sup>, 276.3; found, 276.1; chiral HPLC retention time, 14.3 min; Daicel Chiralpak AS-H (250 mm × 4.6 mm); isocratic 40% EtOH in <i>n</i>-heptane; 1 mL/min; 35 °C.</div><div class="NLM_p last">The title compound was also obtained from racemic <b>5</b> (25 mg) by separation using chiral SFC, Chiralpak IA (3 cm × 15 cm), isocratic 30% MeOH (0.1% DEA)/CO<sub>2</sub>, 70 mL/min) to give a white solid <b>5a</b> (11.5 mg, 97% ee, retention time, 5.2 min; Chiralpak IA (15 cm × 0.46 cm), 3.0 mL/min with isocratic 40% MeOH (0.1% DEA)/CO<sub>2</sub>, 3.0 mL/min). From this resolution process, the opposite enantiomer, (1<i>S</i>,2<i>R</i>)-2-(1<i>H</i>-indazol-6-yl)spiro-[cyclopropane-1,3-indolin]-2′-one (<b>5b</b>) was isolated as a white solid (11.8 mg, >98% ee, retention time: 2.7 min) with <sup>1</sup>H NMR and LCMS as described for <b>5a</b>.</div></div><div id="sec4_2_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (<b>16a</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general method B using <b>23</b> (50 g, 103 mmol). Recrystallization from ethanol gave <b>16a</b> as a beige solid (22.3 g, 71%, 99.4% ee, Chiralpak IA (250 mm × 4.6 mm), 1.0 mL/min with isocratic 30% MeOH (0.1% DEA)/70% CO<sub>2</sub>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.02 (br s, 1H), 10.42 (br s, 1H), 8.02 (s, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 1H), 7.45 (s, 1H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.73 (d, <i>J</i> = 8.2 Hz, 1H), 6.55 (d, <i>J</i> = 8.6 Hz, 1H), 5.62 (s, 1H), 3.20 (s, 3H), 3.18 (t, <i>J</i> = 8.7 Hz, 1H), 2.34–2.28 (m, 1H), 1.98–1.95 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 306.1; found, 306.1. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −225° (<i>c</i> 0.44, MeOH).</div></div><div id="sec4_2_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>27</b>)</h5><div class="NLM_p last">The title compound was prepared according to the method B using <b>24</b> (1.16 g, 3.06 mmol). Purification via column chromatography (silica gel, 3–6% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) yielded the title compound as a pale-yellow solid (656 mg, 74%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.06 (br. s, 1H), 8.05 (s, 1H), 7.64 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (s, 1H), 7.14 (t, <i>J</i> = 8.7 Hz, 1H), 6.97 (d, <i>J</i> = 8.7 Hz, 1H), 6.87 (d, <i>J</i> = 8.2 Hz, 1H), 6.62 (t, <i>J</i> = 7.6 Hz, 1H), 5.91 (d, <i>J</i> = 7.9 Hz, 1H), 3.46 (t, <i>J</i> = 7.8 Hz, 1H), 3.34 (s, 3H), 2.26–2.23 (m, 1H), 2.08–2.04 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O + H]<sup>+</sup>, 290.13; found, 290.1.</div></div><div id="sec4_2_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)-5′-methoxy-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>28</b>)</h5><div class="NLM_p last">Prepared according to the general method B using <b>25</b> (0.875 g, 2.1 mmol). The resultant pale-yellow residue was purified by silica gel column chromatography using 5–10% EtOAc in hexane to give the title compound as an off-white solid (445 mg, 65%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.47 (s, 1H), 6.95–6.90 (m, 2H), 6.68 (d, <i>J</i> = 8.8 Hz, 1H), 5.58 (s, 1H), 3.38 (t, <i>J</i> = 8.4 Hz, 1H), 3.32 (s, 3H), 3.20 (s, 3H), 2.28 (dd, <i>J</i> = 9.2, 4.4 Hz, 1H), 2.06 (dd, <i>J</i> = 8.4, 4.8 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 320.2; found, 320.1.</div></div><div id="sec4_2_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)-5′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>29</b>)</h5><div class="NLM_p last">Prepared according to the general method B using <b>26</b> (1.4 g, 3 mmol). Purification by Biotage Isolera (10–95% EtOAc in hexane) gave the title compound as a light solid (680 mg, 53%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.46 (s, 1H), 6.94 (d, <i>J</i> = 8.4 Hz, 1H), 6.85 (d, <i>J</i> = 8.0 Hz, 1H), 6.81 (d, <i>J</i> = 7.6 Hz, 1H), 5.78 (s, 1H), 3.34–3.03 (m, 1H), 2.20–2.12 (m, 2H), 1.87 (s, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O + H]<sup>+</sup>, 290.1; found, 290.1.</div></div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Iodination: General Method C</h4><div class="NLM_p">To a solution of cyclopropylindolin-2-one (1 equiv) and K<sub>2</sub>CO<sub>3</sub> (2 equiv) in DMF was added iodine (1.5 equiv). The resulting mixture was stirred for 18 h at rt and then poured with stirring into 1% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>·5H<sub>2</sub>O. The resulting solid was filtered and washed with water (2×) to give a crude product, which was further purified by trituration or silica gel chromatography.</div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>rac</i>-(1<i>R</i>,2<i>S</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>17</b>)</h5><div class="NLM_p last">Prepared according to general method C by treating a solution of <b>5</b> (200 mg, 0.72 mmol) and <i>K</i><sub>2</sub>CO<sub>3</sub> (300 mg, 2.15 mmol) in dry DMF (2 mL) with a solution of I<sub>2</sub> (500 mg, 1.97 mmol) in dry DMF (2 mL). The crude product was triturated with diethyl ether to give a beige solid (225 mg, 78%) identical to the material previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (1<i>R</i>,2<i>S</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>17a</b>) and (1<i>S</i>,2<i>R</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>17b</b>)</h5><div class="NLM_p">The title compounds were obtained from racemic (1<i>R</i>*,2<i>S</i>*)-2-(3-iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (1 g) by separation using chiral SFC: Chiralcel OJ-H (2 cm × 25 cm), isocratic 40% methanol (0.1% DEA)/CO<sub>2</sub>, 100 bar at 50 mL/min), to give a white solid <b>17a</b> (478 mg) with >99% ee and a retention time of 1.7 min (Chiralcel OJ-H (10 cm × 0.46 cm), isocratic 40% methanol (0.1% DEA)/CO<sub>2</sub>; 3.0 mL/min). From this resolution process, the opposite enantiomer, <b>17b</b> was isolated as a white solid (426 mg, >99% ee, retention time: 2.5 min).</div><div class="NLM_p last">Compound <b>17a</b> was also obtained by direct preparation: <b>5a</b> (10.6 g, 38 mmol) was dissolved into dioxane (150 mL) and 2 M aq NaOH (150 mL). Iodine (13.4 g, 53.3 mmol) was added portionwise, and the reaction was stirred for 12 h. The reaction was quenched with 1% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>·5H<sub>2</sub>O and extracted with EtOAc (3 × 150 mL). Purification by column chromatography on silica (20 cm depth × 4 cm diameter) using 1:1 EtOAc/cyclohexane gave the title compound <b>17a</b> (7.0 g, 46%, 98.5% ee) as an off-white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.47 (s, 1H), 10.62 (s, 1H), 7.47 (s, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.02–6.98 (m, 2H), 6.84 (d, <i>J</i> = 7.6 Hz, 1H), 6.53 (t, <i>J</i> = 7.6 Hz, 1H), 5.97 (d, <i>J</i> = 7.6 Hz, 1H), 3.18 (q, <i>J</i> = 8.4 Hz, 1H), 2.31 (dd, <i>J</i> = 7.2, 4.8 Hz, 1H), 1.98 (dd, <i>J</i> = 8.8, 4.8 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>12</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 402.0; found, 402.0. Optical rotation: [α]<sup>22</sup><sub>D</sub> = −118° (<i>c</i> 0.57, MeOH). Chiral HPLC retention time, 14.1 min; Daicel Chiralpak AS-H (250 mm × 4.6 mm); isocratic 40% EtOH in <i>n</i>-heptane; 1 mL/min; 35 °C.</div></div><div id="sec4_2_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (1<i>R</i>,2<i>S</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (<b>18a</b>)</h5><div class="NLM_p">The title compound was obtained from racemic (1<i>R</i>,2<i>S</i>)-2-(3-iodo-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (15 g) by separation using chiral SFC: Chiralcel OJ-H (3 cm × 15 cm), (30% methanol (0.1% DEA)/CO<sub>2</sub>, 75 mL/min), to give a white solid <b>18a</b> (6.75 g, 99% ee; chiral HPLC retention time, 2.1 min; Chiralpak IA (150 mm × 4.6 mm), 3.0 mL/min isocratic 40% 2-propanol (0.1% DEA)/CO<sub>2</sub>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.48 (br s, 1H), 10.43 (br s, 1H), 7.49 (s, 1H), 7.31 (d, <i>J</i> = 8.6 Hz, 1H), 7.02 (d, <i>J</i> = 8.1 Hz, 1H), 6.73 (d, <i>J</i> = 8.4 Hz, 1H), 6.57 (d, <i>J</i> = 8.6 Hz, 1H), 5.62 (s, 1H), 3.29 (s, 3H), 3.19 (t, <i>J</i> = 8.4 Hz, 1H), 2.36–2.32 (m, 1H), 1.99–1.96 (m 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>IN<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 432.0; found, 432.1 [M + 1]<sup>+</sup>. From this resolution process, the opposite enantiomer (1<i>S</i>,2<i>R</i>)-2-(3-iodo-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one <b>18b</b> was isolated as a white solid (6.6 g, 99% ee, chiral HPLC retention time, 3.4 min) with <sup>1</sup>H NMR and LCMS as described for <b>18a</b>.</div><div class="NLM_p last">Alternatively, a solution of <b>16a</b> (250 g, 0.82 mol) in DMF (500 mL) and MeOH (500 mL) was treated with potassium carbonate (226 g, 1.64 mol). Iodine (340 g, 1.06 mol) was dissolved into DMF (475 mL) and added to the mixture. The mixture was stirred at rt for 6 h and quenched with sodium thiosulfate pentahydrate (360 g, 1.46 mol) in water (5.7 L). The mixture was stirred at rt for 4 h and filtered. The solid was washed with water (2 L) and dried under vacuum at 50 °C to give the title compound as a white solid (334 g, 95%, 98% ee) with <sup>1</sup>H NMR and LCMS as described above. Optical rotation: [α]<sup>22</sup><sub>D</sub> = −143° (<i>c</i> 0.40, MeOH).</div></div><div id="sec4_2_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (1<i>R</i>,2<i>S</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>30</b>)</h5><div class="NLM_p last">Prepared according to the general method C using <b>27</b> (930 mg, 3.21 mmol). Precipitation with EtOAc followed by filtration and rinsing with EtOAc gave the title compound (970 mg, 73%, >98% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.96 (br. s, 1H), 7.43–7.39 (m, 2H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 7.05 (d, <i>J</i> = 8.0 Hz, 1H), 6.89 (d, <i>J</i> = 7.8 Hz, 1H), 6.66 (t, <i>J</i> = 7.2 Hz, 1H), 5.91 (d, <i>J</i> = 8.0 Hz, 1H), 3.47 (t, <i>J</i> = 8.4 Hz, 1H), 3.35 (s, 3H), 2.30–2.26 (m, 1H), 2.08–2.04 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 416.03; found, 416.0. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −210° (<i>c</i> 0.4, MeOH). Chiral HPLC retention time, 2.4 min; Phenomenex Lux 5 μ Amylose-2 150 mm × 4.6 mm (2.5 mL/min with isocratic at 20% EtOH in hexane for 0.5 min, then gradient 20–50% EtOH in hexane over 2.5 min, then isocratic at 50% for 1 min).</div></div><div id="sec4_2_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (1<i>R</i>,2<i>S</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)-5′-methoxy-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>31</b>)</h5><div class="NLM_p last">Prepared according to the general method C using <b>28</b> (1.34 g, 4.19 mmol). The title compound was isolated as a cream-colored solid (1.71 g, 91%, 97.9% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.38 (s, 1H), 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 7.35 (s, 1H), 7.04 (d, <i>J</i> = 8.8 Hz, 1H), 6.77 (d, <i>J</i> = 8.4 Hz, 1H), 6.66 (d, <i>J</i> = 8.4 Hz, 1H), 5.53 (s, 1H), 3.46 (t, <i>J</i> = 8.0 Hz, 1H), 3.38 (s, 3H), 3.32 (s, 3H), 2.24 (dd, <i>J</i> = 8.4, 4.8 Hz, 1H), 2.04 (dd, <i>J</i> = 12.4, 4.8 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>16</sub>IN<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 446.0; found, 446.1 [M + 1]<sup>+</sup>. Optical rotation: [α]<sup>22</sup><sub>D</sub> = −134° (<i>c</i> 0.24, MeOH). Chiral HPLC retention time, 2.6 min; Phenomenex Lux 5μ Amylose-2 150 mm × 4.6 mm (2.5 mL/min with isocratic at 20% EtOH in hexane for 0.5 min, then gradient 20–50% EtOH in hexane over 2.5 min, then isocratic at 50% for 1 min).</div></div><div id="sec4_2_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (1<i>R</i>,2<i>S</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)-5′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>32</b>)</h5><div class="NLM_p last">Prepared according to the general method C using <b>29</b> (680 mg, 2.35 mmol). Purification by Biotage Isolera (EtOAc/hexane gradient: 10–90%) gave the title compound as a light-yellow solid (794 mg, 81%, >98% ee). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.43 (s, 1H), 10.51 (s, 1H), 7.47 (s, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.8 Hz, 1H), 6.81 (d, <i>J</i> = 8.4 Hz, 1H), 6.73 (d, <i>J</i> = 7.6 Hz, 1H), 5.86 (s, 1H), 3.18 (t, <i>J</i> = 8.2 Hz, 1H), 2.30–2.20 (m 1H), 2.00–1.90 (m, 1H), 1.85 (s, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 416.0; found, 416.0. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −145° (<i>c</i> 0.49, MeOH). Chiral HPLC retention time, 9.6 min; Phenomenex Lux 5μ Cellulose-2 (150 mm × 4.6 mm); isocratic 10% EtOH in <i>n</i>-hexane (1.75 mL/min at ambient temperature).</div></div><div id="sec4_2_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (1<i>R</i>,2<i>S</i>)-2-(1-Benzyl-3-iodo-1<i>H</i>-indazol-6-yl)-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>33</b>)</h5><div class="NLM_p last">To compound <b>30</b> (200 mg, 0.48 mmol) in DCM (3.5 mL) and 50% aq KOH (1 mL) was added benzyl bromide (69 μL, 0.58 mmol) and TBAB (2 mg, 0.005 mmol). The mixture was stirred overnight at 0 °C. The reaction was warmed to rt. DCM (10 mL) was added, and the mixture was washed with brine (2 × 5 mL), dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by Biotage silica gel chromatography (99:1 to 95:5 DCM/MeOH). The title compound was recrystallized from hot methanol to give a white crystalline solid (150 mg, 63%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.35 (d, <i>J</i> = 8.3 Hz, 1H), 7.20–7.32 (m, 4H), 7.07–7.18 (m, 4H), 6.98 (d, <i>J</i> = 8.3 Hz, 1H), 6.86 (d, <i>J</i> = 8.0 Hz, 1H), 6.56 (t, <i>J</i> = 7.6 Hz, 1H), 5.72 (d, <i>J</i> = 7.55 Hz, 1H), 5.63- 5.49 (m, 2H), 3.39 (t, <i>J</i> = 8.5 Hz, 1H), 3.32 (s, 3H), 2.20 (dd, <i>J</i> = 4.6, 8.4 Hz, 1H), 1.87–1.99 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>25</sub>H<sub>20</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 506.1; found, 506.1. Single crystal X-ray crystallography structure determination was performed at the Service Crystallography Laboratory, University of Toronto, Toronto, ON. The crystal and structure refinement data for compound <b>33</b> is given in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, and the corresponding ORTEP diagram is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Suzuki–Miyaura Cross Coupling of 3-Iodospirocyclopropaneindolinones</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> General Method D</h4><div class="NLM_p last">The appropriate 3-iodospirocyclopropaneindolinone (1 equiv) was dissolved into dioxane and 1 M aq Na<sub>2</sub>CO<sub>3</sub> (5 equiv). The appropriate vinyl boronic ester (1.2 equiv), LiCl (3 equiv), and catalyst, Pd(PPh<sub>3</sub>)<sub>4</sub> (2.5 mol %), were added and resulting mixture purged with argon. The mixture was heated on an oil bath for 18 h, cooled to rt, and diluted with satd NaHCO<sub>3</sub> and extracted with 3 volumes of EtOAc. The combined organic fractions were dried over MgSO<sub>4</sub> and concentrated. After removal of solvents, the residue was either purified by prep-HPLC to give the title compound as a TFA salt or by flash chromatography, followed by treatment with 1 M HCl in ether to generate the HCl salt.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> General Method E</h4><div class="NLM_p">The appropriate 3-iodospirocyclopropaneindolinone (1 equiv) was dissolved into 2:1 toluene/ethanol and 1 M aq  Na<sub>2</sub>CO<sub>3</sub> (2 equiv). The appropriate vinyl boronic ester (1.2 equiv) and catalyst, Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mol %), were added, and the resulting mixture was heated in a microwave for 2 h at 125 °C. After cooling to rt, the mixture was diluted with H<sub>2</sub>O, extracted with EtOAc (×2), and dried (MgSO<sub>4</sub>). After removal of solvents, the residue was redissolved in MeOH and filtered through a Waters CX column and either purified by prep-HPLC to give the title compound as a TFA salt or by flash chromatography followed by treatment with 1 M HCl in ether to generate the HCl salt.</div><div id="sec4_3_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>3a</b>)</h5><div class="NLM_p last">To a solution of <b>17a</b> (125 mg, 0.31 mmol) in DMF (1.6 mL) and water (0.4 mL) was added (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl) methanamine (143 mg, 0.5 mmol), potassium fluoride (36 mg, 0.62 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (18 mg, 0.015 mmol). The mixture was heated to 120 °C for 2 h under microwave irradiation. EtOAc (50 mL) was added, and the solution was washed with water (2 × 5 mL) and brine (5 mL) and dried over MgSO<sub>4</sub>. Purification by reverse phase prep-HPLC gave the title compound as a yellow solid (73 mg, 44%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.02 (d, <i>J</i> = 8.3 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.56–7.48 (m, 5H), 7.08–7.04 (m, 2H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (t, <i>J</i> = 7.8 Hz, 1H), 6.00 (d, <i>J</i> = 8.0 Hz, 1H), 4.38 (s, 2H), 3.39–3.33 (m, 1H), 2.90 (s, 6H), 2.28–2.22 (m, 1H), 2.22–2.17 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O + H]<sup>+</sup>, 435.2185; found, 435.2192. HPLC: 99.1% at 270 nM.</div></div><div id="sec4_3_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> (1<i>S</i>,2<i>R</i>)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>3b</b>)</h5><div class="NLM_p last">To a solution of <b>17b</b> (20 mg, 0.05 mmol) in DMF (0.4 mL) and water (0.1 mL) was added (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl) methanamine (25 mg, 0.08 mmol), potassium fluoride (6 mg, 0.1 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (3 mg, 0.002 mmol). The mixture was heated to 120 °C for 2 h under microwave irradiation. EtOAc (50 mL) was added, and the solution was washed with water (2 × 5 mL) and brine (5 mL) and dried over MgSO<sub>4</sub>. Purification by reverse phase prep-HPLC gave the title compound as a yellow solid (4 mg, 15%) with <sup>1</sup>H NMR and MS results identical to <b>3a</b>. HPLC purity: 99.8% at 270 nM.</div></div><div id="sec4_3_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> (1<i>R</i>,2<i>S</i>)-5′-Methoxy-2-(3-(4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>4a</b>)</h5><div class="NLM_p last">Prepared according to general method D using <b>18a</b> (5.3 g, 12.3 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (4.86 g, 14.8 mmol). The residue was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1) to give a solid, which was sonicated with Et<sub>2</sub>O and filtered to give a white solid. The solid was dissolved into THF (50 mL), and then HCl (9 mL of a 1 M solution in Et<sub>2</sub>O) was added. A precipitate formed immediately, and further precipitate was obtained on addition of more Et<sub>2</sub>O (150 mL). The solid was quickly filtered and washed with Et<sub>2</sub>O to give an off-white solid (3.2 g, 48%, 99% ee). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 8.2 Hz, 2H), 7.75–7.50 (m, 5H), 7.07 (d, <i>J</i> = 8.6 Hz, 1H), 6.83 (d, <i>J</i> = 8.5 Hz, 1H), 6.61 (dd, <i>J</i> = 8.5 Hz, 2.2 Hz, 1H), 5.58 (d, <i>J</i> = 2.2 Hz, 1H), 4.39 (s, 2H), 4.09–4.04 (m, 2H), 3.78–3.72 (m, 2H), 3.43–3.33 (m, 3H), 3.27–3.20 (m, 5H), 2.27–2.23 (m, 1H), 2.21–2.16 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 507.2396 [M + 1]<sup>+</sup>; found, 507.2395. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −97° (<i>c</i> 0.5, MeOH). HPLC purity: 97.1% at 270 nM.</div></div><div id="sec4_3_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> (1<i>S</i>,2<i>R</i>)-5′-Methoxy-2-(3-((<i>E</i>)-4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>4b</b>)</h5><div class="NLM_p last">Prepared according to the general method D using <b>18b</b> (509 mg, 1.18 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (468 mg, 1.42 mmol). Silica gel purification (93:7 to 92:8, CH<sub>2</sub>Cl<sub>2</sub>/MeOH) gave 374 mg of the free base, which was dissolved into THF (15 mL) and treated with HCl (0.9 mL of a 1 M solution in Et<sub>2</sub>O), and the resulting precipitate was filtered and washed with Et<sub>2</sub>O to give the title compound as an off-white powder (329 mg, 51%) with <sup>1</sup>H NMR and MS results identical to <b>4a</b>. Optical rotation: [α]<sup>24</sup><sub>D</sub> = +102° (<i>c</i> 0.53, MeOH). HPLC purity: 99.2% at 270 nM.</div></div><div id="sec4_3_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-2-(Pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>34</b>)</h5><div class="NLM_p last">Prepared according to general method D, using <b>17a</b> (61 mg, 0.147 mmol) and (<i>E</i>)-3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridine (50 mg, 0.2 mmol) (58 mg, 0.176 mmol). EtOAc (50 mL) was added, and the solution was washed with water (2 × 5 mL), brine (5 mL) and dried over MgSO<sub>4</sub>. Purification by reverse phase prep-HPLC gave the title compound as a yellow solid (20 mg, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.21 (s, 1H), 10.64 (s, 1H), 8.86 (s, 1H), 8.45 (d, <i>J</i> = 3.2 Hz, 1H), 8.15 (d, <i>J</i> = 8.0 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.65 (d, <i>J</i> = 16.8 Hz, 1H), 7.49 (d, <i>J</i> = 16.8 Hz, 1H), 7.47 (s, 1H), 7.40 (dd, <i>J</i> = 8.0 Hz, 4.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.99 (d, <i>J</i> = 7.2 Hz, 1H), 6.86 (d, <i>J</i> = 7.6 Hz, 1H), 6.53 (t, <i>J</i> = 7.4 Hz, 1H), 6.01 (d, <i>J</i> = 7.6 Hz, 1H), 3.21 (t, <i>J</i> = 8.4 Hz, 1H), 2.32 (dd, <i>J</i> = 7.6 Hz, 4.8 Hz, 1H), 2.00 (dd, <i>J</i> = 9.0 Hz, 4.8 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O + H]<sup>+</sup>, 379.1; found, 379.1. HPLC purity; 95% at 270 nM.</div></div><div id="sec4_3_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> (1<i>R</i>,2<i>S</i>)-5′-Methoxy-2-(3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>35</b>)</h5><div class="NLM_p last">Prepared according to the general method D using <b>18a</b> (130 mg, 0.30 mmol) with (<i>E</i>)-1-methyl-4-(5-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridin-2-yl)piperazine (119 mg, 0.36 mmol). The reaction mixture was diluted with MeOH (12.5 mL) and filtered through a plug of silica (5 g), eluting with 2 M NH<sub>3</sub> in MeOH (100 mL). After removal of the solvents in vacuo, the title compound was purified by prep-HPLC to yield a yellow solid (104 mg, 34%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.26 (s, 1H), 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.92 (d, <i>J</i> = 9.2 Hz, 1H), 7.45 (s, 1H), 7.40 (d, <i>J</i> = 16.8 Hz, 1H), 7.28 (d, <i>J</i> = 16.8 Hz, 1H), 7.03 (d, <i>J</i> = 7.6 Hz, 1H), 6.87 (d, <i>J</i> = 9.2 Hz, 1H), 6.83 (d, <i>J</i> = 8.4 Hz, 1H), 6.61 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 5.58 (d, <i>J</i> = 2.0 Hz, 1H), 3.61 (m, 4H), 3.38 (m, 1H), 3.26 (s, 3H), 2.57 (m, 4H), 2.36 (s, 3H), 2.21 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>30</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup>, 507.2508; found, 507.2497. HPLC: 99.9% at 270 nM.</div></div><div id="sec4_3_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> (1<i>R</i>,2<i>S</i>)-1′-Methyl-2-(3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one bis(2,2,2-trifluoroacetate) (<b>36</b>)</h5><div class="NLM_p last">Prepared according to general method D, using <b>30</b> (61 mg, 0.147 mmol) and (<i>E</i>)-1-methyl-4-(5-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridin-2-yl)piperazine (58 mg, 0.176 mmol). Purification by prep-HPLC resulted in a pale-yellow solid, which was sonicated with Et<sub>2</sub>O and filtered to give the title compound (21 mg, 20%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.35 (s, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.2 Hz, 1H), 7.44–7.33 (m, 3H), 7.14 (t, <i>J</i> = 7.5 Hz, 1H), 7.06–6.99 (m, 3H), 6.63 (t, <i>J</i> = 6.7 Hz, 1H), 6.02 (d, <i>J</i> = 7.7 Hz, 1H), 4.60–4.30 (m, 4H), 3.60–3.08 (m, 4H), 3.47–3.33 (m, 4H), 2.97 (s, 3H), 2.28–2.25 (m, 1H), 2.21–2.18 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>30</sub>N<sub>6</sub>O + H]<sup>+</sup>, 491.2559; found, 491.2560. HPLC: 98.5% at 270 nM.</div></div><div id="sec4_3_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-(Piperazin-1-yl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>37</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> (40 mg, 0.1 mmol) and (<i>E</i>)-<i>tert</i>-butyl 4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)piperazine-1-carboxylate (50 mg, 0.12 mmol). The crude Boc-protected amine from the reaction was dissolved into CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and TFA (1 mL) was added. The reaction was stirred for 3 h, the solvent was removed and the residue purified by prep-HPLC to yield the title compound (23 mg, 40%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.97 (d, <i>J</i> = 8.1 Hz, 1H), 7.57 (d, <i>J</i> = 8.6 Hz, 2H), 7.47–7.42 (m, 2H), 7.30 (d, <i>J</i> = 17 Hz, 1H), 7.06–7.01 (m, 4H), 6.93 (d, <i>J</i> = 7.6 Hz, 1H), 6.58 (t, <i>J</i> = 7.6 Hz, 1H), 5.98 (d, <i>J</i> = 8.0 Hz, 1H), 3.49–3.44 (m, 4H), 3.40–3.31 (m, 5H), 2.26–2.22 (m, 1H), 2.19–2.16 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>27</sub>N<sub>5</sub>O + H]<sup>+</sup>, 462.2294; found, 462.2290. HPLC: 97.8% at 270 nM.</div></div><div id="sec4_3_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>38</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>18a</b> (251 mg, 0.58 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (191 mg, 0.67 mmol). The product was extracted using EtOAc (40 mL) with a Varian 3 mL ChemElut cartridge. After removal of the solvents in vacuo, the title compound was purified by chromatography on Biotage (silica, SNAP-25g, 5–20% MeOH in DCM). Trituration with 1:1 Et<sub>2</sub>O/DCM yielded the title compound (92 mg, 34%). HCl (1 M in Et<sub>2</sub>O, 0.25 mL, 0.25 mmol) was added in a dropwise manner to an ice cooled solution of the free base (92 mg, 0.20 mmol) in THF (10 mL), and the resulting mixture was allowed to stir in ice for 40 min, then Et<sub>2</sub>O (10 mL) was added to the mixture. Filtration under vacuum yielded the title compound as the hydrochloride salt (orange–red solid, 79 mg, 79%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 2H), 7.48–7.63 (m, 5H), 7.09 (d, <i>J</i> = 8.3 Hz, 1H), 6.84 (d, <i>J</i> = 8.5 Hz, 1H), 6.61 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 5.61 (d, <i>J</i> = 2.3 Hz, 1H), 4.36 (s, 2 H), 3.35 (m, 1H), 3.28 (s, 3H), 2.89 (s, 6H), 2.26 (dd, <i>J</i> = 7.7, 5.1 Hz, 1H), 2.18 (dd, <i>J</i> = 8.8, 4.8 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 465.2291; found, 465.2288. Optical rotation: [α]<sup>24</sup><sub>D</sub> = −70° (<i>c</i> 0.44, MeOH). HPLC: 99.8% at 270 nM.</div></div><div id="sec4_3_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>39</b>)</h5><div class="NLM_p last">Prepared according to the general method D using <b>30</b> (134 mg, 0.32 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (111 mg, 0.39 mmol). Purification by prep-HPLC resulted in a pale-yellow solid, which was triturated with Et<sub>2</sub>O and filtered to give the title compound (42 mg, 23%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 2H), 7.54–7.47 (m, 5H), 7.15 (t, <i>J</i> = 8.2 Hz, 1H), 7.03 (d, <i>J</i> = 7.8 Hz, 2H), 6.64 (t, <i>J</i> = 7.5 Hz, 1H), 6.02 (d, <i>J</i> = 7.0 Hz, 1H), 4.33 (s, 2H), 3.41–3.35 (m, 4H), 2.88 (s, 6H), 2.29–2.26 (m, 1H), 2.22–2.19 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O + H]<sup>+</sup>, 449.2341; found, 449.2336. Optical rotation: [α]<sup>22</sup><sub>D</sub> = −152° (<i>c</i> 0.42, MeOH). HPLC: 96.8% at 270 nM.</div></div><div id="sec4_3_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-(Pyrolidin-1-ylmethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>40</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E, using <b>17a</b> (600 mg, 1.5 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)pyrrolidine (460 mg, 1.5 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow solid (337 mg, 45%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.6 Hz, 1H), 7.76 (d, <i>J</i> = 8.6 Hz, 2H), 7.55–7.48 (m, 5H), 7.08–7.05 (m, 2H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.59 (t, <i>J</i> = 7.5 Hz, 1H), 5.99 (d, <i>J</i> = 7.5 Hz, 1H) 4.40 (s, 2H), 3.55–3.46 (m, 2H), 3.38–3.34 (m, 1H), 3.27–3.16 (m, 2H), 2.27–2.17 (m, 4H), 2.06–1.98 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>28</sub>N<sub>4</sub>O + H]<sup>+</sup>, 461.2341; found, 461.2336. Optical rotation: [α]<sup>24</sup><sub>D</sub> = −117° (<i>c</i> 0.52, MeOH). HPLC purity: 98.8% at 270 nM.</div></div><div id="sec4_3_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-(((<i>R</i>)-3-Fluoropyrrolidin-1-yl)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>41</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method D, using <b>17a</b> (630 mg, 1.57 mmol) and (3<i>R</i>)-3-fluoro-1-(4-((<i>E</i>)-2-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)vinyl)benzyl)pyrrolidine (622 mg, 1.88 mmol). The title product was obtained as a pale-yellow solid after prep-HPLC purification (338 mg, 48%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.98 (d, <i>J</i> = 8.3 Hz, 1H), 7.73 (d, <i>J</i> = 7.8 Hz, 2H), 7.55–7.45 (m, 5H), 7.06–7.00 (m, 2H), 6.93 (d, <i>J</i> = 7.7 Hz, 1H), 6.56 (t, <i>J</i> = 7.5 Hz, 1H), 5.97 (d, <i>J</i> = 7.5 Hz, 1H), 5.46 (d, <i>J</i> = 52.4 Hz, 1H), 4.46 (s, 2H), 3.73–3.31 (m, 5H), 2.65–2.44 (m, 2H), 2.26–2.15 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O + H]<sup>+</sup>, 479.2247; found, 479.2242. Optical rotation: [α]<sup>22</sup><sub>D</sub> = −125° (<i>c</i> 0.44, MeOH). HPLC: 99.2% at 270 nM.</div></div><div id="sec4_3_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-(Piperidin-1-ylmethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>42</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> (175 mg, 0.4 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)piperidine (225 mg, 0.67 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow TFA salt (140 mg, 60%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 7.77 (d, <i>J</i> = 8.6 Hz, 2H), 7.75–7.48 (m, 5H), 7.08–7.05 (m, 2H), 6.94 (d, <i>J</i> = 7.5 Hz, 1H), 6.59 (t, <i>J</i> = 7.7 Hz, 1H), 5.99 (d, <i>J</i> = 7.3 Hz, 1H) 4.31 (s, 2H), 3.53–3.45 (m, 2H), 3.39–3.34 (m, 1H), 3.04–2.93 (m, 2H) 2.27–2.17 (m, 2H), 2.02–1.95 (m, 2H), 1.88–1.71 (m, 3H), 1.57–1.45 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O + H]<sup>+</sup>, 475.2498; found, 475.2501. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −109° (<i>c</i> 0.35, MeOH). HPLC: 98.2% at 270 nM.</div></div><div id="sec4_3_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-5′-Methoxy-2-(3-(4-(piperidin-1-ylmethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>43</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>18a</b> (175 mg, 0.4 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)piperidine (225 mg, 0.67 mmol). Purification by reverse phase prep-HPLC gave a yellow powder (90 mg, 36%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.3 Hz, 1H), 7.75 (d, <i>J</i> = 8.6 Hz, 2H), 7.53–7.49 (m, 5H), 7.05 (d, <i>J</i> = 8.5 Hz, 1H), 6.84 (d, <i>J</i> = 8.5 Hz, 1H), 6.61 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 5.58 (d, <i>J</i> = 2.3 Hz, 1H), 4.30 (s, 2H), 3.52–3.44 (m, 2H), 3.38–3.34 (m, 1H), 3.26 (s, 3H), 3.01–2.93 (m, 2H), 2.26–2.17 (m, 4H), 2.00–1.91 (m, 2H), 1.89–1.67 (m, 3H), 1.58–1.46 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 505.2604; found, 505.2602. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −69° (<i>c</i> 0.29, MeOH). HPLC: 99.9% at 270 nM.</div></div><div id="sec4_3_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-(Morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>44</b>)</h5><div class="NLM_p last">The title compound prepared according to the general method E, using iodide <b>17a</b> (2.5 g, 6.3 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (2.5 g, 7.5 mmol). Purification by Biotage silica gel chromatography (gradient 0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) gave the free base, which was dissolved into THF (50 mL) and treated with 1 M HCl in ether (6 mL) and diluted with diethyl ether (200 mL). The resulting precipitate was collected by filtration to give the title compound as a yellow solid (2.6 g, 79%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (d, <i>J</i> = 8.3 Hz, 1H), 7.78 (d, <i>J</i> = 7.5 Hz, 2H), 7.49–7.61 (m, 5H), 7.05 (t, <i>J</i> = 8.3 Hz, 2H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 6.58 (t, <i>J</i> = 7.4 Hz, 1H), 5.99 (d, <i>J</i> = 7.0 Hz, 1H), 4.40 (s, 2H), 4.08–4.05 (m, 2H), 3.80–3.74 (m, 2H), 3.43–3.36 (m, 3H), 3.27–3.21 (m, 2H), 2.26–2.18 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 477.2291; found, 477.2284. Optical rotation [α]<sup>24</sup><sub>D</sub> = −79° (<i>c</i> 0.33, MeOH). HPLC: 95.1% at 270 nM.</div></div><div id="sec4_3_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-5′-Methyl-2-(3-(4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>45</b>)</h5><div class="NLM_p last">Prepared according to the general method E using <b>32</b> (415 mg, 1 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (329 mg, 1 mmol). Purification by prep-HPLC gave title compound as a yellow solid (470 mg, 78%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (d, <i>J</i> = 8.0 Hz, 2H), 7.44 (d, <i>J</i> = 8.0 Hz, 2H), 7.38 (s, 1H), 7.32 (d, <i>J</i> = 16.8 Hz, 1H), 7.27 (d, <i>J</i> = 16.8 Hz, 1H), 6.82 (d, <i>J</i> = 8.4 Hz, 1H), 6.77 (d, <i>J</i> = 8.0 Hz, 1H), 6.73 (d, <i>J</i> = 8.0 Hz, 1H), 5.78 (s, 1H), 4.29 (s, 2H), 3.99 (d, <i>J</i> = 11.2 Hz, 2H), 3.75 (t, <i>J</i> = 11.6 Hz, 2H), 3.42–3.32 (m, 2H), 3.21 (t, <i>J</i> = 8.4 Hz, 1H), 3.18–3.08 (m, 2H), 2.09–2.01 (m, 2H), 1.72 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 491.2447; found, 491.2445. Optical rotation [α]<sup>23</sup><sub>D</sub> = −89° (<i>c</i> 0.28, MeOH). HPLC: 99.5% at 270 nM.</div></div><div id="sec4_3_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-5′-Methoxy-1′-methyl-2-(3-(4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro-[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>46</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method D using <b>31</b> (5 g, 11.2 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (4.8 g, 14.6 mmol). Purification by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5 to 92:8) gave the free base as a yellow solid, which was dissolved into THF (100 mL) and treated with (11.2 mL of a 1 M solution in Et<sub>2</sub>O) which gave after drying, the title product as a pale-yellow solid (3.9 g, 67%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.6 Hz, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 2H), 7.56–7.49 (m, 5H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.92 (d, <i>J</i> = 7.8 Hz, 1H), 6.69 (d, <i>J</i> = 8.6 Hz, 1H), 5.63 (s, 1H), 4.39 (s, 2H), 4.08–4.05 (m, 2H), 3.77–3.71 (m, 2H), 3.35–3.23 (m, 11H), 2.27–2.25 (m, 1H), 2.22–2.19 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 521.2553; found, 521.2551. Optical rotation: [α]<sup>22</sup><sub>D</sub> = −85° (<i>c</i> 0.59, MeOH). HPLC: 97.0% at 270 nM. Anal. (C<sub>32</sub>H<sub>36</sub>ClN<sub>4</sub>O<sub>3</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-<i>cis</i>-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>47</b>)</h5><div class="NLM_p last">Prepared according to the general method E using <b>17a</b> (8 g, 20 mmol) and <i>cis</i>-2,6-dimethyl-4-(4-((<i>E</i>)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (8.4 g, 24 mmol). The residue was purified by Biotage silica gel chromatography using a gradient of 0–10% methanol in DCM. The free base was dissolved in THF (100 mL) and treated with 1 M HCl in ether (12 mL). Diethyl ether (200 mL) was added, and the precipitate was collected by filtration to give a yellow solid (5.6 g, 52%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (d, <i>J</i> = 8.3 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.49–7.64 (m, 5H), 7.00–7.10 (m, 2H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.58 (t, <i>J</i> = 7.5 Hz, 1H), 5.99 (d, <i>J</i> = 7.5 Hz, 1H), 4.37 (s, 2H), 3.81–3.95 (m, 2H), 3.34–3.41 (m, 3H), 2.79 (t, <i>J</i> = 11.8 Hz, 2H), 2.14–2.29 (m, 2H), 1.24 (d, <i>J</i> = 6.3 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 505.2604; found, 505.2601. Optical rotation [α]<sup>23</sup><sub>D</sub> = −134° (<i>c</i> 0.27, MeOH). HPLC: 99.9% at 270 nM. Anal. (C<sub>32</sub>H<sub>33</sub>ClN<sub>4</sub>O<sub>2</sub>·2.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-<i>cis</i>-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one Fumarate (<b>48</b>)</h5><div class="NLM_p last">To a solution of <b>18a</b> (20 g, 46 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (18.2 g, 51 mmol) in dioxane (400 mL) and water (80 mL) was added Na<sub>2</sub>CO<sub>3</sub> (9.8 g, 92.8 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (1.61 g, 1.39 mmol). The mixture was heated to 85 °C for 24 h, cooled to rt, and diluted with water (320 mL). The mixture was concentrated to a volume of 450 mL and EtOAc (320 mL) was added and the organic layer was separated and washed with water (80 mL). The solution was concentrated and redissolved into EtOAc (300 mL) and treated with charcoal (3 g) at 40 °C for 1 h. The charcoal was filtered off and TMT (2.8 g) was added and the mixture stirred at 40 °C for 16 h. The TMT was filtered off, and the organic phase was washed with 0.5 N aq NaOH (3 × 120 mL) and brine (120 mL). The solvents were removed in vacuo, and the resulting residue was recrystallized from methyl acetate (65 mL) to give the free base as a white solid (11.2 g, 48%). The free base (9.0 g, 16.8 mmol) was dissolved into acetone (36 mL) and heated to 50 °C. In a separate flask, fumaric acid (1.94 g, 16.8 mmol) was dissolved into acetone (120 mL), heated to 50 °C, and added to the free base solution. The solution was concentrated to a volume of 50 mL, and MTBE was added (25 mL). The solution was cooled to rt and stirred 24 h. The filtrate was collected and dried under high vacuum at 70 °C to give the title compound as a white crystalline solid (10.1 g, 92%, 99.9% ee). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 7.50–7.45 (m, 5H), 7.03 (d, <i>J</i> = 8.1 Hz, 1H), 6.83 (d, <i>J</i> = 8.4 Hz, 1H), 6.73 (s, 2H), 6.60 (dd, <i>J</i> = 8.4, 2.5 Hz, 1H), 5.58 (s, 1H), 4.00 (s, 2H), 3.82–3.78 (m, 2H), 3.36 (t, <i>J</i> = 8.4 Hz, 1H), 3.26 (s, 3H), 3.13–3.10 (m, 2H), 2.34 (t, <i>J</i> = 11.4 Hz, 2H), 2.25–2.16 (m, 2H), 1.01 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>34</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 535.2709; found, 535.2712. Optical rotation [α]<sup>20</sup><sub>D</sub> = −97° (<i>c</i> 0.5, MeOH). HPLC: 99.7% at 270 nm. Anal. (C<sub>37</sub>H<sub>38</sub>N<sub>4</sub>O<sub>7</sub>) C, H, N.</div></div><div id="sec4_3_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-(4-<i>cis</i>-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxy-1′-methylspiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>49</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E, using <b>31</b> (100 mg, 0.23 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (100 mg, 0.26 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow solid (72 mg, 49%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 2H), 7.52 (d, <i>J</i> = 7.8 Hz, 2H), 7.49–7.45 (m, 3H), 6.95 (d, <i>J</i> = 8.5 Hz, 1H), 6.89 (d, <i>J</i> = 8.5 Hz, 1H), 6.66 (d, <i>J</i> = 8.5 Hz, 1H), 5.62 (s, 1H), 4.35 (s, 2H), 3.90–3.82 (s, 2H), 3.34–3.43 (m, 2H), 3.30 (s, 3H), 3.26 (s, 3H), 2.76 (t, <i>J</i> = 11.5 Hz, 2H), 2.13–2.28 (m, 2H), 1.23 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>34</sub>H<sub>36</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 549.2866; found, 549.2855. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −69° (<i>c</i> 0.41, MeOH). HPLC: 98.2% at 270 nM.</div></div><div id="sec4_3_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(3-(Morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>50</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> (160 mg, 0.4 mmol) and (<i>E</i>)-4-(3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (184 mg, 0.56 mmol). Purification by prep-HPLC gave the title compound as a yellow solid (158 mg, 67%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.88 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (s, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.50–7.38 (m, 5H), 6.98 (t, <i>J</i> = 7.8 Hz, 1H), 6.91 (d, <i>J</i> = 8.0 Hz, 2H), 6.48 (t, <i>J</i> = 7.6 Hz, 1H), 5.92 (d, <i>J</i> = 7.2 Hz, 1H), 4.36 (s, 2H), 4.03 (d, <i>J</i> = 11.6 Hz, 2H), 3.76 (t, <i>J</i> = 12.0 Hz, 2H), 3.45–3.14 (m, 5H), 2.17–2.08 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 477.2291; found, 477.2284. Optical rotation [α]<sup>23</sup><sub>D</sub> = −144° (<i>c</i> 0.34, MeOH). HPLC: 97.7% at 270 nM.</div></div><div id="sec4_3_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-3-((<i>cis</i>-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>51</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> and (<i>cis</i>)-2,6-dimethyl-4-(3-((<i>E</i>)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (105 mg, 0.3 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow TFA salt (65 mg, 41%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.95 (d, <i>J</i> = 8.5 Hz, 1H), 7.67–7.81 (m, 2H), 7.36–7.57 (m, 5H), 6.88–7.08 (m, 3H), 6.53 (t, <i>J</i> = 7.6 Hz, 1H), 5.96 (d, <i>J</i> = 7.5 Hz, 1H), 4.37 (s, 2H), 3.87 (s, 2H), 3.34–3.45 (m, 3H), 2.81–2.75 (m, 2H), 2.05–2.26 (m, 2H), 1.22 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 505.2604; found, 505.2600. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −128° (<i>c</i> 0.5, MeOH). HPLC: 99.5% at 270 nM.</div></div><div id="sec4_3_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-((<i>S</i>)-1-Morpholinoethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>52</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method D, using <b>17a</b> (244 mg, 0.61 mmol) and 4-((1<i>S</i>)-1-(4-((<i>E</i>)-2-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)vinyl)phenyl)ethyl)morpholine (230 mg, 0.67 mmol). Silica gel purification (94:6 to 95:5, CH<sub>2</sub>Cl<sub>2</sub>/MeOH) gave 105 mg, 35% of the free base which was dissolved into THF (10 mL) and treated with HCl (0.5 mL of a 1 M solution in Et<sub>2</sub>O), and the resulting precipitate was filtered and washed with Et<sub>2</sub>O to give the title compound as an off-white powder (87 mg, 29%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.56–7.47 (m, 5H), 7.07–7.03 (m, 2H), 6.93 (d, <i>J</i> = 7.5 Hz, 1H), 6.57 (t, <i>J</i> = 7.6 Hz, 1H), 5.98 (d, <i>J</i> = 7.7 Hz, 1H), 4.50 (q, <i>J</i> = 6.9 Hz, 1H), 4.12–4.09 (m, 1H), 4.00–3.96 (m, 1H), 3.87–3.81 (m, 1H), 3.73–3.67 (m, 2H), 3.35 (t, <i>J</i> = 8.2 Hz, 1H), 3.20–3.03 (m, 3H), 2.26–2.22 (m, 1H), 2.20–2.17 (m, 1H), 1.79 (d, <i>J</i> = 6.9 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 491.2447; found, 491.2446. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −183° (<i>c</i> 0.58, MeOH). HPLC: 99.1% at 270 nM.</div></div><div id="sec4_3_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-ylmethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one Hydrochloride (<b>53</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method D using <b>17a</b> (250 mg, 0.62 mmol) and (<i>E</i>)-3-(4-(2-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)vinyl)benzyl)-8-oxa-3-azabicyclo[3.2.1]octane (332 mg, 0.93 mmol). Silica gel purification (96:4 to 95:5, CH<sub>2</sub>Cl<sub>2</sub>/MeOH) gave a crude material which was triturated with 4:1 hexanes/EtOAc to give 110 mg of the free base which was then dissolved into THF (2 mL) and treated with HCl (0.3 mL, 1 M in Et<sub>2</sub>O), and the resulting precipitate was filtered and washed with Et<sub>2</sub>O to give the title compound as an off-white powder (97 mg, 31%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.01 (d, <i>J</i> = 8.7 Hz, 1H), 7.76 (d, <i>J</i> = 8.2 Hz, 2H), 7.58–7.48 (m, 5H), 7.07–7.03 (m, 2H), 6.93 (d, <i>J</i> = 7.8 Hz, 1H), 6.58 (t, <i>J</i> = 7.5 H, 1H), 5.98 (d, <i>J</i> = 7.5 Hz, 1H), 4.53 (bs, 2H), 4.35 (s, 2H), 3.36 (t, <i>J</i> = 8.8 Hz, 1H), 3.30–3.25 (m, 4H), 2.26–2.23 (m, 1H), 2.20–2.17 (m, 1H), 2.14–1.87 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 503.2447; found, 503.2443. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −174° (<i>c</i> 0.54, MeOH). HPLC: 99.6% at 270 nM.</div></div><div id="sec4_3_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-((1,4-Oxazepan-4-yl)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate Salt (<b>54</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E, using <b>17a</b> (100 mg, 0.25 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)-1,4-oxazepane (103 mg, 0.30 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow powder (38 mg, 26%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 9.0 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.61–7.53 (m, 4H), 7.48 (s, 1H), 7.08–7.04 (m, 2H), 6.94 (d, <i>J</i> = 7.5 Hz, 1H), 6.60–6.56 (m, 1H), 5.99 (d, <i>J</i> = 7.8 Hz, 1H), 4.45 (s, 2H), 4.02–3.80 (m, 4H), 3.65–3.60 (m, 1H), 3.57–3.35 (m, 4H), 2.29–2.12 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 491.2447; found, 491.2440. Optical rotation [α]<sup>23</sup><sub>D</sub> = −146° (<i>c</i> 0.39, MeOH). HPLC: 95.1% at 270 nM.</div></div><div id="sec4_3_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(((3<i>S</i>,5<i>R</i>)-3,4,5-Trimethylpiperazin-1-yl)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>55</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> (600 mg, 1.5 mmol) and (2<i>S</i>,6<i>R</i>)-1,2,6-trimethyl-4-(4-((<i>E</i>)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)piperazine (618 mg, 1.8 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow powder (296 mg, 31%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.97 (d, <i>J</i> = 8.5 Hz, 1H), 7.67 (d, <i>J</i> = 7.8 Hz, 2H), 7.51–7.41 (m, 5H), 7.08–6.98 (m, 2H), 6.94 (d, <i>J</i> = 8.0 Hz, 1H), 6.56 (t, <i>J</i> = 7.5 Hz, 1H), 5.98 (d, <i>J</i> = 7.3 Hz, 1H), 4.00 (s, 2H), 3.62–3.57 (m, 2H), 3.41–3.33 (m, 3H), 2.92 (s, 3H), 2.79 (t, <i>J</i> = 12.3 Hz, 2H), 2.26–2.12 (m, 2H), 1.41 (d, <i>J</i> = 6.3 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>35</sub>N<sub>5</sub>O + H]<sup>+</sup>, 518.2920; found, 518.2920. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −113° (<i>c</i> 0.37, MeOH). HPLC: 96.3% at 270 nM.</div></div><div id="sec4_3_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> (1<i>R</i>,2<i>S</i>)-5′-Methoxy-2-(3-((<i>E</i>)-4-(((2<i>R</i>,6<i>S</i>)-2,4,6-trimethylpiperazin-1-yl)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>56</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>18a</b> (60 mg, 0.14 mmol) and (2<i>R</i>,6<i>S</i>)-2,4,6-trimethyl-1-(4-((<i>E</i>)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)-benzyl)piperazine (60 mg, 0.16 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow powder (35 mg, 46%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.00 (d, <i>J</i> = 8.5 Hz, 1H), 7.58–7.67 (m, <i>J</i> = 8.0 Hz, 2H), 7.44–7.50 (m, 3H), 7.36–7.44 (m, 2H), 7.03 (d, <i>J</i> = 7.5 Hz, 1H), 6.83 (d, <i>J</i> = 8.5 Hz, 1H), 6.61 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 5.59 (d, <i>J</i> = 2.5 Hz, 1H), 3.75 (s, 2H), 3.44 (bs, 2H), 3.36 (t, <i>J</i> = 8.5 Hz, 1H), 3.26 (s, 3H), 3.17–3.14 (m, 2H), 2.90 (s, 3H), 2.46–2.40 (m, 2H), 2.28–2.14 (m, 2H), 1.37 (d, <i>J</i> = 6.5 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>34</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 548.3026; found, 548.3021. HPLC: 99.2% at 270 nM.</div></div><div id="sec4_3_2_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> (1<i>R</i>,2<i>S</i>)-(<i>E</i>)-2-(3-(4-(1-Methylpiperidin-4-yloxy)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate Salt (<b>57</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> (100 mg, 0.25 mmol) and (<i>E</i>)-1-methyl-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenoxy)piperidine (105 mg, 0.3 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow powder (35 mg, 25%). <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.99–7.97 (m, 1H), 7.63–7.56 (m, 2H), 7.50–7.42 (m, 2H), 7.36–7.28 (m, 1H), 7.10–7.01 (m, 4H), 6.97–6.91 (m, 1H), 6.59 (t, <i>J</i> = 7.7 Hz, 1H), 5.99 (d, <i>J</i> = 7.8 Hz, 1H), 4.84–4.79 (m, 0.5H), 4.65–4.60 (m, 0.5H), 3.65–3.62 (m, 1H), 3.47–3.34 (m, 2H), 3.25–3.13 (m, 1H), 2.94 (s, 3H), 2.44–2.40 (m, 1H), 2.32–2.01 (m, 5H), 1.96–1.81 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 491.2447; found, 491.2446. Optical rotation [α]<sup>22</sup><sub>D</sub> = −154° (<i>c</i> 0.43, MeOH). HPLC: 98.9% at 270 nM.</div></div><div id="sec4_3_2_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-((1-Isopropylpiperidin-4-yl)oxy)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one 2,2,2-trifluoroacetate (<b>58</b>)</h5><div class="NLM_p last">The title compound was synthesized according to the general method E using <b>17a</b> (100 mg, 0.25 mmol) and ((<i>E</i>)-1-isopropyl-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenoxy)piperidine (111 mg, 0.3 mmol). Purification by reverse phase prep-HPLC gave the title compound as a yellow powder (73 mg, 49%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.98 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.64 (m, 2H), 7.42–7.50 (m, 2H), 7.27–7.36 (m, 1H), 6.98–7.09 (m, 4H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.58 (t, <i>J</i> = 7.4 Hz, 1H), 5.99 (d, <i>J</i> = 7.3 Hz, 1H), 4.83 (bs, 1H), 3.60–3.54 (m, 2H), 3.41–3.35 (m, 2H), 3.29–3.17 (m, 1H), 2.47–2.43 (m, 1H), 2.37–2.10 (m, 5H), 1.94–1.88 (m, 1H), 1.33–1.44 (m, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 519.2760; found, 519.2758. Optical rotation: [α]<sup>23</sup><sub>D</sub> = −127° (<i>c</i> 0.48, MeOH). HPLC: 95.6% at 270 nM.</div></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Biochemical Assays</h3><div class="NLM_p">Active PLK4 was purified and used to measure PLK4 activity, using an indirect ELISA detection system, as previously described.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> PLK1, PLK2, PLK3, AURKA, and AUKB/INCENP compound inhibition were determined using FRET-based homogeneous assay kits from Invitrogen (Burlington, Ontario, Canada). Recombinant kinase enzymes were purchased from Invitrogen, with the exception of AURKB/INCENP, which was purchased from Millipore (Billerica, MA). The assays were performed according to the manufacturer’s specifications with ATP concentrations of 25, 60, and 80 μM, respectively, for PLK1, PLK2, and PLK3 and ATP concentrations of 20 and 128 μM, respectively, for AURKA and AURKB/INCENP.</div><div class="NLM_p">Compound inhibition was determined at either a fixed concentration (10 μM) or at a variable inhibitor concentration (typically 50–0.1 μM in a 10-point dose response titration). Compounds were mixed with enzyme prior to addition of ATP and the activity remaining quantified using the above-described activity assay. The % inhibition of a compound was determined using the following formula; % inhibition = 100(1 – (experimental value – background value)/(high activity control – background value)). The IC<sub>50</sub> value was determined using a nonlinear four-parameter logistic curve fit (XLfit4, IDBS, Guildford, Surrey, UK) with the formula: (<i>A</i> + (<i>B</i>/(1 + ((<i>x</i>/<i>C</i>)<sup><i>D</i></sup>))), where <i>A</i> = background value, <i>B</i> = range, <i>C</i> = inflection point, <i>D</i> = curve fit parameter. Unless otherwise designated, the kinase IC<sub>50</sub> values given in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> are the results of a single determination. For values determined by averaging three replicates, the standard deviation is given in the PLK4 IC<sub>50</sub> column.</div><div class="NLM_p">The apparent <i>K</i><sub>i</sub>s for compounds <b>46</b>, <b>47</b>, and <b>48</b> against PLK4 were estimated to be 0.10, 0.73, and 0.26 nM, respectively, by varying the ATP concentration in a series of PLK4 inhibition experiments at 0, 2.0, and 10 μM and applying nonlinear regression analysis (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">The selectivity of inhibitors <b>46</b>, <b>47</b>, and <b>48</b> against 274 protein kinases was assessed by Millipore (Dundee, Scotland) using a radiometric assay. Inhibition was determined at 0.1 μM inhibitor concentration with ATP at <i>K</i><sub>m</sub>; % inhibition was determined as stated in the preceding paragraph (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). For compound <b>48</b>, the inhibition constants (IC<sub>50</sub>s) were determined against selected kinases: TIE2, TRKA, and TRKB.</div><div class="NLM_p">Fluorogenic cytochrome P450 inhibition studies were conducted at 37 °C in 96-well plates, as previously described,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> for CYP 1A2, CYP 2D6, CYP 2C9, CYP 2C19, and CYP 3A4 (BFC and DBF substrates).</div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Cell Viability Assay (GI<sub>50</sub>)</h4><div class="NLM_p">MDA-MB-468, MCF-7, HCC1954, MDA-MB-231, SKBr-3, Cal-51, and BT-20 breast cancer cells were seeded into 96-well plates at 3000, 4000, 4000, 2500, 4000, 3000, and 6000 cells per 80 μL, respectively, 24 h before compound overlay and cultured at 37 °C and 5% CO<sub>2</sub>. Compounds were prepared as 10 mM stocks in 100% DMSO. Each 10 mM stock was diluted with DMEM (Dulbecco’s Modified Eagle’s Medium) cell growth medium (Invitrogen, Burlington, ON, Canada) containing 10% FBS (fetal bovine serum) such that the final concentrations ranged from 50 nM to 250 μM. Aliquots (20 μL) from each concentration were overlaid to 80 μL of preseeded cells to achieve final concentrations of 10 nM to 50 μM. After 5 d, the cells were fixed in situ by gently removing the culture media and adding 50 μL of ice-cold 10% trichloroacetic acid (TCA) per well and incubation at 4 °C for 30 min. The plates were washed with water five times and allowed to air-dry for 5 min. Then 50 μL of 0.4% (w/v) sulforhodamine B (SRB) (Sigma, Oakville, ON, Canada) solution in 1% (v/v) acetic acid was added to each well, followed by incubation for 30 min at rt. The plates were washed four times with 1% acetic acid to remove unbound SRB and air-dried for 5 min. The SRB was solubilized with 100 μL of 10 mM Tris pH 10.5 per well, and absorbance was read at 570 nm using a SpectraPlus microplate reader (Molecular Devices Corporation). The percentage (%) of relative inhibition of cell viability was calculated by comparing to DMSO treated only cells with the maximal response pegged at 100%. GI<sub>50</sub>s (concentrations required to inhibit growth by 50%) were calculated using GraphPad PRISM software (GraphPad Software, Inc., San Diego, CA, USA).</div><div class="NLM_p last">In a similar manner, lung (A549), ovarian (OVCAR-3), and colon (SW620, Colo-205, and HCT116+/+) cancer cell lines were seeded at 1500, 6000, 1500, 3000, and 800 cells, respectively, overlaid with compounds <b>45</b>, <b>46</b>, and <b>48</b>, incubated (5 d), fixed, and read using the SRB assay.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Microsomal Stability Assay</h4><div class="NLM_p last">Microsomal half-life (<i>T</i><sub>1/2</sub>) for selected compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) was determined with human (h), dog (d), rat (r), and mouse (m) liver microsomes as previously described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Curve fitting was used to determine <i>k</i> (first-order rate constant) using an exponential fit; the half-life was calculated as microsomal <i>T</i><sub>1/2</sub> = ln(2)/<i>k</i>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Mouse Plasma Levels</h4><div class="NLM_p last">Adult female athymic CD1 nude mice (Charles River) were used in the experiments; all animal experiments were approved by UHN Animal Care Committee. Dosing solutions were prepared by dissolving the compound in 30% PEG400/70% deionized water such that the dose volume was 10 mL/kg of animal body weight. In some instances, brief sonication or vortexing and/or gentle warming was required to ensure dissolution and/or dispersion. Nine mice were dosed with compounds at 10 mg/kg (free base equivalents) via oral gavage by standard methods. Saphenous vein blood was collected from three mice per time point over an 8 h period. The plasma samples were analyzed for drug and internal standard via LCMS/MS protocol using a Waters (Millford, MA, USA) UPLC coupled to either a Q-ToF Premier, or a XevoTQ mass spectrometer. The pharmacokinetic parameters were calculated using Microsoft Excel with pharmacokinetic add-in functions from Usansky et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Parameters were calculated using plasma concentration time data for composite averages.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Xenograft Models</h4><div class="NLM_p">MDA-MB-468 breast cancer cells (Basal, HER-2 negative), A549 lung cancer cells, and SW620 colon cancer cells were purchased from ATCC (American Type Culture Collections) and cultured in DMEM (Dulbecco’s Modified Eagle Medium, purchased from GIBCO) supplemented with 10% fetal calf serum. Five million MDA-MB468, 5 million A549, and 3 million SW620 were injected subcutaneously into the right flank of 6–8 week old female CB-17 SCID mice supplied by Charles River. When the tumor volume reached 80–120 mm<sup>3</sup>, mice were randomized into groups (<i>n</i> = 8) and received either vehicle or compound at the doses indicated. Compounds <b>46</b>, <b>47</b>, and <b>48</b> were weighed and dissolved in 30% PEG 400/70% water. The compound was dispensed in aliquots and stored at −20 C for duration of the study, and each aliquot was thawed at rt before each dose. The mice were dosed via oral gavage daily for 21 d. Tumor volume and body weight were measured at least three times weekly. Efficacy data were graphically represented as the mean tumor volume. Tumor volume was calculated by the following formula: <i>x</i><sup>2</sup><i>y</i>/2. Percent tumor growth inhibition after initiation of treatment with compound was calculated by TGI = 100 × 1 – (tumor volume<sub>final</sub> – tumor volume<sub>initial</sub> for compound treated group)/(tumor volume<sub>final</sub> – tumor volume<sub>initial</sub> for compound control group).</div><div class="NLM_p last">HCT116 colon cancer cells were purchased, cultured, and injected (1 million HCT116 cancer cells) into the right flank of 6–8 week old female athymic CD1 nude mice (Charles River) as described above. Upon reaching a tumor volume of 80–120 mm<sup>3</sup>, mice were randomized into groups (<i>n</i> = 8) and received either vehicle or weighed compounds <b>46</b>, <b>47</b>, and <b>48</b> dissolved in 30% PEG 400/70% water as described above. The mice were dosed via oral gavage on days 1, 5, 9, 13, 17, and 21 and sacrificed on day 35. Tumor volume, body weight, and percent growth inhibition were determined as described above.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Rat and Dog Pharmacokinetic Studies</h4><div class="NLM_p">The pharmacokinetic studies were performed by Shanghai Chempartner, 720 Cailun Road, Pudong New Area, Shanghai, China. Compounds were dissolved in 10% NMP/40% PEG/50% water. Male SD rats (200–230 g, purchased from SLAC Laboratory Animal Co. LTD) were administered IV (foot dorsal vein) and PO (oral gavage); blood samples were collected via cannulated jugular veins and stored frozen until analysis.</div><div class="NLM_p">Seven male beagle dogs (6.5–9 kg), were purchased from Suzhou Xishan Zhongke laboratory animal breeding center and with Qualification no. SCXK 2007-0005, 0014369. The IV dose (3 dogs) was conducted via cephalic vein injection, PO (3 dosage), via intragastric administration. Approximately 0.5 mL blood/time point was collected from cephalic or saphenous veins into precold EDTA tubes. Blood samples were put on wet ice and centrifuged at 4 °C to obtain plasma within 30 min of sample collection and stored frozen until analysis. One animal, not placed on study, was used for collection of blank blood (5–10 mL). The resulting blank plasma was used for the development of the bioanalytical method and standard curve.</div><div class="NLM_p last">Diluted time point samples were analyzed by LCMSMS-02 (API 4000, triple quadrupole) using a standard curve. The PK parameters were determined by a noncompartmental model using WinNonlin Professional 5.2.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94"><a href="/doi/suppl/10.1021/jm5005336">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Double reciprocal plot of PLK4 inhibition by compound <b>48</b>; synthesis of compound intermediates; atomic coordinates, bond lengths and angles, and anisotropic displacement parameters for an X-ray structure of compound <b>33</b>; inhibition data for the shortlisted compounds (<b>46</b>, <b>47</b>, and <b>48</b>) at 0.1 μM against a 274 member kinase panel.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5005336/suppl_file/jm5005336_si_001.pdf">jm5005336_si_001.pdf (838.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5005336" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry W. Pauls</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8fe7ffeefae3fccffae7e1fdeafceaeefdece7a1ecee"><span class="__cf_email__" data-cfemail="dbb3abbaaeb7a89baeb3b5a9bea8bebaa9b8b3f5b8ba">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter B. Sampson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Liu</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan Forrest</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham Cumming</span> - <span class="hlFld-Affiliation affiliation">Celtic Catalysts, 1-03 Nova Centre, Belfield, Dublin 4, Ireland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sze-Wan Li</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narendra Kumar Patel</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Edwards</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Radoslaw Laufer</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miklos Feher</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fuqiang Ban</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald E. Awrey</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guodong Mao</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Plotnikova</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Hodgson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Beletskaya</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline M. Mason</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xunyi Luo</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Nadeem</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wei</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reza Kiarash</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Madeira</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Huang</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tak W. Mak</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guohua Pan</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Institute for Breast Cancer Research, University
Health Network, TMDT
East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d5409e8286-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Homer Pearce for helpful discussion during the course of the work and Dr. Alan Lough, X-ray Crystallography, University of Toronto, for X-ray data collection and structure refinement. The Princess Margaret Cancer Foundation, the Canadian Institute of Health Research, and the Canadian Foundation for Innovation are acknowledged for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i97" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i97"> Abbreviations Used</h2><tr><td class="NLM_term">aq</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">anhyd</td><td class="NLM_def"><p class="first last">anhydrous</p></td></tr><tr><td class="NLM_term">Ar</td><td class="NLM_def"><p class="first last">argon</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">b</td><td class="NLM_def"><p class="first last">broad</p></td></tr><tr><td class="NLM_term">calcd</td><td class="NLM_def"><p class="first last">calculated</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicycloundec-7-ene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethyl-aminopyridine</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino) ferrocene</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">FMS-related tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal cell growth inhibitory concentration</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple-bond correlation spectroscopy</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography coupled to mass spectrometry</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">myelin basic protein</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term">MS ESI</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PCR polymerase chain reaction</td><td class="NLM_def"></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">poly(ethylene glycol) 400</p></td></tr><tr><td class="NLM_term">pin</td><td class="NLM_def"><p class="first last">pinacol</p></td></tr><tr><td class="NLM_term">PMB</td><td class="NLM_def"><p class="first last"><i>p</i>-methoxybenzyl</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">prep</td><td class="NLM_def"><p class="first last">preparative</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">RBF</td><td class="NLM_def"><p class="first last">round-bottomed flask</p></td></tr><tr><td class="NLM_term">RNAi</td><td class="NLM_def"><p class="first last">RNA interference</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">satd</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxy]methyl</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SMs</td><td class="NLM_def"><p class="first last">starting materials</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">TBAB</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium bromide</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">temp</td><td class="NLM_def"><p class="first last">temperature</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TMT</td><td class="NLM_def"><p class="first last">2,4,6-trimercaptotriazine</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultra performance liquid chromatography</p></td></tr><tr><td class="NLM_term">UHN IACUC</td><td class="NLM_def"><p class="first last">University Health Network Institutional Animal Care and Use Committee</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silljé, H. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell division</span> <span class="citation_source-journal">Nature Rev. Mod. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H.+W.+Sillj%C3%A9author=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0lhr71RR_HdV_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillj%25C3%25A9%26aufirst%3DH.%2BH.%2BW.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520division%26jtitle%3DNature%2520Rev.%2520Mod.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Archambault, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">Polo-like kinases: conservation and divergence in their functions and regulation</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fnrm2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=19305416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=265-275&author=V.+Archambaultauthor=D.+M.+Glover&title=Polo-like+kinases%3A+conservation+and+divergence+in+their+functions+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: conservation and divergence in their functions and regulation</span></div><div class="casAuthors">Archambault, Vincent; Glover, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are potent regulators of M-phase that are conserved from yeasts to humans.  Their roles in mitotic entry, spindle pole functions, and cytokinesis are broadly conserved despite phys. and mol. differences in these processes in disparate organisms.  Plks are characterized by their Polo-box domain, which mediates protein interactions.  They are addnl. controlled by phosphorylation, proteolysis, and transcription, depending on the biol. context.  Plks are now recognized to link cell division to developmental processes and to function in differentiated cells.  A comparison of Plk function and regulation between organisms offers insight into the rich variations of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIkNbJzhkm7Vg90H21EOLACvtfcHk0ljiqVThHnhQEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D&md5=6f9339e80588d04f5f156f1900718193</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2653%26sid%3Dliteratum%253Aachs%26aulast%3DArchambault%26aufirst%3DV.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DPolo-like%2520kinases%253A%2520conservation%2520and%2520divergence%2520in%2520their%2520functions%2520and%2520regulation%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schoffski, P.</span><span> </span><span class="NLM_article-title">Polo-like kinase inhibitors in preclinical and early clinical development</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffski&title=Polo-like+kinase+inhibitors+in+preclinical+and+early+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffski%26aufirst%3DP.%26atitle%3DPolo-like%2520kinase%2520inhibitors%2520in%2520preclinical%2520and%2520early%2520clinical%2520development%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sillibourne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornens, M.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4: the odd one out of the family</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1186%2F1747-1028-5-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=20920249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-34&author=J.+E.+Sillibourneauthor=M.+Bornens&title=Polo-like+kinase+4%3A+the+odd+one+out+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 4: the odd one out of the family</span></div><div class="casAuthors">Sillibourne James E; Bornens Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.  The turn-over of this kinase must be strictly controlled to prevent centriole amplification.  This is achieved, in part, by an autoregulatory mechanism, whereby PLK4 autophosphorylates residues in a PEST sequence located carboxy-terminal to its catalytic domain.  Phosphorylated PLK4 is subsequently recognized by the SCF complex, ubiquitinylated and targeted to the proteasome for degradation.  Recent data have also shown that active PLK4 is restricted to the centrosome, a mechanism that could serve to prevent aberrant centriole assembly elsewhere in the cell.  While significant advances have been made in understanding how PLK4 is regulated it is certain that additional regulatory mechanisms exist to safeguard the fidelity of centriole duplication.  Here, we overview past and present data discussing the regulation and functions of PLK4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQklC7aPJn_9mhHGZei4OW9fW6udTcc2eZjx_F48Bfx9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D&md5=bfde20a11fdea2a94976f97ced04e63d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-5-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-5-25%26sid%3Dliteratum%253Aachs%26aulast%3DSillibourne%26aufirst%3DJ.%2BE.%26aulast%3DBornens%26aufirst%3DM.%26atitle%3DPolo-like%2520kinase%25204%253A%2520the%2520odd%2520one%2520out%2520of%2520the%2520family%26jtitle%3DCell%2520Div.%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmenn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatt, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balloux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">SAK/PLK4 is required for centriole duplication and flagella development</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2Fj.cub.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=16326102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2199-2207&author=M.+Bettencourt-Diasauthor=A.+Rodrigues-Martinsauthor=L.+Carpenterauthor=M.+Riparbelliauthor=L.+Lehmennauthor=M.+K.+Gattauthor=N.+Carmoauthor=F.+Ballouxauthor=G.+Callaniauthor=D.+M.+Glover&title=SAK%2FPLK4+is+required+for+centriole+duplication+and+flagella+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SAK/PLK4 Is Required for Centriole Duplication and Flagella Development</span></div><div class="casAuthors">Bettencourt-Dias, M.; Rodrigues-Martins, A.; Carpenter, L.; Riparbelli, M.; Lehmann, L.; Gatt, M. K.; Carmo, N.; Balloux, F.; Callaini, G.; Glover, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2199-2207</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SAK/PLK4 is a distinct member of the polo-like kinase family.  SAK-/- mice die during embryogenesis, whereas SAK+/- mice develop liver and lung tumors and SAK+/- MEFs show mitotic abnormalities.  However, the mechanism underlying these phenotypes is still not known.  Here, the authors show that downregulation of SAK in Drosophila cells, by mutation or RNAi, leads to loss of centrioles, the core structures of centrosomes.  Such cells are able to undergo repeated rounds of cell division, but display broad disorganized mitotic spindle poles.  The authors also show that SAK mutants lose their centrioles during the mitotic divisions preceding male meiosis but still produce cysts of 16 primary spermatocytes as in the wild-type.  Math. modeling of the stereotyped cell divisions of spermatogenesis can account for such loss by defective centriole duplication.  The majority of spermatids in SAK mutants lack centrioles and so are unable to make sperm axonemes.  Finally, the authors show that depletion of SAK in human cells also prevents centriole duplication and gives rise to mitotic abnormalities.  SAK/PLK4 is necessary for centriole duplication both in Drosophila and human cells.  Drosophila cells tolerate the lack of centrioles and undertake mitosis but cannot form basal bodies and hence flagella.  Human cells depleted of SAK show error-prone mitosis, likely to underlie its tumor-suppressor role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFoGUh8x0B_7Vg90H21EOLACvtfcHk0ljiqVThHnhQEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP&md5=31069d55e1b8e6ecdaaababd791b72a7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DCarpenter%26aufirst%3DL.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DLehmenn%26aufirst%3DL.%26aulast%3DGatt%26aufirst%3DM.%2BK.%26aulast%3DCarmo%26aufirst%3DN.%26aulast%3DBalloux%26aufirst%3DF.%26aulast%3DCallani%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DSAK%252FPLK4%2520is%2520required%2520for%2520centriole%2520duplication%2520and%2520flagella%2520development%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D2199%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">The Polo kinase PLK4 functions in centriole duplication</span> <span class="citation_source-journal">Nature. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fncb1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=16244668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1140-1146&author=R.+Habedanckauthor=Y.-D.+Stierhofauthor=C.+J.+Wilkinsonauthor=E.+A.+Nigg&title=The+Polo+kinase+PLK4+functions+in+centriole+duplication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Polo kinase Plk4 functions in centriole duplication</span></div><div class="casAuthors">Habedanck, Robert; Stierhof, York-Dieter; Wilkinson, Christopher J.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human Polo-like kinase 1 (PLK1) and its functional homologs that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division.  By contrast, the functions of other mammalian Polo family members remain largely unknown.  Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development.  Here, we identify Plk4 as a key regulator of centriole duplication.  Both gain- and loss-of-function expts. demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reprodn. of centrosomes during the cell cycle.  These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqCnuaYPx-YrVg90H21EOLACvtfcHk0ljpyrExKny2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL&md5=dda15e878cf410e2de8796a4345aa405</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fncb1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1335%26sid%3Dliteratum%253Aachs%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DWilkinson%26aufirst%3DC.%2BJ.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DThe%2520Polo%2520kinase%2520PLK4%2520functions%2520in%2520centriole%2520duplication%26jtitle%3DNature.%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kleylein-Sohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Clech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Plk4-induced centriole biogenesis in human cells</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=190-202&author=J.+Kleylein-Sohnauthor=J.+Westendorfauthor=M.+Le+Clechauthor=R.+Habedanckauthor=Y.-D.+Stierhofauthor=E.+A.+Nigg&title=Plk4-induced+centriole+biogenesis+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKleylein-Sohn%26aufirst%3DJ.%26aulast%3DWestendorf%26aufirst%3DJ.%26aulast%3DLe%2BClech%26aufirst%3DM.%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPlk4-induced%2520centriole%2520biogenesis%2520in%2520human%2520cells%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D13%26spage%3D190%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, C. J.</span><span> </span><span class="NLM_article-title">Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fng1605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=16025114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=883-888&author=M.+A.+Koauthor=C.+O.+Rosarioauthor=J.+W.+Hudsonauthor=S.+Kulkarniauthor=A.+Pollettauthor=J.+W.+Dennisauthor=C.+J.+Swallow&title=Plk4+haploinsufficiency+causes+mitotic+infidelity+and+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis</span></div><div class="casAuthors">Ko, Michael A.; Rosario, Carla O.; Hudson, John W.; Kulkarni, Sarang; Pollett, Aaron; Dennis, James W.; Swallow, Carol J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">883-888</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The polo-like kinase Plk4 (also called Sak) is required for late mitotic progression, cell survival and post-gastrulation embryonic development.  Here we identified a phenotype resulting from Plk4 haploinsufficiency in Plk4 heterozygous cells and mice.  Plk4+/- embryonic fibroblasts had increased centrosomal amplification, multipolar spindle formation and aneuploidy compared with wild-type cells.  The incidence of spontaneous liver and lung cancers was ∼15 times high in elderly Plk4+/- mice than in Plk4+/+ littermates.  Using the in vivo model of partial hepatectomy to induce synchronous cell cycle entry, we detd. that the precise regulation of cyclins D1, E and B1 and of Cdk1 was impaired in Plk4+/- regenerating liver, and p53 activation and p21 and BubR1 expression were suppressed.  These defects were assocd. with progressive cell cycle delays, increased spindle irregularities and accelerated hepatocellular carcinogenesis in Plk4+/- mice.  Loss of heterozygosity occurs frequently (∼60%) at polymorphic markers adjacent to the PLK4 locus in human hepatoma.  Reduced Plk4 gene dosage increases the probability of mitotic errors and cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7LpIkMJSp3LVg90H21EOLACvtfcHk0ljpyrExKny2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFKls70%253D&md5=1e9cda495a2eb955676186823bba630f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng1605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1605%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BA.%26aulast%3DRosario%26aufirst%3DC.%2BO.%26aulast%3DHudson%26aufirst%3DJ.%2BW.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DPollett%26aufirst%3DA.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DSwallow%26aufirst%3DC.%2BJ.%26atitle%3DPlk4%2520haploinsufficiency%2520causes%2520mitotic%2520infidelity%2520and%2520carcinogenesis%26jtitle%3DNature%2520Genet.%26date%3D2005%26volume%3D37%26spage%3D883%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Basto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinadogrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khodjakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raff, J. W.</span><span> </span><span class="NLM_article-title">Centrosome amplification can initiate tumorigenesis in flies</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=1032-1042&author=R.+Bastoauthor=K.+Brunkauthor=T.+Vinadogrovaauthor=N.+Peelauthor=A.+Franzauthor=A.+Khodjakovauthor=J.+W.+Raff&title=Centrosome+amplification+can+initiate+tumorigenesis+in+flies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBasto%26aufirst%3DR.%26aulast%3DBrunk%26aufirst%3DK.%26aulast%3DVinadogrova%26aufirst%3DT.%26aulast%3DPeel%26aufirst%3DN.%26aulast%3DFranz%26aufirst%3DA.%26aulast%3DKhodjakov%26aufirst%3DA.%26aulast%3DRaff%26aufirst%3DJ.%2BW.%26atitle%3DCentrosome%2520amplification%2520can%2520initiate%2520tumorigenesis%2520in%2520flies%26jtitle%3DCell%26date%3D2008%26volume%3D133%26spage%3D1032%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J.</span><span> </span><span class="NLM_article-title">Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e41293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e41293&author=L.+Liuauthor=C.+Z.+Zhangauthor=M.+Caiauthor=J.+Fuauthor=G.+G.+Chenauthor=J.+Yun&title=Downregulation+of+polo-like+kinase+4+in+hepatocellular+carcinoma+associates+with+poor+prognosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%2BZ.%26aulast%3DCai%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%2BG.%26aulast%3DYun%26aufirst%3DJ.%26atitle%3DDownregulation%2520of%2520polo-like%2520kinase%25204%2520in%2520hepatocellular%2520carcinoma%2520associates%2520with%2520poor%2520prognosis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De41293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qaqish, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livasy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dressler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewend, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrico, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olopade, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span> </span><span class="NLM_article-title">The molecular portraits of breast tumors are conserved across microarray platforms</span> <span class="citation_source-journal">BMC Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=96-108&author=Z.+Huauthor=C.+Fanauthor=D.+S.+Ohauthor=J.+S.+Marronauthor=X.+Heauthor=B.+F.+Qaqishauthor=C.+Livasyauthor=L.+A.+Careyauthor=E.+Reynoldsauthor=L.+Dresslerauthor=A.+Nobelauthor=J.+Parkerauthor=M.+G.+Ewendauthor=L.+R.+Sawyerauthor=J.+Wuauthor=Y.+Liuauthor=R.+Nandaauthor=M.+Tretiakovaauthor=A.+R.+Orricoauthor=D.+Dreherauthor=J.+P.+Palazzoauthor=L.+Perreardauthor=E.+Nelsonauthor=M.+Moneauthor=H.+Hansenauthor=M.+Mullinsauthor=J.+F.+Quackenbushauthor=M.+J.+Ellisauthor=O.+I.+Olopadeauthor=P.+S.+Bernardauthor=C.+M.+Perou&title=The+molecular+portraits+of+breast+tumors+are+conserved+across+microarray+platforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DJ.%2BS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DQaqish%26aufirst%3DB.%2BF.%26aulast%3DLivasy%26aufirst%3DC.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26aulast%3DReynolds%26aufirst%3DE.%26aulast%3DDressler%26aufirst%3DL.%26aulast%3DNobel%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DJ.%26aulast%3DEwend%26aufirst%3DM.%2BG.%26aulast%3DSawyer%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNanda%26aufirst%3DR.%26aulast%3DTretiakova%26aufirst%3DM.%26aulast%3DOrrico%26aufirst%3DA.%2BR.%26aulast%3DDreher%26aufirst%3DD.%26aulast%3DPalazzo%26aufirst%3DJ.%2BP.%26aulast%3DPerreard%26aufirst%3DL.%26aulast%3DNelson%26aufirst%3DE.%26aulast%3DMone%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DMullins%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DJ.%2BF.%26aulast%3DEllis%26aufirst%3DM.%2BJ.%26aulast%3DOlopade%26aufirst%3DO.%2BI.%26aulast%3DBernard%26aufirst%3DP.%2BS.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26atitle%3DThe%2520molecular%2520portraits%2520of%2520breast%2520tumors%2520are%2520conserved%2520across%2520microarray%2520platforms%26jtitle%3DBMC%2520Genomics%26date%3D2006%26volume%3D7%26spage%3D96%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">van di Vijver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van ’t Veer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskuil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterse, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteveen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartelink, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">A gene-expression signature as a predictor of survival in breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1056%2FNEJMoa021967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=12490681" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=1999-2009&author=M.+J.+van+di+Vijverauthor=Y.+D.+Heauthor=L.+van+%E2%80%99t+Veerauthor=H.+Daiauthor=A.+A.+M.+Hartauthor=D.+W.+Voskuilauthor=G.+J.+Schreiberauthor=J.+L.+Peterseauthor=C.+Robertsauthor=M.+J.+Martonauthor=M.+Parrishauthor=D.+Atsmaauthor=A.+Witteveenauthor=A.+Glasauthor=L.+Delahayeauthor=T.+van+der+Veldeauthor=H.+Bartelinkauthor=S.+Rodenhuisauthor=E.+T.+Rutgersauthor=S.+H.+Friendauthor=R.+Bernards&title=A+gene-expression+signature+as+a+predictor+of+survival+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa021967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa021967%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bdi%2BVijver%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3Dvan%2B%25E2%2580%2599t%2BVeer%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DHart%26aufirst%3DA.%2BA.%2BM.%26aulast%3DVoskuil%26aufirst%3DD.%2BW.%26aulast%3DSchreiber%26aufirst%3DG.%2BJ.%26aulast%3DPeterse%26aufirst%3DJ.%2BL.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DParrish%26aufirst%3DM.%26aulast%3DAtsma%26aufirst%3DD.%26aulast%3DWitteveen%26aufirst%3DA.%26aulast%3DGlas%26aufirst%3DA.%26aulast%3DDelahaye%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BVelde%26aufirst%3DT.%26aulast%3DBartelink%26aufirst%3DH.%26aulast%3DRodenhuis%26aufirst%3DS.%26aulast%3DRutgers%26aufirst%3DE.%2BT.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520gene-expression%2520signature%2520as%2520a%2520predictor%2520of%2520survival%2520in%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D1999%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeds, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawitan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span> </span><span class="NLM_article-title">An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">13550</span><span class="NLM_x">–</span> <span class="NLM_lpage">13555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13550-13555&author=L.+D.+Millerauthor=J.+Smedsauthor=J.+Georgeauthor=V.+B.+Vegaauthor=L.+Vergaraauthor=A.+Plonerauthor=Y.+Pawitanauthor=P.+Hallauthor=S.+Klaarauthor=E.+T.+Liuauthor=J.+Bergh&title=An+expression+signature+for+p53+status+in+human+breast+cancer+predicts+mutation+status%2C+transcriptional+effects%2C+and+patient+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DSmeds%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DVega%26aufirst%3DV.%2BB.%26aulast%3DVergara%26aufirst%3DL.%26aulast%3DPloner%26aufirst%3DA.%26aulast%3DPawitan%26aufirst%3DY.%26aulast%3DHall%26aufirst%3DP.%26aulast%3DKlaar%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DBergh%26aufirst%3DJ.%26atitle%3DAn%2520expression%2520signature%2520for%2520p53%2520status%2520in%2520human%2520breast%2520cancer%2520predicts%2520mutation%2520status%252C%2520transcriptional%2520effects%252C%2520and%2520patient%2520survival%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13550%26epage%3D13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mason, J.; Wei, S.; Luo, S.; Nadeem, V.; Kiarash, R.; Huang, P.; Awrey, A.; Leung, G.; Beletskaya, I.; Feher, M.; Forrest, B.; Laufer, R.; Sampson, P.; Li, S.-W.; Liu, Y.; Lang, Y.; Pauls, H. W.; Mak, T. W.; Pan, J. G.</span><span> </span><span class="NLM_article-title">Inhibition of Polo-like kinase 4 as an anti-cancer strategy</span>. <span class="NLM_conf-name">AACR 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2–6, 2011</span>,  <span class="NLM_fpage">LB-215</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.%3B+Wei%2C+S.%3B+Luo%2C+S.%3B+Nadeem%2C+V.%3B+Kiarash%2C+R.%3B+Huang%2C+P.%3B+Awrey%2C+A.%3B+Leung%2C+G.%3B+Beletskaya%2C+I.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Laufer%2C+R.%3B+Sampson%2C+P.%3B+Li%2C+S.-W.%3B+Liu%2C+Y.%3B+Lang%2C+Y.%3B+Pauls%2C+H.+W.%3B+Mak%2C+T.+W.%3B+Pan%2C+J.+G.+Inhibition+of+Polo-like+kinase+4+as+an+anti-cancer+strategy.+AACR+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2%E2%80%936%2C+2011%2C+LB-215."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Polo-like%2520kinase%25204%2520as%2520an%2520anti-cancer%2520strategy%26spage%3DLB-215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the Cell Cycle in Cancer: TTK (MPS1) and PLK4 as Novel Mitotic Targets</span>. <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+Cell+Cycle+in+Cancer%3A+TTK+%28MPS1%29+and+PLK4+as+Novel+Mitotic+Targets.+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520Cell%2520Cycle%2520in%2520Cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520Novel%2520Mitotic%2520Targets" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">PLK4 inhibitors of novel structure as potent anti-proliferative agents</span>. <span class="NLM_conf-name">241st ACS National Meeting</span>, <span class="NLM_conf-loc">Anaheim, CA</span>, <span class="NLM_conf-date">March 27–31, 2011</span>,  <span class="NLM_fpage">MEDI 189</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+PLK4+inhibitors+of+novel+structure+as+potent+anti-proliferative+agents.+241st+ACS+National+Meeting%2C+Anaheim%2C+CA%2C+March+27%E2%80%9331%2C+2011%2C+MEDI+189."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DPLK4%2520inhibitors%2520of%2520novel%2520structure%2520as%2520potent%2520anti-proliferative%2520agents%26spage%3DMEDI%2520189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors: (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as novel anti-proliferative agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6069</span><span class="NLM_x">–</span> <span class="NLM_lpage">6087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400380m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6069-6087&author=R.+Lauferauthor=B.+Forrestauthor=S.-W.+Liauthor=P.+Sampsonauthor=Y.+Liuauthor=L.+Edwardsauthor=Y.+Langauthor=D.+Awreyauthor=V.+Maoauthor=O.+Plotnikovaauthor=G.+Leungauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=J.+Masonauthor=S.+Weiauthor=X.+Luoauthor=V.+Nadeemauthor=M.+Feherauthor=R.+Kiarashauthor=E.+Greenauthor=T.+W.+Makauthor=J.+G.+Panauthor=H.+W.+Pauls&title=The+discovery+of+PLK4+inhibitors%3A+%28E%29-3-%28%281H-indazol-6-yl%29methylene%29indolin-2-ones+as+novel+anti-proliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DAwrey%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DV.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DJ.%2BG.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%253A%2520%2528E%2529-3-%2528%25281H-indazol-6-yl%2529methylene%2529indolin-2-ones%2520as%2520novel%2520anti-proliferative%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6069%26epage%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0ljv5KBFCnDDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sebolt-Leopold, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span> </span><span class="NLM_article-title">Mechanisms of drug inhibition of signalling molecules</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=457-462&author=J.+S.+Sebolt-Leopoldauthor=J.+M.+English&title=Mechanisms+of+drug+inhibition+of+signalling+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%2BS.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520drug%2520inhibition%2520of%2520signalling%2520molecules%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D457%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0ljv5KBFCnDDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lhXHSaKFIX7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">McInnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Progress in the discovery of polo-like kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.2174%2F1568026053507660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=15853646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=181-197&author=C.+McInnesauthor=M.+Meznaauthor=P.+M.+Fischer&title=Progress+in+the+discovery+of+polo-like+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the discovery of polo-like kinase inhibitors</span></div><div class="casAuthors">McInnes, Campbell; Mezna, Mokdad; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-197</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (PLKs) are key enzymes that control mitotic entry of proliferating cells and regulate many aspects of mitosis necessary for successful cytokinesis.  Of the 4 known human PLKs, PLK1 is the best characterized and is overexpressed in many tumor types with aberrant elevation frequently constituting a prognostic indicator of poor disease outcome.  Despite the fact that PLK1 was regarded as a validated mitotic cancer target for a no. of years, very few reports of small-mol. PLK inhibitors have appeared to date.  In order to provide a starting point for the discovery and development of selective PLK inhibitors, the authors have characterized a no. of known generic kinase inhibitors with hitherto unknown activity against PLK1, as well as discovering novel inhibitors through structure-guided design.  Previously, the only characterized biochem. PLK1 inhibitor was scytonemin, a sym. indolic marine natural product that is a micromolar non-specific ATP competitor.  In addn. to the progress in the development of ATP-competitive small-mol. PLK inhibitors, recent reports on the use of antisense oligonucleotides (ASONs) and small interfering RNAs (siRNAs) directed against PLK1 have shown selective antiproliferative effects on cancer cells both in vitro and in vivo, producing phenotypes consistent with known PLK functions, and confirming that targeting PLKs with conventional small-mol. agents may be a valid and effective anticancer strategy.  Here the authors present a progress update on the approaches taken so far in developing PLK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR3BwTS0270bVg90H21EOLACvtfcHk0lhXHSaKFIX7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksb0%253D&md5=4d0df58d06f076e1f6ba7e5f2671d779</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1568026053507660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507660%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DProgress%2520in%2520the%2520discovery%2520of%2520polo-like%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D181%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Reindl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein–protein interactions</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2Fj.chembiol.2008.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=18482698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=459-466&author=W.+Reindlauthor=J.+Yuanauthor=A.+Kramerauthor=K.+Strebhardtauthor=T.+Berg&title=Inhibition+of+polo-like+kinase+1+by+blocking+polo-box+domain-dependent+protein%E2%80%93protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Polo-like Kinase 1 by Blocking Polo-Box Domain-Dependent Protein-Protein Interactions</span></div><div class="casAuthors">Reindl, Wolfgang; Yuan, Juping; Kraemer, Andrea; Strebhardt, Klaus; Berg, Thorsten</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Ser/Thr kinase Polo-like kinase 1 (Plk1) is overexpressed in many types of human cancers, and was implicated as an adverse prognostic marker for cancer patients.  Plk1 localizes to its intracellular anchoring sites via its polo-box domain (PBD).  Here we show that Plk1 can be inhibited by small mols. which interfere with its intracellular localization by inhibiting the function of the PBD.  We report the natural product thymoquinone and, esp., the synthetic thymoquinone deriv. Poloxin as inhibitors of the Plk1 PBD.  Both compds. inhibit the function of the Plk1 PBD in vitro, and cause Plk1 mislocalization, chromosome congression defects, mitotic arrest, and apoptosis in HeLa cells.  These data validate the Plk1 PBD as an anticancer target and provide a rationale for developing thymoquinone derivs. as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVCWgVzGi04rVg90H21EOLACvtfcHk0lhXHSaKFIX7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsL8%253D&md5=cb8a592799b8ac1a1d08868d1f0b7033</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DReindl%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DStrebhardt%26aufirst%3DK.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520polo-like%2520kinase%25201%2520by%2520blocking%2520polo-box%2520domain-dependent%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Sampson, P. B.; Liu, Y.; Patel, N. K.; Feher, M.; Forrest, B.; Li, S.-W.; Edwards, L.; Laufer, R.; Lang, Y.; Ban, F.; Awrey, D.; Mao, G.; Plotnikova, O.; Leung, G.; Hodgson, R.; Mason, J.; Wei, X.; Kiarash, R.; Green, E.; Qiu, W.; Chirgadze, N. Y.; Mak, T. W.; Pan, G.; Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors: design and optimization of spiro[cyclopropane-1,3′[3<i>H</i>]indol]-2′(1′<i>H</i>)-ones as anti-cancer agents</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI <span class="refDoi"> DOI: 10.1021/jm500537u</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm500537u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sampson%2C+P.+B.%3B+Liu%2C+Y.%3B+Patel%2C+N.+K.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Li%2C+S.-W.%3B+Edwards%2C+L.%3B+Laufer%2C+R.%3B+Lang%2C+Y.%3B+Ban%2C+F.%3B+Awrey%2C+D.%3B+Mao%2C+G.%3B+Plotnikova%2C+O.%3B+Leung%2C+G.%3B+Hodgson%2C+R.%3B+Mason%2C+J.%3B+Wei%2C+X.%3B+Kiarash%2C+R.%3B+Green%2C+E.%3B+Qiu%2C+W.%3B+Chirgadze%2C+N.+Y.%3B+Mak%2C+T.+W.%3B+Pan%2C+G.%3B+Pauls%2C+H.+W.+The+discovery+of+PLK4+inhibitors%3A+design+and+optimization+of+spiro%5Bcyclopropane-1%2C3%E2%80%B2%5B3H%5Dindol%5D-2%E2%80%B2%281%E2%80%B2H%29-ones+as+anti-cancer+agents.+J.+Med.+Chem.+DOI+10.1021%2Fjm500537u."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm500537u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500537u%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DP.%2BB.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%253A%2520design%2520and%2520optimization%2520of%2520spiro%255Bcyclopropane-1%252C3%25E2%2580%25B2%255B3H%255Dindol%255D-2%25E2%2580%25B2%25281%25E2%2580%25B2H%2529-ones%2520as%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm500537u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Li, A.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, V. K.</span><span> </span><span class="NLM_article-title">Asymmetric ylide reactions: epoxidation, cyclo-propanation, aziridination, olefination, and rearrangement</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2341</span><span class="NLM_x">–</span> <span class="NLM_lpage">2372</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr960411r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=2341-2372&author=A.-H.+Liauthor=L.-X.+Daiauthor=V.+K.+Aggarwal&title=Asymmetric+ylide+reactions%3A+epoxidation%2C+cyclo-propanation%2C+aziridination%2C+olefination%2C+and+rearrangement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcr960411r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr960411r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.-H.%26aulast%3DDai%26aufirst%3DL.-X.%26aulast%3DAggarwal%26aufirst%3DV.%2BK.%26atitle%3DAsymmetric%2520ylide%2520reactions%253A%2520epoxidation%252C%2520cyclo-propanation%252C%2520aziridination%252C%2520olefination%252C%2520and%2520rearrangement%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D2341%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Aggarwal, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynd, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcelloni, M.</span><span> </span><span class="NLM_article-title">Application of chiral sulfides to catalytic asymmetric aziridination and cyclopropanation with in situ generation of the diazo compound</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1002%2F1521-3773%2820010417%2940%3A8%3C1433%3A%3AAID-ANIE1433%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFyrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=1433-1436&author=V.+K.+Aggarwalauthor=E.+Alonsoauthor=G.+Fangauthor=M.+Ferraraauthor=G.+Hyndauthor=M.+Porcelloni&title=Application+of+chiral+sulfides+to+catalytic+asymmetric+aziridination+and+cyclopropanation+with+in+situ+generation+of+the+diazo+compound"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Application of chiral sulfides to catalytic asymmetric aziridination and cyclopropanation with in situ generation of the diazo compound</span></div><div class="casAuthors">Aggarwal, Varinder K.; Alonso, Emma; Fang, Guangyu; Ferrara, Marco; Hynd, George; Porcelloni, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1433-1436</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The chiral sulfide I [n = 1] effectively catalyzed the reaction of imines with PhCH:NNNaTs in presence of Rh2(OAc)4 to give aziridines with high stereoselectivity.  N-protection with the SO2CH2CH2SiMe3 group was particularly effective.  I [n = 2] was more effective in the cyclopropanation of alkenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQrLMlbJNJtrVg90H21EOLACvtfcHk0ljgbdXK0pmRLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFyrsrY%253D&md5=88812b40e8f86ed6ec910d205e3cfca6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010417%2940%3A8%3C1433%3A%3AAID-ANIE1433%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010417%252940%253A8%253C1433%253A%253AAID-ANIE1433%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DV.%2BK.%26aulast%3DAlonso%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DHynd%26aufirst%3DG.%26aulast%3DPorcelloni%26aufirst%3DM.%26atitle%3DApplication%2520of%2520chiral%2520sulfides%2520to%2520catalytic%2520asymmetric%2520aziridination%2520and%2520cyclopropanation%2520with%2520in%2520situ%2520generation%2520of%2520the%2520diazo%2520compound%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D1433%26epage%3D1436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Marti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span> </span><span class="NLM_article-title">Total synthesis of (−)-spirotryprostatin B: synthesis and related studies</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">11505</span><span class="NLM_x">–</span> <span class="NLM_lpage">11515</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0518880" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=11505-11515&author=C.+Martiauthor=E.+M.+Carreira&title=Total+synthesis+of+%28%E2%88%92%29-spirotryprostatin+B%3A+synthesis+and+related+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja0518880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0518880%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DC.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-spirotryprostatin%2520B%253A%2520synthesis%2520and%2520related%2520studies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D11505%26epage%3D11515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Vicinal diol cyclic sulfates. Like epoxides only more reactive</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7538</span><span class="NLM_x">–</span> <span class="NLM_lpage">7539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=7538-7539&author=G.+Yunauthor=K.+B.+Sharpless&title=Vicinal+diol+cyclic+sulfates.+Like+epoxides+only+more+reactive"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DVicinal%2520diol%2520cyclic%2520sulfates.%2520Like%2520epoxides%2520only%2520more%2520reactive%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D7538%26epage%3D7539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors as novel anti-proliferative agents</span>. <span class="NLM_conf-name">Canadian Chemistry Conference & Exhibition</span>, <span class="NLM_conf-loc">Quebec City, QC</span>, <span class="NLM_conf-date">May 26–29, 2013</span>,  <span class="NLM_fpage">BM7-00029</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+The+discovery+of+PLK4+inhibitors+as+novel+anti-proliferative+agents.+Canadian+Chemistry+Conference+%26+Exhibition%2C+Quebec+City%2C+QC%2C+May+26%E2%80%9329%2C+2013%2C+BM7-00029."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%2520as%2520novel%2520anti-proliferative%2520agents%26spage%3DBM7-00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Haddach, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton-Rewolinski, M. V.</span><span> </span><span class="NLM_article-title">An efficient method for the <i>N</i>-debenzylation of aromatic heterocycles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2FS0040-4039%2801%2902192-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=399-402&author=A.+A.+Haddachauthor=A.+Kellemanauthor=M.+V.+Deaton-Rewolinski&title=An+efficient+method+for+the+N-debenzylation+of+aromatic+heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient method for the N-debenzylation of aromatic heterocycles</span></div><div class="casAuthors">Haddach, Aubrey A.; Kelleman, Audrey; Deaton-Rewolinski, Melissa V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-402</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The treatment of N-benzylated heterocycles with K tert-butoxide/DMSO and O at room temp. cleanly affords N-debenzylated products in high yield.  This procedure can be used on a variety of functionalized N-contg. heterocycles such as imidazoles, benzimidazoles, pyrazoles, indazoles, carbazoles, and indoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxH_1cyKPnwLVg90H21EOLACvtfcHk0liTCV7LXlxZTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlSg&md5=d58503d132cc29a1d75ba44ab13040c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902192-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902192-X%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DA.%2BA.%26aulast%3DKelleman%26aufirst%3DA.%26aulast%3DDeaton-Rewolinski%26aufirst%3DM.%2BV.%26atitle%3DAn%2520efficient%2520method%2520for%2520the%2520N-debenzylation%2520of%2520aromatic%2520heterocycles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D399%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Williams, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwast, E.</span><span> </span><span class="NLM_article-title">Carbanion-mediated oxidative deprotection of non-enolizable benzylated amides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1989&pages=451-454&author=R.+M.+Williamsauthor=E.+Kwast&title=Carbanion-mediated+oxidative+deprotection+of+non-enolizable+benzylated+amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26aulast%3DKwast%26aufirst%3DE.%26atitle%3DCarbanion-mediated%2520oxidative%2520deprotection%2520of%2520non-enolizable%2520benzylated%2520amides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1989%26volume%3D30%26spage%3D451%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">Performed by Lotus Separations, Princeton NJ.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanNiewenhze, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Catalytic assymmetric dihydroxylation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2483</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00032a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1994&pages=2483-2547&author=H.+C.+Kolbauthor=M.+S.+VanNiewenhzeauthor=K.+B.+Sharpless&title=Catalytic+assymmetric+dihydroxylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr00032a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00032a009%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DVanNiewenhze%26aufirst%3DM.%2BS.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DCatalytic%2520assymmetric%2520dihydroxylation%26jtitle%3DChem.%2520Rev.%26date%3D1994%26volume%3D94%26spage%3D2483%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hunter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. K. M.</span><span> </span><span class="NLM_article-title">The nature of π–π interactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5525</span><span class="NLM_x">–</span> <span class="NLM_lpage">5534</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00170a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1990&pages=5525-5534&author=C.+A.+Hunterauthor=J.+K.+M.+Sanders&title=The+nature+of+%CF%80%E2%80%93%CF%80+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja00170a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00170a016%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DC.%2BA.%26aulast%3DSanders%26aufirst%3DJ.%2BK.%2BM.%26atitle%3DThe%2520nature%2520of%2520%25CF%2580%25E2%2580%2593%25CF%2580%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1990%26volume%3D112%26spage%3D5525%26epage%3D5534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Bhosale, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, A. S.</span><span> </span><span class="NLM_article-title">A convenient procedure for the preparation of 2-bromo-1-phenylethanol</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1080%2F00304949209356251" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=695-696&author=S.+S.+Bhosaleauthor=P.+L.+Joshiauthor=A.+S.+Rae&title=A+convenient+procedure+for+the+preparation+of+2-bromo-1-phenylethanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F00304949209356251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304949209356251%26sid%3Dliteratum%253Aachs%26aulast%3DBhosale%26aufirst%3DS.%2BS.%26aulast%3DJoshi%26aufirst%3DP.%2BL.%26aulast%3DRae%26aufirst%3DA.%2BS.%26atitle%3DA%2520convenient%2520procedure%2520for%2520the%2520preparation%2520of%25202-bromo-1-phenylethanol%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2009%26volume%3D24%26spage%3D695%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Weinstock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brush, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, N.C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarau, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaim, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setler, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobia, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahns, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and renal vasodilator activity of some dopamine agonist l-aryl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2325</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00161a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=2315-2325&author=J.+Weinstockauthor=D.+L.+Laddauthor=J.+W.+Wilsonauthor=C.+K.+Brushauthor=N.C.+F.+Yimauthor=G.+Gallagherauthor=M.+E.+McCarthyauthor=J.+Silvestriauthor=H.+M.+Sarauauthor=K.+E.+Flaimauthor=D.+M.+Ackermanauthor=P.+E.+Setlerauthor=A.+J.+Tobiaauthor=R.+A.+Hahns&title=Synthesis+and+renal+vasodilator+activity+of+some+dopamine+agonist+l-aryl-2%2C3%2C4%2C5-tetrahydro-1H-3-benzazepine-7%2C8-diols%3A+halogen+and+methyl+analogues+of+fenoldopam"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm00161a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00161a029%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DLadd%26aufirst%3DD.%2BL.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DBrush%26aufirst%3DC.%2BK.%26aulast%3DYim%26aufirst%3DN.C.%2BF.%26aulast%3DGallagher%26aufirst%3DG.%26aulast%3DMcCarthy%26aufirst%3DM.%2BE.%26aulast%3DSilvestri%26aufirst%3DJ.%26aulast%3DSarau%26aufirst%3DH.%2BM.%26aulast%3DFlaim%26aufirst%3DK.%2BE.%26aulast%3DAckerman%26aufirst%3DD.%2BM.%26aulast%3DSetler%26aufirst%3DP.%2BE.%26aulast%3DTobia%26aufirst%3DA.%2BJ.%26aulast%3DHahns%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520renal%2520vasodilator%2520activity%2520of%2520some%2520dopamine%2520agonist%2520l-aryl-2%252C3%252C4%252C5-tetrahydro-1H-3-benzazepine-7%252C8-diols%253A%2520halogen%2520and%2520methyl%2520analogues%2520of%2520fenoldopam%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D2315%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Smolinsky, G.</span><span> </span><span class="NLM_article-title">Formation of azacyclopropenes by pyrolysis of vinyl azides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3557</span><span class="NLM_x">–</span> <span class="NLM_lpage">3559</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01057a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1962&pages=3557-3559&author=G.+Smolinsky&title=Formation+of+azacyclopropenes+by+pyrolysis+of+vinyl+azides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo01057a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01057a037%26sid%3Dliteratum%253Aachs%26aulast%3DSmolinsky%26aufirst%3DG.%26atitle%3DFormation%2520of%2520azacyclopropenes%2520by%2520pyrolysis%2520of%2520vinyl%2520azides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1962%26volume%3D27%26spage%3D3557%26epage%3D3559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Manfredi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecsedy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meetze, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burenkova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoar, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huck, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRoy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysong, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span> </span><span class="NLM_article-title">Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4106</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4106-4111&author=M.+G.+Manfrediauthor=J.+A.+Ecsedyauthor=K.+A.+Meetzeauthor=S.+K.+Balaniauthor=O.+Burenkovaauthor=W.+Chenauthor=K.+M.+Galvinauthor=K.+M.+Hoarauthor=J.+J.+Huckauthor=P.+J.+LeRoyauthor=E.+T.+Rayauthor=T.+B.+Sellsauthor=B.+Stringerauthor=S.+G.+Stroudauthor=T.+J.+Vosauthor=G.+S.+Weatherheadauthor=D.+R.+Wysongauthor=M.+Zhangauthor=J.+B.+Bolenauthor=C.+F.+Claiborne&title=Antitumor+activity+of+MLN8054%2C+an+orally+active+small-molecule+inhibitor+of+Aurora+A+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManfredi%26aufirst%3DM.%2BG.%26aulast%3DEcsedy%26aufirst%3DJ.%2BA.%26aulast%3DMeetze%26aufirst%3DK.%2BA.%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DBurenkova%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26aulast%3DHoar%26aufirst%3DK.%2BM.%26aulast%3DHuck%26aufirst%3DJ.%2BJ.%26aulast%3DLeRoy%26aufirst%3DP.%2BJ.%26aulast%3DRay%26aufirst%3DE.%2BT.%26aulast%3DSells%26aufirst%3DT.%2BB.%26aulast%3DStringer%26aufirst%3DB.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DWeatherhead%26aufirst%3DG.%2BS.%26aulast%3DWysong%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26atitle%3DAntitumor%2520activity%2520of%2520MLN8054%252C%2520an%2520orally%2520active%2520small-molecule%2520inhibitor%2520of%2520Aurora%2520A%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D4106%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Innocenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K-M.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas-Droux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: SAR, structural biology and cellular activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3228</span><span class="NLM_x">–</span> <span class="NLM_lpage">3241</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201683b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3228-3241&author=P.+Innocentiauthor=K-M.J.+Cheungauthor=S.+Solankiauthor=C.+Mas-Drouxauthor=F.+Rowanauthor=S.+Yeohauthor=K.+Boxallauthor=M.+Westlakeauthor=L.+Pickardauthor=T.+Hardyauthor=J.+E.+Baxterauthor=G.+W.+Aherneauthor=R.+Baylissauthor=A.+M.+Fryauthor=S.+Hoelder&title=Design+of+potent+and+selective+hybrid+inhibitors+of+the+mitotic+kinase+Nek2%3A+SAR%2C+structural+biology+and+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm201683b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201683b%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DK-M.J.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DRowan%26aufirst%3DF.%26aulast%3DYeoh%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DWestlake%26aufirst%3DM.%26aulast%3DPickard%26aufirst%3DL.%26aulast%3DHardy%26aufirst%3DT.%26aulast%3DBaxter%26aufirst%3DJ.%2BE.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DFry%26aufirst%3DA.%2BM.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520hybrid%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520Nek2%253A%2520SAR%252C%2520structural%2520biology%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3228%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mason, J. M.; Lin, D.C-C.; Wei, X.; Che, Y.; Yao, Y.; Kiarash, R.; Fletcher, G. C.; Bray, M. R.; Pan, G. J.; Mak, T. W.</span><span> </span><span class="NLM_article-title">Inhibition of PLK4 as a therapeutic strategy for genomically unstable cancers deficient for PTEN</span>. <span class="NLM_conf-name">AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Therapeutics</span>, <span class="NLM_conf-loc">Boston, MA</span>, <span class="NLM_conf-date">October 19–23, 2013</span>,  <span class="NLM_fpage">B267</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.+M.%3B+Lin%2C+D.C-C.%3B+Wei%2C+X.%3B+Che%2C+Y.%3B+Yao%2C+Y.%3B+Kiarash%2C+R.%3B+Fletcher%2C+G.+C.%3B+Bray%2C+M.+R.%3B+Pan%2C+G.+J.%3B+Mak%2C+T.+W.+Inhibition+of+PLK4+as+a+therapeutic+strategy+for+genomically+unstable+cancers+deficient+for+PTEN.+AACR-NCI-EORTC+International+Conference+on+Molecular+Targets+%26+Cancer+Therapeutics%2C+Boston%2C+MA%2C+October+19%E2%80%9323%2C+2013%2C+B267."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520PLK4%2520as%2520a%2520therapeutic%2520strategy%2520for%2520genomically%2520unstable%2520cancers%2520deficient%2520for%2520PTEN%26spage%3DB267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Mason, J. M.; Lin, D.C-C.; Wei, X.; Che, Y.; Yao, Y.; Kiarash, R.; Cescon, D. W.; Fletcher, G. C.; Awrey, D. E.; Bray, M. R.; Pan, G.; Mak, T. W.</span><span> </span><span class="NLM_article-title">Functional characterization of CFI-400945, an inhibitor of PLK4, as a potential anticancer agent</span>. Cancer Cell<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">, </span>in press</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+M.+Mason&author=D.C-C.+Lin&author=X.+Wei&author=Y.+Che&author=Y.+Yao&author=R.+Kiarash&author=D.+W.+Cescon&author=G.+C.+Fletcher&author=D.+E.+Awrey&author=M.+R.+Bray&author=G.+Pan&author=T.+W.+Mak&title=Functional+characterization+of+CFI-400945%2C+an+inhibitor+of+PLK4%2C+as+a+potential+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26atitle%3DFunctional%2520characterization%2520of%2520CFI-400945%252C%2520an%2520inhibitor%2520of%2520PLK4%252C%2520as%2520a%2520potential%2520anticancer%2520agent%26jtitle%3DCancer%2520Cell%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span>ACD/Structure Designer, <span class="NLM_edition">version 12.01</span>; <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Toronto, ON, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACD%2FStructure+Designer%2C+version+12.01%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Toronto%2C+ON%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FStructure%2520Designer%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scavarda, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span> </span><span class="NLM_article-title">Expression and function of TRK-B and BDNF in human neuroblastomas</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=8264643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVemtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=759-767&author=A.+Nakagawaraauthor=C.+G.+Azarauthor=N.+J.+Scavardaauthor=G.+M.+Brodeur&title=Expression+and+function+of+TRK-B+and+BDNF+in+human+neuroblastomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of TRK-B and BDNF in human neuroblastomas</span></div><div class="casAuthors">Nakagawara, Akira; Azar, Christopher G.; Scavarda, Nancy J.; Brodeur, Garrett M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">759-67</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">There is considerable interest in the role of the TRK family of neurotrophin receptors in regulating growth and differentiation in normal and neoplastic nerve cells.  A neuroblastoma is a common pediatric tumor derived from the neural crest, and the majority of favorable neuroblastomas express a high level of TRK-A mRNA.  However, little is known about the expression or function of TRK-B in these tumors.  TRK-B encodes a tyrosine kinase that binds to brain-derived neurotrophic factor (BDNF), as well as neurotrophin-3 (NT-3) and NT-4/5.  The authors have studied the N-myc-amplified human neuroblastoma cell line, SMS-KCN, which expresses both TRK-B and BDNF.  Exogenous BDNF induces tyrosine phosphorylation of TRK-B as well as phosphorylation of phospholipase C-γ1, the extracellular signal-regulated kinases 1 and 2, and phosphatidylinositol-3 kinase.  BDNF also induces expression of the immediate-early genes c-FOS and NGFI-A but not NGFI-B or NGFI-C.  In addn., BDNF appears to promote cell survival and neurite outgrowth.  SMS-KCN cells also express TRK-A, which is phosphorylated in response to nerve growth factor.  However, the downstream TRK-A signaling is apparently defective.  Finally, the authors detd. that in a series of 74 primary neuroblastomas, 36% express TRK-B mRNA, 68% express BDNF mRNA, and 31% express both.  Truncated TRK-B appears to be preferentially expressed in more-differentiated tumors (ganglioneuromas and ganglioneuroblastomas), whereas full-length TRK-B is expressed almost exclusively in immature neuroblastomas with N-myc amplification.  The authors' findings suggest that in TRK-B-expressing human neuroblastomas, BDNF promotes survival and induces neurite outgrowth in an autocrine or paracrine manner.  The BDNF/TRK-B pathway may be particularly important for growth and differentiation of neuroblastomas with N-myc amplification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFRcpiAn-I7Vg90H21EOLACvtfcHk0lg2sP3W9Me2vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVemtLY%253D&md5=4624d1dc084091171f9ccb94017b8eec</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DAzar%26aufirst%3DC.%2BG.%26aulast%3DScavarda%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26atitle%3DExpression%2520and%2520function%2520of%2520TRK-B%2520and%2520BDNF%2520in%2520human%2520neuroblastomas%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D759%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Peters, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coogan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iglehart, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontos, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trogan, E.</span><span> </span><span class="NLM_article-title">Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumour angiogenesis</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fbjc.1998.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=9459145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADyaK1cXoslersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=51-56&author=K.+G.+Petersauthor=A.+Cooganauthor=D.+Berryauthor=J.+Marksauthor=J.+D.+Iglehartauthor=C.+D.+Kontosauthor=P.+Raoauthor=S.+Sankarauthor=E.+Trogan&title=Expression+of+Tie2%2FTek+in+breast+tumor+vasculature+provides+a+new+marker+for+evaluation+of+tumour+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis</span></div><div class="casAuthors">Peters, K. G.; Coogan, A.; Berry, D.; Marks, J.; Iglehart, J. D.; Kontos, C. D.; Rao, P.; Sankar, S.; Trogan, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Endothelial receptor tyrosine kinases may play important roles in pathol. vascular growth, particularly in tumors.  In this study, immunohistochem. was used to evaluate the expression of a novel endothelial receptor tyrosine kinase, Tie2/Tek, in the endothelium of vascular "hotspots" in normal breast tissue (n = 10), benign breast lesions (n = 10) and in breast tumors (n = 123).  Tie2 expression was detected in the endothelium of all breast tissues examd.  However, the strongest expression of Tie-2 was seen in vascular "hot spots" within the inflammatory infiltrate at the periphery of invasive tumors.  Moreover, the proportion of Tie2-pos. vessels (Tie2 counts/CD31 counts) was significantly higher in breast tumors than the proportion of Tie2-pos. vessels in either normal breast tissue or benign breast lesions (P = 0.004 and 0.0001 resp.).  These data are consistent with a role for Tie2 in tumor angiogenesis and demonstrate the potential use of Tie2 expression as a novel marker of the tumor vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrajg5HegFblbVg90H21EOLACvtfcHk0lg2sP3W9Me2vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXoslersw%253D%253D&md5=1e6d0e96050dbcf308fc472f75c0cb70</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.8%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DK.%2BG.%26aulast%3DCoogan%26aufirst%3DA.%26aulast%3DBerry%26aufirst%3DD.%26aulast%3DMarks%26aufirst%3DJ.%26aulast%3DIglehart%26aufirst%3DJ.%2BD.%26aulast%3DKontos%26aufirst%3DC.%2BD.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DSankar%26aufirst%3DS.%26aulast%3DTrogan%26aufirst%3DE.%26atitle%3DExpression%2520of%2520Tie2%252FTek%2520in%2520breast%2520tumor%2520vasculature%2520provides%2520a%2520new%2520marker%2520for%2520evaluation%2520of%2520tumour%2520angiogenesis%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26spage%3D51%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Fister, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span> </span><span class="NLM_article-title">Optimal control applied to cell-cycle-specific cancer chemotherapy</span> <span class="citation_source-journal">SIAM J. Appl. Math.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=1059-1072&author=R.+Fisterauthor=J.+C.+Panetta&title=Optimal+control+applied+to+cell-cycle-specific+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFister%26aufirst%3DR.%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26atitle%3DOptimal%2520control%2520applied%2520to%2520cell-cycle-specific%2520cancer%2520chemotherapy%26jtitle%3DSIAM%2520J.%2520Appl.%2520Math.%26date%3D2000%26volume%3D60%26spage%3D1059%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Venugopal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristeleit, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourneau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellemans, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsayed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcclue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forslund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, T. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerji, U.</span><span> </span><span class="NLM_article-title">A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4262</span><span class="NLM_x">–</span> <span class="NLM_lpage">4272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1158%2F1078-0432.CCR-13-0312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=23741066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4262-4272&author=B.+Venugopalauthor=R.+Bairdauthor=R.+S.+Kristeleitauthor=R.+Plummerauthor=R.+Cowanauthor=A.+Stewartauthor=N.+Fourneauauthor=P.+Hellemansauthor=Y.+Elsayedauthor=S.+Mcclueauthor=J.+W.+Smitauthor=A.+Forslundauthor=C.+Phelpsauthor=J.+Cammauthor=T.+R.+J.+Evansauthor=J.+S.+de+Bonoauthor=U.+Banerji&title=A+phase+I+study+of+quisinostat+%28JNJ-26481585%29%2C+an+oral+hydroxamate+histone+deacetylase+inhibitor+with+evidence+of+target+modulation+and+antitumor+activity%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Venugopal, Balaji; Baird, Richard; Kristeleit, Rebecca S.; Plummer, Ruth; Cowan, Richard; Stewart, Adam; Fourneau, Nele; Hellemans, Peter; Elsayed, Yusri; McClue, Steve; Smit, Johan W.; Forslund, Ann; Phelps, Charles; Camm, John; Evans, T. R. Jeffry; de Bono, Johann S.; Banerji, Udai</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4262-4272</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD), dose-limiting toxicities (DLT), and pharmacokinetic and pharmacodynamic profile of quisinostat, a novel hydroxamate, pan-histone deacetylase inhibitor (HDACi).  Exptl. Design: In this first-in-human phase I study, quisinostat was administered orally, once daily in three weekly cycles to patients with advanced malignancies, using a two-stage accelerated titrn. design.  Three intermittent schedules were subsequently explored: four days on/three days off; every Monday, Wednesday, Friday (MWF); and every Monday and Thursday (M-Th).  Toxicity, pharmacokinetics, pharmacodynamics, and clin. efficacy were evaluated at each schedule.  Results: Ninety-two patients were treated in continuous daily (2-12 mg) and three intermittent dosing schedules (6-19 mg).  Treatment-emergent adverse events included: fatigue, nausea, decreased appetite, lethargy, and vomiting.  DLTs obsd. were predominantly cardiovascular, including nonsustained ventricular tachycardia, ST/T-wave abnormalities, and other tachyarhythmias.  Noncardiac DLTs were fatigue and abnormal liver function tests.  The max. plasma concn. (Cmax) and area under the plasma concn.-time curve (AUC) of quisinostat increased proportionally with dose.  Pharmacodynamic evaluation showed increased acetylated histone 3 in hair follicles, skin and tumor biopsies, and in peripheral blood mononuclear cells as well as decreased Ki67 in skin and tumor biopsies.  A partial response lasting five months was seen in one patient with melanoma.  Stable disease was seen in eight patients (duration 4-10.5 mo).  Conclusions: The adverse event profile of quisinostat was comparable with that of other HDACi.  Intermittent schedules were better tolerated than continuous schedules.  On the basis of tolerability, pharmacokinetic predictions, and pharmacodynamic effects, the recommended dose for phase II studies is 12 mg on the MWF schedule.  Clin Cancer Res; 19(15); 4262-72. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhELE0VMCPbVg90H21EOLACvtfcHk0lgQHnGuDhVRVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amt7zP&md5=f4db895a7878fddce61ea9640e427d4d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0312%26sid%3Dliteratum%253Aachs%26aulast%3DVenugopal%26aufirst%3DB.%26aulast%3DBaird%26aufirst%3DR.%26aulast%3DKristeleit%26aufirst%3DR.%2BS.%26aulast%3DPlummer%26aufirst%3DR.%26aulast%3DCowan%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DFourneau%26aufirst%3DN.%26aulast%3DHellemans%26aufirst%3DP.%26aulast%3DElsayed%26aufirst%3DY.%26aulast%3DMcclue%26aufirst%3DS.%26aulast%3DSmit%26aufirst%3DJ.%2BW.%26aulast%3DForslund%26aufirst%3DA.%26aulast%3DPhelps%26aufirst%3DC.%26aulast%3DCamm%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DT.%2BR.%2BJ.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DBanerji%26aufirst%3DU.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520quisinostat%2520%2528JNJ-26481585%2529%252C%2520an%2520oral%2520hydroxamate%2520histone%2520deacetylase%2520inhibitor%2520with%2520evidence%2520of%2520target%2520modulation%2520and%2520antitumor%2520activity%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4262%26epage%3D4272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Wei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denlinger, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsaparikos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jani, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span> </span><span class="NLM_article-title">Evaluation of selective γ-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1618</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1158%2F1535-7163.MCT-10-0034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=20530712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1618-1628&author=P.+Weiauthor=M.+Wallsauthor=M.+Qiuauthor=R.+Dingauthor=R.+H.+Denlingerauthor=A.+Wongauthor=K.+Tsaparikosauthor=J.+P.+Janiauthor=N.+Hoseaauthor=M.+Sandsauthor=S.+Randolphauthor=T.+Smeal&title=Evaluation+of+selective+%CE%B3-secretase+inhibitor+PF-03084014+for+its+antitumor+efficacy+and+gastrointestinal+safety+to+guide+optimal+clinical+trial+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design</span></div><div class="casAuthors">Wei, Ping; Walls, Marlena; Qiu, Ming; Ding, Richard; Denlinger, Robert H.; Wong, Anthony; Tsaparikos, Kosta; Jani, Jitesh P.; Hosea, Natilie; Sands, Michelle; Randolph, Sophia; Smeal, Tod</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1618-1628</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant regulation of Notch signaling has been implicated in tumorigenesis.  Proteolytic release of the Notch intracellular domain (NICD) by γ-secretase plays a key role in Notch-dependent nuclear signaling. γ-Secretase is an attractive pharmaceutical target for therapeutic intervention in cancer.  We describe the potent antitumor effects of PF-03084014, a small mol. that is a reversible, noncompetitive, and selective γ-secretase inhibitor.  The ability of PF-03084014 to inhibit γ-secretase activity was shown by the redn. of endogenous NICD levels and by the downregulation of Notch target genes Hes-1 and cMyc in the T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL.  PF-03084014 caused cell growth inhibition of several T-ALL cell lines via cell cycle arrest and induction of apoptosis.  PF-03084014 treatment also resulted in robust NICD redn. in HBP-ALL xenograft models.  Broad antitumor efficacy at well-tolerated dose levels was obsd. in six Notch-dependent models.  Addnl. mechanism-of-action studies showed inhibition of tumor cell proliferation and induction of apoptosis in HPB-ALL tumors, suggesting that the antitumor activity of PF-03084014 may be mediated by its direct effects on tumor cell growth or survival.  Further studies on PF-03084014-induced gastrointestinal toxicity identified an intermittent dosing schedule that displayed reduced body wt. loss and sustained antitumor efficacy.  We also showed that glucocorticoids abrogated PF-03084014-induced gastrointestinal toxicity and delayed administration of glucocorticoids did not compromise its protection effect.  Collectively, the results show that inhibition of Notch signaling by PF-03084014 while minimizing gastrointestinal toxicity presents a promising approach for development of therapies for Notch receptor-dependent cancers.  This compd. is being investigated for the treatment of T-ALL and advanced solid tumors in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGDbqFGE2aDbVg90H21EOLACvtfcHk0lgQHnGuDhVRVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbY%253D&md5=b997504049b97258cc54016424ee7405</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0034%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DP.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DR.%26aulast%3DDenlinger%26aufirst%3DR.%2BH.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DTsaparikos%26aufirst%3DK.%26aulast%3DJani%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DSands%26aufirst%3DM.%26aulast%3DRandolph%26aufirst%3DS.%26aulast%3DSmeal%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520selective%2520%25CE%25B3-secretase%2520inhibitor%2520PF-03084014%2520for%2520its%2520antitumor%2520efficacy%2520and%2520gastrointestinal%2520safety%2520to%2520guide%2520optimal%2520clinical%2520trial%2520design%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1618%26epage%3D1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Awar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvic, M.</span><span> </span><span class="NLM_article-title">Treatment of transformed mycosis fungoides with intermittent low-dose Gemcitabine</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=130-135&author=O.+Awarauthor=M.+Duvic&title=Treatment+of+transformed+mycosis+fungoides+with+intermittent+low-dose+Gemcitabine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAwar%26aufirst%3DO.%26aulast%3DDuvic%26aufirst%3DM.%26atitle%3DTreatment%2520of%2520transformed%2520mycosis%2520fungoides%2520with%2520intermittent%2520low-dose%2520Gemcitabine%26jtitle%3DOncology%26date%3D2007%26volume%3D73%26spage%3D130%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2005.06</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec, H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2005.06%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec%2C+H3A+2R7%2C+Canada%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span><span> </span><span class="NLM_article-title">PK Functions for Microsoft Excel</span>. Pharmacokinetic Software; <span class="NLM_publisher-name">David W. A. Bourne</span>,<span class="NLM_x"> </span><span class="NLM_year">2001–2003</span><span class="NLM_x">; </span><a href="http://www.boomer.org/pkin/soft.html" class="extLink">http://www.boomer.org/pkin/soft.html</a>, Accessed November,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001%E2%80%932003&author=J.+I.+Usansky&author=A.+Desai&author=D.+Tang-Liu&title=PK+Functions+for+Microsoft+Excel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26atitle%3DPK%2520Functions%2520for%2520Microsoft%2520Excel%26jtitle%3DPharmacokinetic%2520Software%26pub%3DDavid%2520W.%2520A.%2520Bourne%26date%3D2001%25E2%2580%25932003%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':[],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 70 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Francesca Turnu, Alberto Luridiana, Andrea Cocco, Stefania Porcu, Angelo Frongia, Giorgia Sarais, <span class="NLM_string-name hlFld-ContribAuthor">Francesco Secci</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Tandem Friedel–Crafts Alkylation/C4–C3 Ring-Contraction Reaction: An Efficient Route for the Synthesis of Indolyl Cyclopropanecarbaldehydes and Ketones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (18)
                                     , 7329-7332. <a href="https://doi.org/10.1021/acs.orglett.9b02617" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02617%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BTandem%252BFriedel%2525E2%252580%252593Crafts%252BAlkylation%25252FC4%2525E2%252580%252593C3%252BRing-Contraction%252BReaction%25253A%252BAn%252BEfficient%252BRoute%252Bfor%252Bthe%252BSynthesis%252Bof%252BIndolyl%252BCyclopropanecarbaldehydes%252Band%252BKetones%26aulast%3DTurnu%26aufirst%3DFrancesca%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25072019%26date%3D06092019%26volume%3D21%26issue%3D18%26spage%3D7329%26epage%3D7332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ting Liu, Jiajie Feng, Chen Chen, Zhuoji Deng, Rajendraprasad Kotagiri, Guangxiong Zhou, Xinhao Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Qian Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(I)-Catalyzed Intramolecular Asymmetric Double C-Arylation for the Formation of Chiral Spirocyclic Bis-oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (12)
                                     , 4505-4509. <a href="https://doi.org/10.1021/acs.orglett.9b01373" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01373%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper%252528I%252529-Catalyzed%252BIntramolecular%252BAsymmetric%252BDouble%252BC-Arylation%252Bfor%252Bthe%252BFormation%252Bof%252BChiral%252BSpirocyclic%252BBis-oxindoles%26aulast%3DLiu%26aufirst%3DTing%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18042019%26date%3D03062019%26volume%3D21%26issue%3D12%26spage%3D4505%26epage%3D4509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Saumen Hajra, Sayan Roy, <span class="NLM_string-name hlFld-ContribAuthor">SK Abu Saleh</span>. </span><span class="cited-content_cbyCitation_article-title">Domino Corey–Chaykovsky Reaction for One-Pot Access to Spirocyclopropyl Oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (15)
                                     , 4540-4544. <a href="https://doi.org/10.1021/acs.orglett.8b01840" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDomino%252BCorey%2525E2%252580%252593Chaykovsky%252BReaction%252Bfor%252BOne-Pot%252BAccess%252Bto%252BSpirocyclopropyl%252BOxindoles%26aulast%3DHajra%26aufirst%3DSaumen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13062018%26date%3D23072018%26volume%3D20%26issue%3D15%26spage%3D4540%26epage%3D4544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Jiang</span>, <span class="hlFld-ContribAuthor ">Hong-Mei  Guo</span>, <span class="hlFld-ContribAuthor ">Sheng  Yao</span>, <span class="hlFld-ContribAuthor ">De-Qing  Shi</span>, and <span class="hlFld-ContribAuthor ">Wen-Jing  Xiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Spiro[pyrazolin-3,3′-oxindoles] and 3-Arylcarbonylmethyl Substituted Ylideneoxindoles by 1,3-Dipolar Cycloadditions of 3-Ylideneoxindoles and In-Situ-Generated α-Diazoketones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (19)
                                     , 10433-10443. <a href="https://doi.org/10.1021/acs.joc.7b01907" title="DOI URL">https://doi.org/10.1021/acs.joc.7b01907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b01907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b01907%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BSpiro%25255Bpyrazolin-3%25252C3%2525E2%252580%2525B2-oxindoles%25255D%252Band%252B3-Arylcarbonylmethyl%252BSubstituted%252BYlideneoxindoles%252Bby%252B1%25252C3-Dipolar%252BCycloadditions%252Bof%252B3-Ylideneoxindoles%252Band%252BIn-Situ-Generated%252B%2525CE%2525B1-Diazoketones%26aulast%3DJiang%26aufirst%3DShan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30072017%26date%3D27092017%26date%3D06102017%26date%3D20092017%26volume%3D82%26issue%3D19%26spage%3D10433%26epage%3D10443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Lu</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Zhu-Yin  Wang</span>, and <span class="hlFld-ContribAuthor ">Peng-Fei  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">PPh3 Mediated Reductive Annulation Reaction between Isatins and Electron Deficient Dienes to Construct Spirooxindole Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (11)
                                     , 5782-5789. <a href="https://doi.org/10.1021/acs.joc.7b00595" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00595%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPPh3%252BMediated%252BReductive%252BAnnulation%252BReaction%252Bbetween%252BIsatins%252Band%252BElectron%252BDeficient%252BDienes%252Bto%252BConstruct%252BSpirooxindole%252BCompounds%26aulast%3DZhang%26aufirst%3DLei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D19052017%26date%3D02062017%26date%3D15052017%26volume%3D82%26issue%3D11%26spage%3D5782%26epage%3D5789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Bryan  Forrest</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Genie  Leung</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 130-146. <a href="https://doi.org/10.1021/jm500537u" title="DOI URL">https://doi.org/10.1021/jm500537u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500537u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500537u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BPolo-Like%252BKinase%252B4%252BInhibitors%25253A%252BDesign%252Band%252BOptimization%252Bof%252BSpiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2%25255B3H%25255Dindol%25255D-2%2525E2%252580%2525B2%2525281%2525E2%252580%2525B2H%252529-ones%252Bas%252BOrally%252BBioavailable%252BAntitumor%252BAgents%26aulast%3DSampson%26aufirst%3DPeter%2BB.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D04042014%26date%3D24062014%26date%3D08012015%26date%3D27052014%26volume%3D58%26issue%3D1%26spage%3D130%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Armen  Parsyan</span>, <span class="hlFld-ContribAuthor ">Jennifer  Cruickshank</span>, <span class="hlFld-ContribAuthor ">Kelsey  Hodgson</span>, <span class="hlFld-ContribAuthor ">Drew  Wakeham</span>, <span class="hlFld-ContribAuthor ">Sierra  Pellizzari</span>, <span class="hlFld-ContribAuthor ">Vasudeva  Bhat</span>, <span class="hlFld-ContribAuthor ">David W.  Cescon</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">The Breast</span><span> <strong>2021,</strong> <em>58 </em>, 6-9. <a href="https://doi.org/10.1016/j.breast.2021.03.011" title="DOI URL">https://doi.org/10.1016/j.breast.2021.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.breast.2021.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.breast.2021.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Breast%26atitle%3DAnticancer%252Beffects%252Bof%252Bradiation%252Btherapy%252Bcombined%252Bwith%252BPolo-Like%252BKinase%252B4%252B%252528PLK4%252529%252Binhibitor%252BCFI-400945%252Bin%252Btriple%252Bnegative%252Bbreast%252Bcancer%26aulast%3DParsyan%26aufirst%3DArmen%26date%3D2021%26volume%3D58%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maaged  Abdullah</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 3D motifs based on sequences and structures for binding to CFI‐400945, and deep screening‐based design of new lead molecules for PLK‐4. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>21 </em><a href="https://doi.org/10.1111/cbdd.13908" title="DOI URL">https://doi.org/10.1111/cbdd.13908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13908%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Bof%252B3D%252Bmotifs%252Bbased%252Bon%252Bsequences%252Band%252Bstructures%252Bfor%252Bbinding%252Bto%252BCFI%2525E2%252580%252590400945%25252C%252Band%252Bdeep%252Bscreening%2525E2%252580%252590based%252Bdesign%252Bof%252Bnew%252Blead%252Bmolecules%252Bfor%252BPLK%2525E2%252580%2525904%26aulast%3DAbdullah%26aufirst%3DMaaged%26date%3D2021%26date%3D2021%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Szymon P.  Rekowski</span>, <span class="hlFld-ContribAuthor ">Bettina K.  Kroener</span>, <span class="hlFld-ContribAuthor ">Deepika  Kathuria</span>, <span class="hlFld-ContribAuthor ">Aabid A.  Wani</span>, <span class="hlFld-ContribAuthor ">Sumit S.  Chourasiya</span>, <span class="hlFld-ContribAuthor ">Jürgen  Conrad</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Frey</span>, <span class="hlFld-ContribAuthor ">Uwe  Beifuss</span>. </span><span class="cited-content_cbyCitation_article-title">A novel copper-catalyzed, hydrazine-free synthesis of N-1 unsubstituted 1H-indazoles using stable guanylhydrazone salts as substrates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>91 </em>, 132192. <a href="https://doi.org/10.1016/j.tet.2021.132192" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132192%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bnovel%252Bcopper-catalyzed%25252C%252Bhydrazine-free%252Bsynthesis%252Bof%252BN-1%252Bunsubstituted%252B1H-indazoles%252Busing%252Bstable%252Bguanylhydrazone%252Bsalts%252Bas%252Bsubstrates%26aulast%3DRekowski%26aufirst%3DSzymon%2BP.%26date%3D2021%26volume%3D91%26spage%3D132192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenzhong  Li</span>, <span class="hlFld-ContribAuthor ">Lorenz  Rösler</span>, <span class="hlFld-ContribAuthor ">Till  Wissel</span>, <span class="hlFld-ContribAuthor ">Hergen  Breitzke</span>, <span class="hlFld-ContribAuthor ">Kathrin  Hofmann</span>, <span class="hlFld-ContribAuthor ">Hans-Heinrich  Limbach</span>, <span class="hlFld-ContribAuthor ">Torsten  Gutmann</span>, <span class="hlFld-ContribAuthor ">Gerd  Buntkowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Design and characterization of novel dirhodium coordination polymers – the impact of ligand size on selectivity in asymmetric cyclopropanation. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Science & Technology</span><span> <strong>2021,</strong> <em>11 </em>
                                    (10)
                                     , 3481-3492. <a href="https://doi.org/10.1039/D1CY00109D" title="DOI URL">https://doi.org/10.1039/D1CY00109D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CY00109D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CY00109D%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Science%2520%2526%2520Technology%26atitle%3DDesign%252Band%252Bcharacterization%252Bof%252Bnovel%252Bdirhodium%252Bcoordination%252Bpolymers%252B%2525E2%252580%252593%252Bthe%252Bimpact%252Bof%252Bligand%252Bsize%252Bon%252Bselectivity%252Bin%252Basymmetric%252Bcyclopropanation%26aulast%3DLi%26aufirst%3DZhenzhong%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D10%26spage%3D3481%26epage%3D3492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Wu</span>, <span class="hlFld-ContribAuthor ">Cailing  Gan</span>, <span class="hlFld-ContribAuthor ">Xingping  Su</span>, <span class="hlFld-ContribAuthor ">Hongyao  Liu</span>, <span class="hlFld-ContribAuthor ">Hanyun  Que</span>, <span class="hlFld-ContribAuthor ">Qianyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xue</span>, <span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (26)
                                     , 15675-15687. <a href="https://doi.org/10.1039/D1RA01147B" title="DOI URL">https://doi.org/10.1039/D1RA01147B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA01147B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA01147B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bindazole%252Bderivatives%252Bas%252Banti-cancer%252Bagents%26aulast%3DWei%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D26%26spage%3D15675%26epage%3D15687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darshana  Bora</span>, <span class="hlFld-ContribAuthor ">Anjali  Kaushal</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113263. <a href="https://doi.org/10.1016/j.ejmech.2021.113263" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113263%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnticancer%252Bpotential%252Bof%252Bspirocompounds%252Bin%252Bmedicinal%252Bchemistry%25253A%252BA%252Bpentennial%252Bexpedition%26aulast%3DBora%26aufirst%3DDarshana%26date%3D2021%26volume%3D215%26spage%3D113263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debra R.  Garvey</span>, <span class="hlFld-ContribAuthor ">Gagan  Chhabra</span>, <span class="hlFld-ContribAuthor ">Mary A.  Ndiaye</span>, <span class="hlFld-ContribAuthor ">Nihal  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2021,</strong> <em>20 </em>
                                    (4)
                                     , 632-640. <a href="https://doi.org/10.1158/1535-7163.MCT-20-0741" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-20-0741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-20-0741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-20-0741%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DRole%252Bof%252BPolo-Like%252BKinase%252B4%252B%252528PLK4%252529%252Bin%252BEpithelial%252BCancers%252Band%252BRecent%252BProgress%252Bin%252Bits%252BSmall%252BMolecule%252BTargeting%252Bfor%252BCancer%252BManagement%26aulast%3DGarvey%26aufirst%3DDebra%2BR.%26date%3D2021%26date%3D2021%26volume%3D20%26issue%3D4%26spage%3D632%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prajwal  Dhokne</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113334. <a href="https://doi.org/10.1016/j.ejmech.2021.113334" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113334%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Binsights%252Bof%252Boxindole%252Bbased%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252BRecent%252Badvances%26aulast%3DDhokne%26aufirst%3DPrajwal%26date%3D2021%26volume%3D216%26spage%3D113334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyang  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Wei</span>, <span class="hlFld-ContribAuthor ">Hao  Liang</span>, <span class="hlFld-ContribAuthor ">Lei  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.587554" title="DOI URL">https://doi.org/10.3389/fonc.2021.587554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.587554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.587554%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DPolo-Like%252BKinase%252B4%2525E2%252580%252599s%252BCritical%252BRole%252Bin%252BCancer%252BDevelopment%252Band%252BStrategies%252Bfor%252BPlk4-Targeted%252BTherapy%26aulast%3DZhang%26aufirst%3DXiaoyang%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Pritish  Kansal</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and Applications of Spirocyclopropyl Oxindoles: A Decade Review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (5)
                                     , 757-772. <a href="https://doi.org/10.1002/ejoc.202001261" title="DOI URL">https://doi.org/10.1002/ejoc.202001261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001261%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSyntheses%252Band%252BApplications%252Bof%252BSpirocyclopropyl%252BOxindoles%25253A%252BA%252BDecade%252BReview%26aulast%3DSakla%26aufirst%3DAkash%2BP.%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D5%26spage%3D757%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonal  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Priyanka  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Centrosome dysfunction in human diseases. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2021,</strong> <em>110 </em>, 113-122. <a href="https://doi.org/10.1016/j.semcdb.2020.04.019" title="DOI URL">https://doi.org/10.1016/j.semcdb.2020.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2020.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2020.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DCentrosome%252Bdysfunction%252Bin%252Bhuman%252Bdiseases%26aulast%3DJaiswal%26aufirst%3DSonal%26date%3D2021%26volume%3D110%26spage%3D113%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Yun-Hua  Zheng</span>, <span class="hlFld-ContribAuthor ">Qi-Yuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>, <span class="hlFld-ContribAuthor ">Jian-Hong  Yang</span>, <span class="hlFld-ContribAuthor ">He-Ying  Pei</span>, <span class="hlFld-ContribAuthor ">Ling  Liu</span>, <span class="hlFld-ContribAuthor ">Kong-Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Lin-Lin  Xue</span>, <span class="hlFld-ContribAuthor ">De-Xin  Deng</span>, <span class="hlFld-ContribAuthor ">Lun  Wang</span>, <span class="hlFld-ContribAuthor ">Xu  Ma</span>, <span class="hlFld-ContribAuthor ">Su-Hong  Fu</span>, <span class="hlFld-ContribAuthor ">Ai-Hua  Peng</span>, <span class="hlFld-ContribAuthor ">Ming-Hai  Tang</span>, <span class="hlFld-ContribAuthor ">Yun-Zi  Luo</span>, <span class="hlFld-ContribAuthor ">Hao-Yu  Ye</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112922. <a href="https://doi.org/10.1016/j.ejmech.2020.112922" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112922%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bcompounds%252Bbearing%252B3-%2525284-aminopiperidin-1-yl%252529methyl%252Bmagnolol%252Bscaffold%252Bas%252Banticancer%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bvia%252Btargeting%252Bautophagy%26aulast%3DZhao%26aufirst%3DMin%26date%3D2021%26volume%3D209%26spage%3D112922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rail R.  Gataullin</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Synthesis of Benzo‐Fused Spiro Nitrogen Heterocycles: New Approaches and Modification of Old Strategies. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2020,</strong> <em>103 </em>
                                    (12)
                                     <a href="https://doi.org/10.1002/hlca.202000137" title="DOI URL">https://doi.org/10.1002/hlca.202000137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.202000137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.202000137%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BBenzo%2525E2%252580%252590Fused%252BSpiro%252BNitrogen%252BHeterocycles%25253A%252BNew%252BApproaches%252Band%252BModification%252Bof%252BOld%252BStrategies%26aulast%3DGataullin%26aufirst%3DRail%2BR.%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiangqiang  Hou</span>, <span class="hlFld-ContribAuthor ">Xin  Lin</span>, <span class="hlFld-ContribAuthor ">Xiang  Lu</span>, <span class="hlFld-ContribAuthor ">Chengfeng  Bai</span>, <span class="hlFld-ContribAuthor ">Hanlin  Wei</span>, <span class="hlFld-ContribAuthor ">Guoshun  Luo</span>, <span class="hlFld-ContribAuthor ">Hua  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (23)
                                     , 115763. <a href="https://doi.org/10.1016/j.bmc.2020.115763" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115763%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bsteroidal-chalcone%252Bhybrids%252Bwith%252Bpotent%252Band%252Bselective%252Bactivity%252Bagainst%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DHou%26aufirst%3DQiangqiang%26date%3D2020%26volume%3D28%26issue%3D23%26spage%3D115763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophie L.  Kerschner-Morales</span>, <span class="hlFld-ContribAuthor ">Marie  Kühne</span>, <span class="hlFld-ContribAuthor ">Sabine  Becker</span>, <span class="hlFld-ContribAuthor ">James F.  Beck</span>, <span class="hlFld-ContribAuthor ">Jürgen  Sonnemann</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2020,</strong> <em>146 </em>
                                    (11)
                                     , 2871-2883. <a href="https://doi.org/10.1007/s00432-020-03346-z" title="DOI URL">https://doi.org/10.1007/s00432-020-03346-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-020-03346-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-020-03346-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DAnticancer%252Beffects%252Bof%252Bthe%252BPLK4%252Binhibitors%252BCFI-400945%252Band%252Bcentrinone%252Bin%252BEwing%2525E2%252580%252599s%252Bsarcoma%252Bcells%26aulast%3DKerschner-Morales%26aufirst%3DSophie%2BL.%26date%3D2020%26date%3D2020%26volume%3D146%26issue%3D11%26spage%3D2871%26epage%3D2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing-Ru  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Shan  Jin</span>, <span class="hlFld-ContribAuthor ">Jin  Sun</span>, <span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Ming  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Time-Economical Synthesis of Bis-Spiro Cyclopropanes via Cascade 1,6-Conjugate Addition/Dearomatization Reaction of
              para
              -Quinone Methides with 3-Chlorooxindoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (31)
                                     , 4988-4994. <a href="https://doi.org/10.1002/ejoc.202000830" title="DOI URL">https://doi.org/10.1002/ejoc.202000830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000830%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTime-Economical%252BSynthesis%252Bof%252BBis-Spiro%252BCyclopropanes%252Bvia%252BCascade%252B1%25252C6-Conjugate%252BAddition%25252FDearomatization%252BReaction%252Bof%252Bpara%252B-Quinone%252BMethides%252Bwith%252B3-Chlorooxindoles%26aulast%3DZhang%26aufirst%3DJing-Ru%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D31%26spage%3D4988%26epage%3D4994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenzhong  Li</span>, <span class="hlFld-ContribAuthor ">Lorenz  Rösler</span>, <span class="hlFld-ContribAuthor ">Kevin  Herr</span>, <span class="hlFld-ContribAuthor ">Martin  Brodrecht</span>, <span class="hlFld-ContribAuthor ">Hergen  Breitzke</span>, <span class="hlFld-ContribAuthor ">Kathrin  Hofmann</span>, <span class="hlFld-ContribAuthor ">Hans‐Heinrich  Limbach</span>, <span class="hlFld-ContribAuthor ">Torsten  Gutmann</span>, <span class="hlFld-ContribAuthor ">Gerd  Buntkowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Dirhodium Coordination Polymers for Asymmetric Cyclopropanation of Diazooxindoles with Olefins: Synthesis and Spectroscopic Analysis. </span><span class="cited-content_cbyCitation_journal-name">ChemPlusChem</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 1737-1746. <a href="https://doi.org/10.1002/cplu.202000421" title="DOI URL">https://doi.org/10.1002/cplu.202000421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cplu.202000421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcplu.202000421%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPlusChem%26atitle%3DDirhodium%252BCoordination%252BPolymers%252Bfor%252BAsymmetric%252BCyclopropanation%252Bof%252BDiazooxindoles%252Bwith%252BOlefins%25253A%252BSynthesis%252Band%252BSpectroscopic%252BAnalysis%26aulast%3DLi%26aufirst%3DZhenzhong%26date%3D2020%26date%3D2020%26volume%3D85%26issue%3D8%26spage%3D1737%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Ming  Zhou</span>, <span class="hlFld-ContribAuthor ">Ren-Yu  Qu</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of spirooxindole as a promising scaffold for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (5)
                                     , 603-625. <a href="https://doi.org/10.1080/17460441.2020.1733526" title="DOI URL">https://doi.org/10.1080/17460441.2020.1733526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1733526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1733526%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Boverview%252Bof%252Bspirooxindole%252Bas%252Ba%252Bpromising%252Bscaffold%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DZhou%26aufirst%3DLi-Ming%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D5%26spage%3D603%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Suleman</span>, <span class="hlFld-ContribAuthor ">Zhenmin  Li</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Dimerization of Sulfoxonium Ylides with 3-Diazoindolin-2-imines: A Practical and Efficient Approach to Spiro[cyclopropane-1,3′-indolin]-2′-imines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (27)
                                     , 4447-4456. <a href="https://doi.org/10.1002/ejoc.201900675" title="DOI URL">https://doi.org/10.1002/ejoc.201900675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900675%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BDimerization%252Bof%252BSulfoxonium%252BYlides%252Bwith%252B3-Diazoindolin-2-imines%25253A%252BA%252BPractical%252Band%252BEfficient%252BApproach%252Bto%252BSpiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-imines%26aulast%3DSuleman%26aufirst%3DMuhammad%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D27%26spage%3D4447%26epage%3D4456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael F.  Press</span>, <span class="hlFld-ContribAuthor ">Bin  Xie</span>, <span class="hlFld-ContribAuthor ">Simon  Davenport</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Roberta  Guzman</span>, <span class="hlFld-ContribAuthor ">Garry P.  Nolan</span>, <span class="hlFld-ContribAuthor ">Neil  O’Brien</span>, <span class="hlFld-ContribAuthor ">Michael  Palazzolo</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Joan S.  Brugge</span>, <span class="hlFld-ContribAuthor ">Dennis J.  Slamon</span>. </span><span class="cited-content_cbyCitation_article-title">Role for polo-like kinase 4 in mediation of cytokinesis. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (23)
                                     , 11309-11318. <a href="https://doi.org/10.1073/pnas.1818820116" title="DOI URL">https://doi.org/10.1073/pnas.1818820116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1818820116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1818820116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DRole%252Bfor%252Bpolo-like%252Bkinase%252B4%252Bin%252Bmediation%252Bof%252Bcytokinesis%26aulast%3DPress%26aufirst%3DMichael%2BF.%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D23%26spage%3D11309%26epage%3D11318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Pourshab</span>, <span class="hlFld-ContribAuthor ">Sakineh  Asghari</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Tajbakhsh</span>, <span class="hlFld-ContribAuthor ">Asieh  Khalilpour</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Sonochemical Synthesis of Spirocyclopropaneoxindoles and Evaluation of Their Antioxidant and Cytotoxic Activities. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.1002/cbdv.201900087" title="DOI URL">https://doi.org/10.1002/cbdv.201900087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201900087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201900087%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDiastereoselective%252BSonochemical%252BSynthesis%252Bof%252BSpirocyclopropaneoxindoles%252Band%252BEvaluation%252Bof%252BTheir%252BAntioxidant%252Band%252BCytotoxic%252BActivities%26aulast%3DPourshab%26aufirst%3DMaryam%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Xing  Song</span>, <span class="hlFld-ContribAuthor ">Da-Ming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of spirooxindole-fused spirothiazolones
              via
              squaramide-catalysed reaction of 3-chlorooxindoles with 5-alkenyl thiazolones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (21)
                                     , 5375-5380. <a href="https://doi.org/10.1039/C9OB00998A" title="DOI URL">https://doi.org/10.1039/C9OB00998A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00998A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00998A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252Bspirooxindole-fused%252Bspirothiazolones%252Bvia%252Bsquaramide-catalysed%252Breaction%252Bof%252B3-chlorooxindoles%252Bwith%252B5-alkenyl%252Bthiazolones%26aulast%3DSong%26aufirst%3DYong-Xing%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D21%26spage%3D5375%26epage%3D5380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohong  Liao</span>, <span class="hlFld-ContribAuthor ">Lingrong  Peng</span>, <span class="hlFld-ContribAuthor ">Jin  Zhou</span>, <span class="hlFld-ContribAuthor ">Huiting  Mo</span>, <span class="hlFld-ContribAuthor ">Jialan  Zhao</span>, <span class="hlFld-ContribAuthor ">Zike  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Guo</span>, <span class="hlFld-ContribAuthor ">Peiquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Activity Evaluation of Nasopharyngeal Carcinoma Inhibitors Based on 6‐(Pyrimidin‐4‐yl)‐1
              H
              ‐indazole. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , e1800598. <a href="https://doi.org/10.1002/cbdv.201800598" title="DOI URL">https://doi.org/10.1002/cbdv.201800598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800598%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BActivity%252BEvaluation%252Bof%252BNasopharyngeal%252BCarcinoma%252BInhibitors%252BBased%252Bon%252B6%2525E2%252580%252590%252528Pyrimidin%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590indazole%26aulast%3DLiao%26aufirst%3DBohong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D5%26spage%3De1800598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Maurício T.  Tavares</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Connor P.  Dyer</span>, <span class="hlFld-ContribAuthor ">Alex T.  Grupenmacher</span>, <span class="hlFld-ContribAuthor ">David R.  Piper</span>, <span class="hlFld-ContribAuthor ">Robert A.  Horton</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Saktimayee M.  Roy</span>, <span class="hlFld-ContribAuthor ">Simone T.  Sredni</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (9)
                                     , 2112. <a href="https://doi.org/10.3390/ijms20092112" title="DOI URL">https://doi.org/10.3390/ijms20092112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20092112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20092112%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEvaluation%252Bof%252BProtein%252BKinase%252BInhibitors%252Bwith%252BPLK4%252BCross-Over%252BPotential%252Bin%252Ba%252BPre-Clinical%252BModel%252Bof%252BCancer%26aulast%3DSuri%26aufirst%3DAmreena%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D9%26spage%3D2112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Man  Liu</span>, <span class="hlFld-ContribAuthor ">Chen-Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Lin  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free tandem reaction synthesis of spiro-cyclopropyl fused pyrazolin-5-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (5)
                                     , 664-668. <a href="https://doi.org/10.1039/C8QO01378K" title="DOI URL">https://doi.org/10.1039/C8QO01378K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8QO01378K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8QO01378K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DMetal-free%252Btandem%252Breaction%252Bsynthesis%252Bof%252Bspiro-cyclopropyl%252Bfused%252Bpyrazolin-5-one%252Bderivatives%26aulast%3DLiu%26aufirst%3DMan%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D5%26spage%3D664%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuoxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengguang  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Huang</span>, <span class="hlFld-ContribAuthor ">Yanwei  Liu</span>, <span class="hlFld-ContribAuthor ">Cheng  Wei</span>, <span class="hlFld-ContribAuthor ">Junhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qixue  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Liang</span>, <span class="hlFld-ContribAuthor ">Anling  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangxiu  Wang</span>, <span class="hlFld-ContribAuthor ">Yingwei  Zhen</span>, <span class="hlFld-ContribAuthor ">Lei  Han</span>. </span><span class="cited-content_cbyCitation_article-title">PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>443 </em>, 91-107. <a href="https://doi.org/10.1016/j.canlet.2018.11.034" title="DOI URL">https://doi.org/10.1016/j.canlet.2018.11.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2018.11.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2018.11.034%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DPLK4%252Bis%252Ba%252Bdeterminant%252Bof%252Btemozolomide%252Bsensitivity%252Bthrough%252Bphosphorylation%252Bof%252BIKBKE%252Bin%252Bglioblastoma%26aulast%3DZhang%26aufirst%3DZuoxin%26date%3D2019%26volume%3D443%26spage%3D91%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masanori  Kawakami</span>, <span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Ethan  Dmitrovsky</span>. </span><span class="cited-content_cbyCitation_article-title">New Cell Cycle Inhibitors Target Aneuploidy in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 361-377. <a href="https://doi.org/10.1146/annurev-pharmtox-010818-021649" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010818-021649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010818-021649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010818-021649%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DNew%252BCell%252BCycle%252BInhibitors%252BTarget%252BAneuploidy%252Bin%252BCancer%252BTherapy%26aulast%3DKawakami%26aufirst%3DMasanori%26date%3D2019%26volume%3D59%26issue%3D1%26spage%3D361%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Bailey</span>, <span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Pauline  Chou</span>, <span class="hlFld-ContribAuthor ">Tatiana  Pundy</span>, <span class="hlFld-ContribAuthor ">Samantha  Gadd</span>, <span class="hlFld-ContribAuthor ">Stacey  Raimondi</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>, <span class="hlFld-ContribAuthor ">Simone  Sredni</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB). </span><span class="cited-content_cbyCitation_journal-name">Bioengineering</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 96. <a href="https://doi.org/10.3390/bioengineering5040096" title="DOI URL">https://doi.org/10.3390/bioengineering5040096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/bioengineering5040096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbioengineering5040096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioengineering%26atitle%3DPolo-Like%252BKinase%252B4%252B%252528PLK4%252529%252BIs%252BOverexpressed%252Bin%252BCentral%252BNervous%252BSystem%252BNeuroblastoma%252B%252528CNS-NB%252529%26aulast%3DBailey%26aufirst%3DAnders%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masanori  Kawakami</span>, <span class="hlFld-ContribAuthor ">Lisa Maria  Mustachio</span>, <span class="hlFld-ContribAuthor ">Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Yulong  Chen</span>, <span class="hlFld-ContribAuthor ">Jaime  Rodriguez-Canales</span>, <span class="hlFld-ContribAuthor ">Barbara  Mino</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Kurie</span>, <span class="hlFld-ContribAuthor ">Jason  Roszik</span>, <span class="hlFld-ContribAuthor ">Pamela Andrea  Villalobos</span>, <span class="hlFld-ContribAuthor ">Kelsie L.  Thu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Silvester</span>, <span class="hlFld-ContribAuthor ">David W.  Cescon</span>, <span class="hlFld-ContribAuthor ">Ignacio I.  Wistuba</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Ethan  Dmitrovsky</span>. </span><span class="cited-content_cbyCitation_article-title">Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (46)
                                     , E10810-E10811. <a href="https://doi.org/10.1073/pnas.1813967115" title="DOI URL">https://doi.org/10.1073/pnas.1813967115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1813967115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1813967115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DReply%252Bto%252BOegema%252Bet%252Bal.%25253A%252BCFI-400945%252Band%252BPolo-like%252Bkinase%252B4%252Binhibition%26aulast%3DKawakami%26aufirst%3DMasanori%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D46%26spage%3DE10810%26epage%3DE10811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Weidi  Cao</span>, <span class="hlFld-ContribAuthor ">Hongjiang  Mei</span>, <span class="hlFld-ContribAuthor ">Linfeng  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Synthesis of Chiral Spiro‐cyclopropyl Oxindoles from 3‐Alkenyl‐oxindoles and Sulfoxonium Ylides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (21)
                                     , 4089-4093. <a href="https://doi.org/10.1002/adsc.201800937" title="DOI URL">https://doi.org/10.1002/adsc.201800937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800937%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalytic%252BAsymmetric%252BSynthesis%252Bof%252BChiral%252BSpiro%2525E2%252580%252590cyclopropyl%252BOxindoles%252Bfrom%252B3%2525E2%252580%252590Alkenyl%2525E2%252580%252590oxindoles%252Band%252BSulfoxonium%252BYlides%26aulast%3DWang%26aufirst%3DLifeng%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D21%26spage%3D4089%26epage%3D4093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Qin</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Ke  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient cyclopropanation process of oxindoles via bromoethylsulfonium salt. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (47)
                                     , 6809-6814. <a href="https://doi.org/10.1016/j.tet.2018.09.042" title="DOI URL">https://doi.org/10.1016/j.tet.2018.09.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.09.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bconvenient%252Bcyclopropanation%252Bprocess%252Bof%252Boxindoles%252Bvia%252Bbromoethylsulfonium%252Bsalt%26aulast%3DQin%26aufirst%3DHui%26date%3D2018%26volume%3D74%26issue%3D47%26spage%3D6809%26epage%3D6814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyun  Dong</span>, <span class="hlFld-ContribAuthor ">Qijing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Guang  Huang</span>, <span class="hlFld-ContribAuthor ">Shaoshun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Indazole-based Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1490-1507. <a href="https://doi.org/10.1002/cmdc.201800253" title="DOI URL">https://doi.org/10.1002/cmdc.201800253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BIndazole-based%252BAnticancer%252BAgents%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1490%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Fan  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenbo  Yin</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Chenzhou  Hao</span>, <span class="hlFld-ContribAuthor ">Yu  Pang</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Wu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Haitao  Li</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 197-209. <a href="https://doi.org/10.1016/j.ejmech.2018.05.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bstructure-activity%252Brelationships%252Bstudy%252Band%252BX-ray%252Bcrystallography%252Bof%252B3-substituted-indolin-2-one-5-carboxamide%252Bderivatives%252Bas%252BPAK4%252Binhibitors%26aulast%3DGuo%26aufirst%3DJing%26date%3D2018%26volume%3D155%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea S.  Bauer</span>, <span class="hlFld-ContribAuthor ">Petr V.  Nazarov</span>, <span class="hlFld-ContribAuthor ">Nathalia A.  Giese</span>, <span class="hlFld-ContribAuthor ">Stefania  Beghelli</span>, <span class="hlFld-ContribAuthor ">Anette  Heller</span>, <span class="hlFld-ContribAuthor ">William  Greenhalf</span>, <span class="hlFld-ContribAuthor ">Eithne  Costello</span>, <span class="hlFld-ContribAuthor ">Arnaud  Muller</span>, <span class="hlFld-ContribAuthor ">Melanie  Bier</span>, <span class="hlFld-ContribAuthor ">Oliver  Strobel</span>, <span class="hlFld-ContribAuthor ">Thilo  Hackert</span>, <span class="hlFld-ContribAuthor ">Laurent  Vallar</span>, <span class="hlFld-ContribAuthor ">Aldo  Scarpa</span>, <span class="hlFld-ContribAuthor ">Markus W.  Büchler</span>, <span class="hlFld-ContribAuthor ">John P.  Neoptolemos</span>, <span class="hlFld-ContribAuthor ">Stephanie  Kreis</span>, <span class="hlFld-ContribAuthor ">Jörg D.  Hoheisel</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2018,</strong> <em>142 </em>
                                    (5)
                                     , 1010-1021. <a href="https://doi.org/10.1002/ijc.31087" title="DOI URL">https://doi.org/10.1002/ijc.31087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.31087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.31087%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DTranscriptional%252Bvariations%252Bin%252Bthe%252Bwider%252Bperitumoral%252Btissue%252Benvironment%252Bof%252Bpancreatic%252Bcancer%26aulast%3DBauer%26aufirst%3DAndrea%2BS.%26date%3D2018%26date%3D2017%26volume%3D142%26issue%3D5%26spage%3D1010%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masanori  Kawakami</span>, <span class="hlFld-ContribAuthor ">Lisa Maria  Mustachio</span>, <span class="hlFld-ContribAuthor ">Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Yulong  Chen</span>, <span class="hlFld-ContribAuthor ">Jaime  Rodriguez-Canales</span>, <span class="hlFld-ContribAuthor ">Barbara  Mino</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Kurie</span>, <span class="hlFld-ContribAuthor ">Jason  Roszik</span>, <span class="hlFld-ContribAuthor ">Pamela Andrea  Villalobos</span>, <span class="hlFld-ContribAuthor ">Kelsie L.  Thu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Silvester</span>, <span class="hlFld-ContribAuthor ">David W.  Cescon</span>, <span class="hlFld-ContribAuthor ">Ignacio I.  Wistuba</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Ethan  Dmitrovsky</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (8)
                                     , 1913-1918. <a href="https://doi.org/10.1073/pnas.1719760115" title="DOI URL">https://doi.org/10.1073/pnas.1719760115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1719760115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1719760115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPolo-like%252Bkinase%252B4%252Binhibition%252Bproduces%252Bpolyploidy%252Band%252Bapoptotic%252Bdeath%252Bof%252Blung%252Bcancers%26aulast%3DKawakami%26aufirst%3DMasanori%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D8%26spage%3D1913%26epage%3D1918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radhika Radha  Maniswami</span>, <span class="hlFld-ContribAuthor ">Seema  Prashanth</span>, <span class="hlFld-ContribAuthor ">Archana Venkataramana  Karanth</span>, <span class="hlFld-ContribAuthor ">Sindhu  Koushik</span>, <span class="hlFld-ContribAuthor ">Hemalatha  Govindaraj</span>, <span class="hlFld-ContribAuthor ">Ramesh  Mullangi</span>, <span class="hlFld-ContribAuthor ">Sriram  Rajagopal</span>, <span class="hlFld-ContribAuthor ">Sooriya Kumar  Jegatheesan</span>. </span><span class="cited-content_cbyCitation_article-title">PLK4: a link between centriole biogenesis and cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 59-73. <a href="https://doi.org/10.1080/14728222.2018.1410140" title="DOI URL">https://doi.org/10.1080/14728222.2018.1410140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2018.1410140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2018.1410140%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DPLK4%25253A%252Ba%252Blink%252Bbetween%252Bcentriole%252Bbiogenesis%252Band%252Bcancer%26aulast%3DManiswami%26aufirst%3DRadhika%2BRadha%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D59%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulong  Kuang</span>, <span class="hlFld-ContribAuthor ">Bin  Shen</span>, <span class="hlFld-ContribAuthor ">Li  Dai</span>, <span class="hlFld-ContribAuthor ">Qian  Yao</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Liu</span>, <span class="hlFld-ContribAuthor ">Lili  Lin</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereodivergent asymmetric Michael-alkylation reactions using chiral
              N
              ,
              N
              ′-dioxide/metal complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 688-692. <a href="https://doi.org/10.1039/C7SC02757E" title="DOI URL">https://doi.org/10.1039/C7SC02757E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7SC02757E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7SC02757E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDiastereodivergent%252Basymmetric%252BMichael-alkylation%252Breactions%252Busing%252Bchiral%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-dioxide%25252Fmetal%252Bcomplexes%26aulast%3DKuang%26aufirst%3DYulong%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D688%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone Treiger  Sredni</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Rintaro  Hashizume</span>, <span class="hlFld-ContribAuthor ">Xingyao  He</span>, <span class="hlFld-ContribAuthor ">Nundia  Louis</span>, <span class="hlFld-ContribAuthor ">Tufan  Gokirmak</span>, <span class="hlFld-ContribAuthor ">David R.  Piper</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Watterson</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (67)
                                     , 111190-111212. <a href="https://doi.org/10.18632/oncotarget.22704" title="DOI URL">https://doi.org/10.18632/oncotarget.22704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22704%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252Bpolo-like%252Bkinase%252B4%252B%252528PLK4%252529%25253A%252Ba%252Bnew%252Btherapeutic%252Boption%252Bfor%252Brhabdoid%252Btumors%252Band%252Bpediatric%252Bmedulloblastoma%26aulast%3DSredni%26aufirst%3DSimone%2BTreiger%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D67%26spage%3D111190%26epage%3D111212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivas  Angapelly</span>, <span class="hlFld-ContribAuthor ">P.V.  Sri Ramya</span>, <span class="hlFld-ContribAuthor ">Routhu  SunithaRani</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>, <span class="hlFld-ContribAuthor ">Mohammed  Arifuddin</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasound assisted, VOSO4 catalyzed synthesis of 4-thiazolidinones: Antimicrobial evaluation of indazole-4-thiazolidinone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (49)
                                     , 4632-4637. <a href="https://doi.org/10.1016/j.tetlet.2017.10.070" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.10.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.10.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.10.070%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DUltrasound%252Bassisted%25252C%252BVOSO4%252Bcatalyzed%252Bsynthesis%252Bof%252B4-thiazolidinones%25253A%252BAntimicrobial%252Bevaluation%252Bof%252Bindazole-4-thiazolidinone%252Bderivatives%26aulast%3DAngapelly%26aufirst%3DSrinivas%26date%3D2017%26volume%3D58%26issue%3D49%26spage%3D4632%26epage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone Treiger  Sredni</span>, <span class="hlFld-ContribAuthor ">Mario  Suzuki</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Yang</span>, <span class="hlFld-ContribAuthor ">Jacek  Topczewski</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Tufan  Gokirmak</span>, <span class="hlFld-ContribAuthor ">Jeffrey N.  Gross</span>, <span class="hlFld-ContribAuthor ">Alexandre  de Andrade</span>, <span class="hlFld-ContribAuthor ">Akihide  Kondo</span>, <span class="hlFld-ContribAuthor ">David R.  Piper</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>. </span><span class="cited-content_cbyCitation_article-title">A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain. </span><span class="cited-content_cbyCitation_journal-name">Pediatric Blood & Cancer</span><span> <strong>2017,</strong> <em>64 </em>
                                    (11)
                                     , e26551. <a href="https://doi.org/10.1002/pbc.26551" title="DOI URL">https://doi.org/10.1002/pbc.26551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pbc.26551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpbc.26551%26sid%3Dliteratum%253Aachs%26jtitle%3DPediatric%2520Blood%2520%2526%2520Cancer%26atitle%3DA%252Bfunctional%252Bscreening%252Bof%252Bthe%252Bkinome%252Bidentifies%252Bthe%252BPolo-like%252Bkinase%252B4%252Bas%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bmalignant%252Brhabdoid%252Btumors%25252C%252Band%252Bpossibly%25252C%252Bother%252Bembryonal%252Btumors%252Bof%252Bthe%252Bbrain%26aulast%3DSredni%26aufirst%3DSimone%2BTreiger%26date%3D2017%26date%3D2017%26volume%3D64%26issue%3D11%26spage%3De26551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Yong  Han</span>, <span class="hlFld-ContribAuthor ">Jia  Zhao</span>, <span class="hlFld-ContribAuthor ">Jian-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Bao-Dong  Cui</span>, <span class="hlFld-ContribAuthor ">Nan-Wei  Wan</span>, <span class="hlFld-ContribAuthor ">Yong-Zheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of CF2H-containing spirocyclopropyloxindoles from in situ generated CF2HCHN2 and 3-ylideneoxindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (39)
                                     , 5806-5812. <a href="https://doi.org/10.1016/j.tet.2017.08.022" title="DOI URL">https://doi.org/10.1016/j.tet.2017.08.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.08.022%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSyntheses%252Bof%252BCF2H-containing%252Bspirocyclopropyloxindoles%252Bfrom%252Bin%252Bsitu%252Bgenerated%252BCF2HCHN2%252Band%252B3-ylideneoxindoles%26aulast%3DHan%26aufirst%3DWen-Yong%26date%3D2017%26volume%3D73%26issue%3D39%26spage%3D5806%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao-Lan  Qin</span>, <span class="hlFld-ContribAuthor ">Wen-Ying  Shen</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Zhao</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Yan-Cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Oxoaporphine Metal Complexes (CoII, NiII, ZnII) with High Antitumor Activity by Inducing Mitochondria-Mediated Apoptosis and S-phase Arrest in HepG2. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep46056" title="DOI URL">https://doi.org/10.1038/srep46056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep46056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep46056%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DOxoaporphine%252BMetal%252BComplexes%252B%252528CoII%25252C%252BNiII%25252C%252BZnII%252529%252Bwith%252BHigh%252BAntitumor%252BActivity%252Bby%252BInducing%252BMitochondria-Mediated%252BApoptosis%252Band%252BS-phase%252BArrest%252Bin%252BHepG2%26aulast%3DQin%26aufirst%3DJiao-Lan%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nader  Noroozi Pesyan</span>, <span class="hlFld-ContribAuthor ">Hamid  Rashidnejad</span>. </span><span class="cited-content_cbyCitation_article-title">Decades of synthesis and application of spiro cyclopropanes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2017,</strong> <em>14 </em>
                                    (7)
                                     , 1365-1467. <a href="https://doi.org/10.1007/s13738-017-1086-0" title="DOI URL">https://doi.org/10.1007/s13738-017-1086-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-017-1086-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-017-1086-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DDecades%252Bof%252Bsynthesis%252Band%252Bapplication%252Bof%252Bspiro%252Bcyclopropanes%26aulast%3DNoroozi%2BPesyan%26aufirst%3DNader%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D7%26spage%3D1365%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ines  Lohse</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Mason</span>, <span class="hlFld-ContribAuthor ">Pinjiang Mary  Cao</span>, <span class="hlFld-ContribAuthor ">Melania  Pintilie</span>, <span class="hlFld-ContribAuthor ">Mark  Bray</span>, <span class="hlFld-ContribAuthor ">David W.  Hedley</span>. </span><span class="cited-content_cbyCitation_article-title">Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 3064-3071. <a href="https://doi.org/10.18632/oncotarget.13619" title="DOI URL">https://doi.org/10.18632/oncotarget.13619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.13619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.13619%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DActivity%252Bof%252Bthe%252Bnovel%252Bpolo-like%252Bkinase%252B4%252Binhibitor%252BCFI-400945%252Bin%252Bpancreatic%252Bcancer%252Bpatient-derived%252Bxenografts%26aulast%3DLohse%26aufirst%3DInes%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D3064%26epage%3D3071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Lu  Xiong</span>, <span class="hlFld-ContribAuthor ">Qiang  Feng</span>, <span class="hlFld-ContribAuthor ">Yaojie  Shi</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and efficient synthesis of trans-arylvinylboronates and trans-hetarylvinylboronates using palladium catalyzed cross-coupling. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (8)
                                     , 3172-3176. <a href="https://doi.org/10.1039/C6NJ03984G" title="DOI URL">https://doi.org/10.1039/C6NJ03984G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ03984G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ03984G%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSelective%252Band%252Befficient%252Bsynthesis%252Bof%252Btrans-arylvinylboronates%252Band%252Btrans-hetarylvinylboronates%252Busing%252Bpalladium%252Bcatalyzed%252Bcross-coupling%26aulast%3DLiu%26aufirst%3DZhihao%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D8%26spage%3D3172%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongchao  Zhang</span>, <span class="hlFld-ContribAuthor ">Guoqing  Huang</span>, <span class="hlFld-ContribAuthor ">Guisheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Organoiodine reagent-promoted intermolecular oxidative amination: synthesis of cyclopropyl spirooxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (7)
                                     , 1372-1375. <a href="https://doi.org/10.1039/C7QO00156H" title="DOI URL">https://doi.org/10.1039/C7QO00156H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00156H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00156H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DOrganoiodine%252Breagent-promoted%252Bintermolecular%252Boxidative%252Bamination%25253A%252Bsynthesis%252Bof%252Bcyclopropyl%252Bspirooxindoles%26aulast%3DZhang%26aufirst%3DZhiguo%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D7%26spage%3D1372%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Lei</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Lu  Xiong</span>, <span class="hlFld-ContribAuthor ">Yaojie  Shi</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chao  Gao</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of (E)-4-(3-arylvinyl-1H-indazol-6-yl)pyrimidin-2-amine derivatives as PLK4 inhibitors for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (44)
                                     , 27737-27746. <a href="https://doi.org/10.1039/C7RA02518A" title="DOI URL">https://doi.org/10.1039/C7RA02518A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA02518A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA02518A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%252528E%252529-4-%2525283-arylvinyl-1H-indazol-6-yl%252529pyrimidin-2-amine%252Bderivatives%252Bas%252BPLK4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DLiu%26aufirst%3DZhihao%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D44%26spage%3D27737%26epage%3D27746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garima  Khanna</span>, <span class="hlFld-ContribAuthor ">Komal  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Jitender M.  Khurana</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient catalyst-free synthesis of diversified bis (spirooxindoles) via one-pot, three-component reaction. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2016,</strong> <em>46 </em>
                                    (23)
                                     , 1880-1886. <a href="https://doi.org/10.1080/00397911.2016.1233437" title="DOI URL">https://doi.org/10.1080/00397911.2016.1233437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2016.1233437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2016.1233437%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEfficient%252Bcatalyst-free%252Bsynthesis%252Bof%252Bdiversified%252Bbis%252B%252528spirooxindoles%252529%252Bvia%252Bone-pot%25252C%252Bthree-component%252Breaction%26aulast%3DKhanna%26aufirst%3DGarima%26date%3D2016%26date%3D2016%26volume%3D46%26issue%3D23%26spage%3D1880%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan A.  Denu</span>, <span class="hlFld-ContribAuthor ">Lauren M.  Zasadil</span>, <span class="hlFld-ContribAuthor ">Craig  Kanugh</span>, <span class="hlFld-ContribAuthor ">Jennifer  Laffin</span>, <span class="hlFld-ContribAuthor ">Beth A.  Weaver</span>, <span class="hlFld-ContribAuthor ">Mark E.  Burkard</span>. </span><span class="cited-content_cbyCitation_article-title">Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2016,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-016-2083-x" title="DOI URL">https://doi.org/10.1186/s12885-016-2083-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-016-2083-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-016-2083-x%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DCentrosome%252Bamplification%252Binduces%252Bhigh%252Bgrade%252Bfeatures%252Band%252Bis%252Bprognostic%252Bof%252Bworse%252Boutcomes%252Bin%252Bbreast%252Bcancer%26aulast%3DDenu%26aufirst%3DRyan%2BA.%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Forrest</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>. </span><span class="cited-content_cbyCitation_article-title">Design and optimization of (3-aryl-1 H -indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones as potent PLK4 inhibitors with oral antitumor efficacy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (19)
                                     , 4625-4630. <a href="https://doi.org/10.1016/j.bmcl.2016.08.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Boptimization%252Bof%252B%2525283-aryl-1%252BH%252B-indazol-6-yl%252529spiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-ones%252Bas%252Bpotent%252BPLK4%252Binhibitors%252Bwith%252Boral%252Bantitumor%252Befficacy%26aulast%3DLi%26aufirst%3DSze-Wan%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4625%26epage%3D4630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kishna Ram  Senwar</span>, <span class="hlFld-ContribAuthor ">T. Srinivasa  Reddy</span>, <span class="hlFld-ContribAuthor ">Dinesh  Thummuri</span>, <span class="hlFld-ContribAuthor ">Pankaj  Sharma</span>, <span class="hlFld-ContribAuthor ">V.G.M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Gannoju  Srinivasulu</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3′-methoxy-4′-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 34-46. <a href="https://doi.org/10.1016/j.ejmech.2016.04.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bapoptosis%252Binducing%252Beffect%252Bof%252Bnovel%252B%252528Z%252529-3-%2525283%2525E2%252580%2525B2-methoxy-4%2525E2%252580%2525B2-%2525282-amino-2-oxoethoxy%252529-benzylidene%252529indolin-2-ones%252Bas%252Bpotential%252Bantitumour%252Bagents%26aulast%3DSenwar%26aufirst%3DKishna%2BRam%26date%3D2016%26volume%3D118%26spage%3D34%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Ping-Ping  Qi</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Ruilei  Huang</span>, <span class="hlFld-ContribAuthor ">Hao  Guo</span>, <span class="hlFld-ContribAuthor ">Yi-Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">De-Quan  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>117 </em>, 241-255. <a href="https://doi.org/10.1016/j.ejmech.2016.04.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bnew%252Bantiproliferative%252Bsteroidal%252Bhybrids%252Busing%252Bthe%252Bmolecular%252Bhybridization%252Bapproach%26aulast%3DYu%26aufirst%3DBin%26date%3D2016%26volume%3D117%26spage%3D241%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Zhao</span>, <span class="hlFld-ContribAuthor ">Shuicheng  Guan</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenyong  Han</span>, <span class="hlFld-ContribAuthor ">Baodong  Cui</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Bioreduction of the C C double bond with Pseudomonas monteilii ZMU-T17: one approach to 3-monosubstituted oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (22)
                                     , 3098-3104. <a href="https://doi.org/10.1016/j.tet.2016.04.037" title="DOI URL">https://doi.org/10.1016/j.tet.2016.04.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.04.037%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DBioreduction%252Bof%252Bthe%252BC%252BC%252Bdouble%252Bbond%252Bwith%252BPseudomonas%252Bmonteilii%252BZMU-T17%25253A%252Bone%252Bapproach%252Bto%252B3-monosubstituted%252Boxindoles%26aulast%3DZhao%26aufirst%3DJia%26date%3D2016%26volume%3D72%26issue%3D22%26spage%3D3098%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Ya-Fei  Li</span>, <span class="hlFld-ContribAuthor ">Jun-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Yun-Kai  Shi</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent assembly of novel antiproliferative steroidal dihydropyridinyl spirooxindoles. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2016,</strong> <em>109 </em>, 22-28. <a href="https://doi.org/10.1016/j.steroids.2016.03.005" title="DOI URL">https://doi.org/10.1016/j.steroids.2016.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2016.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DMulticomponent%252Bassembly%252Bof%252Bnovel%252Bantiproliferative%252Bsteroidal%252Bdihydropyridinyl%252Bspirooxindoles%26aulast%3DZhang%26aufirst%3DYan-Ling%26date%3D2016%26volume%3D109%26spage%3D22%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Leoni</span>, <span class="hlFld-ContribAuthor ">Alessandra  Locatelli</span>, <span class="hlFld-ContribAuthor ">Rita  Morigi</span>, <span class="hlFld-ContribAuthor ">Mirella  Rambaldi</span>. </span><span class="cited-content_cbyCitation_article-title">2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 149-173. <a href="https://doi.org/10.1517/13543776.2016.1118059" title="DOI URL">https://doi.org/10.1517/13543776.2016.1118059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2016.1118059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2016.1118059%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D2-Indolinone%252Ba%252Bversatile%252Bscaffold%252Bfor%252Btreatment%252Bof%252Bcancer%25253A%252Ba%252Bpatent%252Breview%252B%2525282008%2525E2%252580%2525932014%252529%26aulast%3DLeoni%26aufirst%3DAlberto%26date%3D2016%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D149%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Hua  Shen</span>, <span class="hlFld-ContribAuthor ">Ke  Xu</span>, <span class="hlFld-ContribAuthor ">Chu-Han  Sun</span>, <span class="hlFld-ContribAuthor ">Hua-Dong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of aza-spirocyclopropanyl oxindoles by the reaction of 3-(2-bromoethyl)-indole with 2,3-dimethylimidazole-1-sulfonyl azide triflate. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (4)
                                     , 1272-1276. <a href="https://doi.org/10.1039/C5OB02192H" title="DOI URL">https://doi.org/10.1039/C5OB02192H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02192H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02192H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFacile%252Bsynthesis%252Bof%252Baza-spirocyclopropanyl%252Boxindoles%252Bby%252Bthe%252Breaction%252Bof%252B3-%2525282-bromoethyl%252529-indole%252Bwith%252B2%25252C3-dimethylimidazole-1-sulfonyl%252Bazide%252Btriflate%26aulast%3DShen%26aufirst%3DMei-Hua%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D4%26spage%3D1272%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Palomba</span>, <span class="hlFld-ContribAuthor ">L.  Rossi</span>, <span class="hlFld-ContribAuthor ">L.  Sancineto</span>, <span class="hlFld-ContribAuthor ">E.  Tramontano</span>, <span class="hlFld-ContribAuthor ">A.  Corona</span>, <span class="hlFld-ContribAuthor ">L.  Bagnoli</span>, <span class="hlFld-ContribAuthor ">C.  Santi</span>, <span class="hlFld-ContribAuthor ">C.  Pannecouque</span>, <span class="hlFld-ContribAuthor ">O.  Tabarrini</span>, <span class="hlFld-ContribAuthor ">F.  Marini</span>. </span><span class="cited-content_cbyCitation_article-title">A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (6)
                                     , 2015-2024. <a href="https://doi.org/10.1039/C5OB02451J" title="DOI URL">https://doi.org/10.1039/C5OB02451J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02451J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02451J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bnew%252Bvinyl%252Bselenone-based%252Bdomino%252Bapproach%252Bto%252Bspirocyclopropyl%252Boxindoles%252Bendowed%252Bwith%252Banti-HIV%252BRT%252Bactivity%26aulast%3DPalomba%26aufirst%3DM.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D6%26spage%3D2015%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjian  Chi</span>, <span class="hlFld-ContribAuthor ">Lihua  Qiu</span>, <span class="hlFld-ContribAuthor ">Xinfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Highly enantioselective synthesis of spirocyclopropyloxindoles via a Rh(
              ii
              )-catalyzed asymmetric cyclopropanation reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (44)
                                     , 10357-10361. <a href="https://doi.org/10.1039/C6OB02160C" title="DOI URL">https://doi.org/10.1039/C6OB02160C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB02160C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB02160C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHighly%252Benantioselective%252Bsynthesis%252Bof%252Bspirocyclopropyloxindoles%252Bvia%252Ba%252BRh%252528%252Bii%252B%252529-catalyzed%252Basymmetric%252Bcyclopropanation%252Breaction%26aulast%3DChi%26aufirst%3DYongjian%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D44%26spage%3D10357%26epage%3D10361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xiao-Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Ping-Ping  Qi</span>, <span class="hlFld-ContribAuthor ">Yi-Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">De-Quan  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of novel antiproliferative steroidal spirooxindoles via the [3+2] cycloaddition reactions of azomethine ylides. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2015,</strong> <em>102 </em>, 92-100. <a href="https://doi.org/10.1016/j.steroids.2015.08.003" title="DOI URL">https://doi.org/10.1016/j.steroids.2015.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2015.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2015.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bnovel%252Bantiproliferative%252Bsteroidal%252Bspirooxindoles%252Bvia%252Bthe%252B%25255B3%25252B2%25255D%252Bcycloaddition%252Breactions%252Bof%252Bazomethine%252Bylides%26aulast%3DYu%26aufirst%3DBin%26date%3D2015%26volume%3D102%26spage%3D92%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kishna Ram  Senwar</span>, <span class="hlFld-ContribAuthor ">Pankaj  Sharma</span>, <span class="hlFld-ContribAuthor ">T. Srinivasa  Reddy</span>, <span class="hlFld-ContribAuthor ">Manish Kumar  Jeengar</span>, <span class="hlFld-ContribAuthor ">V. Lakshma  Nayak</span>, <span class="hlFld-ContribAuthor ">V.G.M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 413-424. <a href="https://doi.org/10.1016/j.ejmech.2015.08.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirooxindole-derived%252Bmorpholine-fused-1%25252C2%25252C3-triazoles%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bcytotoxicity%252Band%252Bapoptosis%252Binducing%252Bstudies%26aulast%3DSenwar%26aufirst%3DKishna%2BRam%26date%3D2015%26volume%3D102%26spage%3D413%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y. L.  Wong</span>, <span class="hlFld-ContribAuthor ">J. V.  Anzola</span>, <span class="hlFld-ContribAuthor ">R. L.  Davis</span>, <span class="hlFld-ContribAuthor ">M.  Yoon</span>, <span class="hlFld-ContribAuthor ">A.  Motamedi</span>, <span class="hlFld-ContribAuthor ">A.  Kroll</span>, <span class="hlFld-ContribAuthor ">C. P.  Seo</span>, <span class="hlFld-ContribAuthor ">J. E.  Hsia</span>, <span class="hlFld-ContribAuthor ">S. K.  Kim</span>, <span class="hlFld-ContribAuthor ">J. W.  Mitchell</span>, <span class="hlFld-ContribAuthor ">B. J.  Mitchell</span>, <span class="hlFld-ContribAuthor ">A.  Desai</span>, <span class="hlFld-ContribAuthor ">T. C.  Gahman</span>, <span class="hlFld-ContribAuthor ">A. K.  Shiau</span>, <span class="hlFld-ContribAuthor ">K.  Oegema</span>. </span><span class="cited-content_cbyCitation_article-title">Reversible centriole depletion with an inhibitor of Polo-like kinase 4. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2015,</strong> <em>348 </em>
                                    (6239)
                                     , 1155-1160. <a href="https://doi.org/10.1126/science.aaa5111" title="DOI URL">https://doi.org/10.1126/science.aaa5111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aaa5111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aaa5111%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DReversible%252Bcentriole%252Bdepletion%252Bwith%252Ban%252Binhibitor%252Bof%252BPolo-like%252Bkinase%252B4%26aulast%3DWong%26aufirst%3DY.%2BL.%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D6239%26spage%3D1155%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Ping-Ping  Qi</span>, <span class="hlFld-ContribAuthor ">De-Quan  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 35-40. <a href="https://doi.org/10.1016/j.ejmech.2015.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Borally%252Bactive%252Banticancer%252Bcandidate%252BCFI-400945%252Bderived%252Bfrom%252Bbiologically%252Bpromising%252Bspirooxindoles%25253A%252BSuccess%252Band%252Bchallenges%26aulast%3DYu%26aufirst%3DBin%26date%3D2015%26volume%3D95%26spage%3D35%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasarao  Arulananda Babu</span>, <span class="hlFld-ContribAuthor ">Rayavarapu  Padmavathi</span>, <span class="hlFld-ContribAuthor ">Nayyar  Ahmad Aslam</span>, <span class="hlFld-ContribAuthor ">Vadla  Rajkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments on the Synthesis and Applications of Natural Products-Inspired Spirooxindole Frameworks. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 227-339. <a href="https://doi.org/10.1016/B978-0-444-63462-7.00008-7" title="DOI URL">https://doi.org/10.1016/B978-0-444-63462-7.00008-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63462-7.00008-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63462-7.00008-7%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bon%252Bthe%252BSynthesis%252Band%252BApplications%252Bof%252BNatural%252BProducts-Inspired%252BSpirooxindole%252BFrameworks%26aulast%3DArulananda%2BBabu%26aufirst%3DSrinivasarao%26date%3D2015%26spage%3D227%26epage%3D339%26pub%3DElsevier%26date%3D2015%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Systematic Optimization of PLK4 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Chiral Indazolyl-spiro[cyclopropane-indolinones] via a Double S<sub>N</sub>2 Displacement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis and Chiral Separation of Racemic (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BnCl, DMSO, <i>t</i>-BuOK, 4 h; (ii) BnCl, 150 °C, 8 h; (iii) 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 80 °C, 7 h; (iv) K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (0.5 mol %), NMO (1.1 equiv), citric acid (2 equiv), <i>t</i>-BuOH/H<sub>2</sub>O, rt 16 h then 50 °C; (v) SO<sub>2</sub>Cl<sub>2</sub>, TEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (vi) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (vii) NaH (60% in oil), THF; (viii) DMSO, <i>t</i>-BuOK, THF, O<sub>2</sub>; (ix) chiral preparative SFC; (x) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>; (xi) Me<sub>3</sub>S(O)I, NaH, DMF, rt; (xii) ArCH═CHBpin, 2:1 PhMe/EtOH, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mol %), microwave 120 °C, 2 h or 1 M aq Na<sub>2</sub>CO<sub>3</sub>, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub> (2.5 mol %), dioxane, reflux, 18 h. Relative and absolute stereochemistry indicated by unwedged (bold and hashed) and wedged (bold and hashed) lines, respectively.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Stereoselective Synthesis of (1<i>R</i>,2<i>S</i>)-2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (DHQ)<sub>2</sub>PHAL, K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (0.5 mol %), K<sub>3</sub>Fe(CN)<sub>6</sub>, K<sub>2</sub>CO<sub>3</sub>, <i>t</i>-BuOH/H<sub>2</sub>O, 0 °C, 5 h; (ii) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (iii) NaH (60% in oil), THF; (iv) DMSO, <i>t</i>-BuOK, THF, O<sub>2</sub>; (v) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF; (vi) BnBr, DCM, 50% aq KOH, TBAB; (vii) ArCH=CHBpin, 2:1 PhMe/EtOH, 1 M Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mol %), microwave 120 °C, 2 h or 1 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub> (2.5 mol %), dioxane, reflux, 18 h.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0015.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. ORTEP diagram for compound <b>33</b> X-ray structure showing the 1<i>R</i>,2<i>S</i> stereochemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0016.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SRB dose–response curves for HCC1954, MCF-7, MDA-MB-231, and MDA-MB-468 cells upon treatment with compound <b>47</b> for 5 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0017.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Correlation of logAUC (experimental) with logAUC (predicted) for PO dosing of PLK4 inhibitors in mice. QSAR analysis established that two independent variables (mouse microsomal <i>T</i><sub>1/2</sub> and log<i>D</i><sub>7.4</sub>) describe logAUC (predicted), with an <i>R</i><sup>2</sup> of 0.43 and RMSE of 0.43 (<i>n</i> = 74).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0018.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode for compound <b>48</b> generated by GlideXP docking in the PLK4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF">4JXF</a>) active site. (A) Top panel shows H-bonds from indolinone carbonyl and NH to Lys41 and Gln160 respectively and H-bonds from indazole to Glu90 and Cys92 of the hinge. (B) Bottom panel shows a similar view with a surface representation on the protein; morpholine is at protein–water interface; the OMe group nestles in a groove bounded by the protein backbone and side chains.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Heat map showing % inhibition of kinases at a screening concentration of 0.1 μM by PLK4 inhibitors <b>46</b>, <b>47</b>, and <b>48</b>. Only kinases inhibited >50% by at least one compound (46 of 274) are represented.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tumor volume and average weight vs days of treatment with compounds <b>47</b> and <b>48</b> in an MDA-MB-468 mouse xenograft model (PO QD dosing).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/medium/jm-2014-005336_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. HCT-116 mouse xenograft model. Solid arrows indicate treatment days with compounds <b>46</b>, <b>47</b>, and <b>48</b> (1 on 3 off, PO); 5-fluorouracil was given at 50 mg/kg IP for 5 days. (A) Top panel shows tumor volume vs day following treatment initiation. (B) Bottom panel shows percent mean body weight loss vs day following treatment initiation. The solid arrows indicate dosing events.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm5005336/20150106/images/large/jm-2014-005336_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5005336&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silljé, H. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell division</span> <span class="citation_source-journal">Nature Rev. Mod. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H.+W.+Sillj%C3%A9author=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0lgQJC8LQXL45g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillj%25C3%25A9%26aufirst%3DH.%2BH.%2BW.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520division%26jtitle%3DNature%2520Rev.%2520Mod.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Archambault, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">Polo-like kinases: conservation and divergence in their functions and regulation</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fnrm2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=19305416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=265-275&author=V.+Archambaultauthor=D.+M.+Glover&title=Polo-like+kinases%3A+conservation+and+divergence+in+their+functions+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: conservation and divergence in their functions and regulation</span></div><div class="casAuthors">Archambault, Vincent; Glover, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are potent regulators of M-phase that are conserved from yeasts to humans.  Their roles in mitotic entry, spindle pole functions, and cytokinesis are broadly conserved despite phys. and mol. differences in these processes in disparate organisms.  Plks are characterized by their Polo-box domain, which mediates protein interactions.  They are addnl. controlled by phosphorylation, proteolysis, and transcription, depending on the biol. context.  Plks are now recognized to link cell division to developmental processes and to function in differentiated cells.  A comparison of Plk function and regulation between organisms offers insight into the rich variations of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIkNbJzhkm7Vg90H21EOLACvtfcHk0lgQJC8LQXL45g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D&md5=6f9339e80588d04f5f156f1900718193</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2653%26sid%3Dliteratum%253Aachs%26aulast%3DArchambault%26aufirst%3DV.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DPolo-like%2520kinases%253A%2520conservation%2520and%2520divergence%2520in%2520their%2520functions%2520and%2520regulation%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schoffski, P.</span><span> </span><span class="NLM_article-title">Polo-like kinase inhibitors in preclinical and early clinical development</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffski&title=Polo-like+kinase+inhibitors+in+preclinical+and+early+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffski%26aufirst%3DP.%26atitle%3DPolo-like%2520kinase%2520inhibitors%2520in%2520preclinical%2520and%2520early%2520clinical%2520development%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sillibourne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornens, M.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4: the odd one out of the family</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1186%2F1747-1028-5-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=20920249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-34&author=J.+E.+Sillibourneauthor=M.+Bornens&title=Polo-like+kinase+4%3A+the+odd+one+out+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 4: the odd one out of the family</span></div><div class="casAuthors">Sillibourne James E; Bornens Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.  The turn-over of this kinase must be strictly controlled to prevent centriole amplification.  This is achieved, in part, by an autoregulatory mechanism, whereby PLK4 autophosphorylates residues in a PEST sequence located carboxy-terminal to its catalytic domain.  Phosphorylated PLK4 is subsequently recognized by the SCF complex, ubiquitinylated and targeted to the proteasome for degradation.  Recent data have also shown that active PLK4 is restricted to the centrosome, a mechanism that could serve to prevent aberrant centriole assembly elsewhere in the cell.  While significant advances have been made in understanding how PLK4 is regulated it is certain that additional regulatory mechanisms exist to safeguard the fidelity of centriole duplication.  Here, we overview past and present data discussing the regulation and functions of PLK4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQklC7aPJn_9mhHGZei4OW9fW6udTcc2eYrfILwaf62D7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D&md5=bfde20a11fdea2a94976f97ced04e63d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-5-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-5-25%26sid%3Dliteratum%253Aachs%26aulast%3DSillibourne%26aufirst%3DJ.%2BE.%26aulast%3DBornens%26aufirst%3DM.%26atitle%3DPolo-like%2520kinase%25204%253A%2520the%2520odd%2520one%2520out%2520of%2520the%2520family%26jtitle%3DCell%2520Div.%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmenn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatt, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balloux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">SAK/PLK4 is required for centriole duplication and flagella development</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2Fj.cub.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=16326102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2199-2207&author=M.+Bettencourt-Diasauthor=A.+Rodrigues-Martinsauthor=L.+Carpenterauthor=M.+Riparbelliauthor=L.+Lehmennauthor=M.+K.+Gattauthor=N.+Carmoauthor=F.+Ballouxauthor=G.+Callaniauthor=D.+M.+Glover&title=SAK%2FPLK4+is+required+for+centriole+duplication+and+flagella+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SAK/PLK4 Is Required for Centriole Duplication and Flagella Development</span></div><div class="casAuthors">Bettencourt-Dias, M.; Rodrigues-Martins, A.; Carpenter, L.; Riparbelli, M.; Lehmann, L.; Gatt, M. K.; Carmo, N.; Balloux, F.; Callaini, G.; Glover, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2199-2207</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SAK/PLK4 is a distinct member of the polo-like kinase family.  SAK-/- mice die during embryogenesis, whereas SAK+/- mice develop liver and lung tumors and SAK+/- MEFs show mitotic abnormalities.  However, the mechanism underlying these phenotypes is still not known.  Here, the authors show that downregulation of SAK in Drosophila cells, by mutation or RNAi, leads to loss of centrioles, the core structures of centrosomes.  Such cells are able to undergo repeated rounds of cell division, but display broad disorganized mitotic spindle poles.  The authors also show that SAK mutants lose their centrioles during the mitotic divisions preceding male meiosis but still produce cysts of 16 primary spermatocytes as in the wild-type.  Math. modeling of the stereotyped cell divisions of spermatogenesis can account for such loss by defective centriole duplication.  The majority of spermatids in SAK mutants lack centrioles and so are unable to make sperm axonemes.  Finally, the authors show that depletion of SAK in human cells also prevents centriole duplication and gives rise to mitotic abnormalities.  SAK/PLK4 is necessary for centriole duplication both in Drosophila and human cells.  Drosophila cells tolerate the lack of centrioles and undertake mitosis but cannot form basal bodies and hence flagella.  Human cells depleted of SAK show error-prone mitosis, likely to underlie its tumor-suppressor role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFoGUh8x0B_7Vg90H21EOLACvtfcHk0lifGYm8dWltVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP&md5=31069d55e1b8e6ecdaaababd791b72a7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DCarpenter%26aufirst%3DL.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DLehmenn%26aufirst%3DL.%26aulast%3DGatt%26aufirst%3DM.%2BK.%26aulast%3DCarmo%26aufirst%3DN.%26aulast%3DBalloux%26aufirst%3DF.%26aulast%3DCallani%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DSAK%252FPLK4%2520is%2520required%2520for%2520centriole%2520duplication%2520and%2520flagella%2520development%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D2199%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">The Polo kinase PLK4 functions in centriole duplication</span> <span class="citation_source-journal">Nature. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fncb1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=16244668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1140-1146&author=R.+Habedanckauthor=Y.-D.+Stierhofauthor=C.+J.+Wilkinsonauthor=E.+A.+Nigg&title=The+Polo+kinase+PLK4+functions+in+centriole+duplication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Polo kinase Plk4 functions in centriole duplication</span></div><div class="casAuthors">Habedanck, Robert; Stierhof, York-Dieter; Wilkinson, Christopher J.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human Polo-like kinase 1 (PLK1) and its functional homologs that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division.  By contrast, the functions of other mammalian Polo family members remain largely unknown.  Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development.  Here, we identify Plk4 as a key regulator of centriole duplication.  Both gain- and loss-of-function expts. demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reprodn. of centrosomes during the cell cycle.  These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqCnuaYPx-YrVg90H21EOLACvtfcHk0lifGYm8dWltVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL&md5=dda15e878cf410e2de8796a4345aa405</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fncb1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1335%26sid%3Dliteratum%253Aachs%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DWilkinson%26aufirst%3DC.%2BJ.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DThe%2520Polo%2520kinase%2520PLK4%2520functions%2520in%2520centriole%2520duplication%26jtitle%3DNature.%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kleylein-Sohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Clech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Plk4-induced centriole biogenesis in human cells</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=190-202&author=J.+Kleylein-Sohnauthor=J.+Westendorfauthor=M.+Le+Clechauthor=R.+Habedanckauthor=Y.-D.+Stierhofauthor=E.+A.+Nigg&title=Plk4-induced+centriole+biogenesis+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKleylein-Sohn%26aufirst%3DJ.%26aulast%3DWestendorf%26aufirst%3DJ.%26aulast%3DLe%2BClech%26aufirst%3DM.%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPlk4-induced%2520centriole%2520biogenesis%2520in%2520human%2520cells%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D13%26spage%3D190%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, C. J.</span><span> </span><span class="NLM_article-title">Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fng1605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=16025114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=883-888&author=M.+A.+Koauthor=C.+O.+Rosarioauthor=J.+W.+Hudsonauthor=S.+Kulkarniauthor=A.+Pollettauthor=J.+W.+Dennisauthor=C.+J.+Swallow&title=Plk4+haploinsufficiency+causes+mitotic+infidelity+and+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis</span></div><div class="casAuthors">Ko, Michael A.; Rosario, Carla O.; Hudson, John W.; Kulkarni, Sarang; Pollett, Aaron; Dennis, James W.; Swallow, Carol J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">883-888</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The polo-like kinase Plk4 (also called Sak) is required for late mitotic progression, cell survival and post-gastrulation embryonic development.  Here we identified a phenotype resulting from Plk4 haploinsufficiency in Plk4 heterozygous cells and mice.  Plk4+/- embryonic fibroblasts had increased centrosomal amplification, multipolar spindle formation and aneuploidy compared with wild-type cells.  The incidence of spontaneous liver and lung cancers was ∼15 times high in elderly Plk4+/- mice than in Plk4+/+ littermates.  Using the in vivo model of partial hepatectomy to induce synchronous cell cycle entry, we detd. that the precise regulation of cyclins D1, E and B1 and of Cdk1 was impaired in Plk4+/- regenerating liver, and p53 activation and p21 and BubR1 expression were suppressed.  These defects were assocd. with progressive cell cycle delays, increased spindle irregularities and accelerated hepatocellular carcinogenesis in Plk4+/- mice.  Loss of heterozygosity occurs frequently (∼60%) at polymorphic markers adjacent to the PLK4 locus in human hepatoma.  Reduced Plk4 gene dosage increases the probability of mitotic errors and cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7LpIkMJSp3LVg90H21EOLACvtfcHk0lj_htlZ5DRpyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFKls70%253D&md5=1e9cda495a2eb955676186823bba630f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng1605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1605%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BA.%26aulast%3DRosario%26aufirst%3DC.%2BO.%26aulast%3DHudson%26aufirst%3DJ.%2BW.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DPollett%26aufirst%3DA.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DSwallow%26aufirst%3DC.%2BJ.%26atitle%3DPlk4%2520haploinsufficiency%2520causes%2520mitotic%2520infidelity%2520and%2520carcinogenesis%26jtitle%3DNature%2520Genet.%26date%3D2005%26volume%3D37%26spage%3D883%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Basto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinadogrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khodjakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raff, J. W.</span><span> </span><span class="NLM_article-title">Centrosome amplification can initiate tumorigenesis in flies</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=1032-1042&author=R.+Bastoauthor=K.+Brunkauthor=T.+Vinadogrovaauthor=N.+Peelauthor=A.+Franzauthor=A.+Khodjakovauthor=J.+W.+Raff&title=Centrosome+amplification+can+initiate+tumorigenesis+in+flies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBasto%26aufirst%3DR.%26aulast%3DBrunk%26aufirst%3DK.%26aulast%3DVinadogrova%26aufirst%3DT.%26aulast%3DPeel%26aufirst%3DN.%26aulast%3DFranz%26aufirst%3DA.%26aulast%3DKhodjakov%26aufirst%3DA.%26aulast%3DRaff%26aufirst%3DJ.%2BW.%26atitle%3DCentrosome%2520amplification%2520can%2520initiate%2520tumorigenesis%2520in%2520flies%26jtitle%3DCell%26date%3D2008%26volume%3D133%26spage%3D1032%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J.</span><span> </span><span class="NLM_article-title">Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e41293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e41293&author=L.+Liuauthor=C.+Z.+Zhangauthor=M.+Caiauthor=J.+Fuauthor=G.+G.+Chenauthor=J.+Yun&title=Downregulation+of+polo-like+kinase+4+in+hepatocellular+carcinoma+associates+with+poor+prognosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%2BZ.%26aulast%3DCai%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%2BG.%26aulast%3DYun%26aufirst%3DJ.%26atitle%3DDownregulation%2520of%2520polo-like%2520kinase%25204%2520in%2520hepatocellular%2520carcinoma%2520associates%2520with%2520poor%2520prognosis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De41293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qaqish, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livasy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dressler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewend, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrico, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olopade, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span> </span><span class="NLM_article-title">The molecular portraits of breast tumors are conserved across microarray platforms</span> <span class="citation_source-journal">BMC Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=96-108&author=Z.+Huauthor=C.+Fanauthor=D.+S.+Ohauthor=J.+S.+Marronauthor=X.+Heauthor=B.+F.+Qaqishauthor=C.+Livasyauthor=L.+A.+Careyauthor=E.+Reynoldsauthor=L.+Dresslerauthor=A.+Nobelauthor=J.+Parkerauthor=M.+G.+Ewendauthor=L.+R.+Sawyerauthor=J.+Wuauthor=Y.+Liuauthor=R.+Nandaauthor=M.+Tretiakovaauthor=A.+R.+Orricoauthor=D.+Dreherauthor=J.+P.+Palazzoauthor=L.+Perreardauthor=E.+Nelsonauthor=M.+Moneauthor=H.+Hansenauthor=M.+Mullinsauthor=J.+F.+Quackenbushauthor=M.+J.+Ellisauthor=O.+I.+Olopadeauthor=P.+S.+Bernardauthor=C.+M.+Perou&title=The+molecular+portraits+of+breast+tumors+are+conserved+across+microarray+platforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DJ.%2BS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DQaqish%26aufirst%3DB.%2BF.%26aulast%3DLivasy%26aufirst%3DC.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26aulast%3DReynolds%26aufirst%3DE.%26aulast%3DDressler%26aufirst%3DL.%26aulast%3DNobel%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DJ.%26aulast%3DEwend%26aufirst%3DM.%2BG.%26aulast%3DSawyer%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNanda%26aufirst%3DR.%26aulast%3DTretiakova%26aufirst%3DM.%26aulast%3DOrrico%26aufirst%3DA.%2BR.%26aulast%3DDreher%26aufirst%3DD.%26aulast%3DPalazzo%26aufirst%3DJ.%2BP.%26aulast%3DPerreard%26aufirst%3DL.%26aulast%3DNelson%26aufirst%3DE.%26aulast%3DMone%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DMullins%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DJ.%2BF.%26aulast%3DEllis%26aufirst%3DM.%2BJ.%26aulast%3DOlopade%26aufirst%3DO.%2BI.%26aulast%3DBernard%26aufirst%3DP.%2BS.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26atitle%3DThe%2520molecular%2520portraits%2520of%2520breast%2520tumors%2520are%2520conserved%2520across%2520microarray%2520platforms%26jtitle%3DBMC%2520Genomics%26date%3D2006%26volume%3D7%26spage%3D96%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">van di Vijver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van ’t Veer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskuil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterse, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteveen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartelink, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">A gene-expression signature as a predictor of survival in breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1056%2FNEJMoa021967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=12490681" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=1999-2009&author=M.+J.+van+di+Vijverauthor=Y.+D.+Heauthor=L.+van+%E2%80%99t+Veerauthor=H.+Daiauthor=A.+A.+M.+Hartauthor=D.+W.+Voskuilauthor=G.+J.+Schreiberauthor=J.+L.+Peterseauthor=C.+Robertsauthor=M.+J.+Martonauthor=M.+Parrishauthor=D.+Atsmaauthor=A.+Witteveenauthor=A.+Glasauthor=L.+Delahayeauthor=T.+van+der+Veldeauthor=H.+Bartelinkauthor=S.+Rodenhuisauthor=E.+T.+Rutgersauthor=S.+H.+Friendauthor=R.+Bernards&title=A+gene-expression+signature+as+a+predictor+of+survival+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa021967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa021967%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bdi%2BVijver%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3Dvan%2B%25E2%2580%2599t%2BVeer%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DHart%26aufirst%3DA.%2BA.%2BM.%26aulast%3DVoskuil%26aufirst%3DD.%2BW.%26aulast%3DSchreiber%26aufirst%3DG.%2BJ.%26aulast%3DPeterse%26aufirst%3DJ.%2BL.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DParrish%26aufirst%3DM.%26aulast%3DAtsma%26aufirst%3DD.%26aulast%3DWitteveen%26aufirst%3DA.%26aulast%3DGlas%26aufirst%3DA.%26aulast%3DDelahaye%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BVelde%26aufirst%3DT.%26aulast%3DBartelink%26aufirst%3DH.%26aulast%3DRodenhuis%26aufirst%3DS.%26aulast%3DRutgers%26aufirst%3DE.%2BT.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520gene-expression%2520signature%2520as%2520a%2520predictor%2520of%2520survival%2520in%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D1999%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeds, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawitan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span> </span><span class="NLM_article-title">An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">13550</span><span class="NLM_x">–</span> <span class="NLM_lpage">13555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13550-13555&author=L.+D.+Millerauthor=J.+Smedsauthor=J.+Georgeauthor=V.+B.+Vegaauthor=L.+Vergaraauthor=A.+Plonerauthor=Y.+Pawitanauthor=P.+Hallauthor=S.+Klaarauthor=E.+T.+Liuauthor=J.+Bergh&title=An+expression+signature+for+p53+status+in+human+breast+cancer+predicts+mutation+status%2C+transcriptional+effects%2C+and+patient+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DSmeds%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DVega%26aufirst%3DV.%2BB.%26aulast%3DVergara%26aufirst%3DL.%26aulast%3DPloner%26aufirst%3DA.%26aulast%3DPawitan%26aufirst%3DY.%26aulast%3DHall%26aufirst%3DP.%26aulast%3DKlaar%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DBergh%26aufirst%3DJ.%26atitle%3DAn%2520expression%2520signature%2520for%2520p53%2520status%2520in%2520human%2520breast%2520cancer%2520predicts%2520mutation%2520status%252C%2520transcriptional%2520effects%252C%2520and%2520patient%2520survival%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13550%26epage%3D13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mason, J.; Wei, S.; Luo, S.; Nadeem, V.; Kiarash, R.; Huang, P.; Awrey, A.; Leung, G.; Beletskaya, I.; Feher, M.; Forrest, B.; Laufer, R.; Sampson, P.; Li, S.-W.; Liu, Y.; Lang, Y.; Pauls, H. W.; Mak, T. W.; Pan, J. G.</span><span> </span><span class="NLM_article-title">Inhibition of Polo-like kinase 4 as an anti-cancer strategy</span>. <span class="NLM_conf-name">AACR 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2–6, 2011</span>,  <span class="NLM_fpage">LB-215</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.%3B+Wei%2C+S.%3B+Luo%2C+S.%3B+Nadeem%2C+V.%3B+Kiarash%2C+R.%3B+Huang%2C+P.%3B+Awrey%2C+A.%3B+Leung%2C+G.%3B+Beletskaya%2C+I.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Laufer%2C+R.%3B+Sampson%2C+P.%3B+Li%2C+S.-W.%3B+Liu%2C+Y.%3B+Lang%2C+Y.%3B+Pauls%2C+H.+W.%3B+Mak%2C+T.+W.%3B+Pan%2C+J.+G.+Inhibition+of+Polo-like+kinase+4+as+an+anti-cancer+strategy.+AACR+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2%E2%80%936%2C+2011%2C+LB-215."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Polo-like%2520kinase%25204%2520as%2520an%2520anti-cancer%2520strategy%26spage%3DLB-215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the Cell Cycle in Cancer: TTK (MPS1) and PLK4 as Novel Mitotic Targets</span>. <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+Cell+Cycle+in+Cancer%3A+TTK+%28MPS1%29+and+PLK4+as+Novel+Mitotic+Targets.+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520Cell%2520Cycle%2520in%2520Cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520Novel%2520Mitotic%2520Targets" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">PLK4 inhibitors of novel structure as potent anti-proliferative agents</span>. <span class="NLM_conf-name">241st ACS National Meeting</span>, <span class="NLM_conf-loc">Anaheim, CA</span>, <span class="NLM_conf-date">March 27–31, 2011</span>,  <span class="NLM_fpage">MEDI 189</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+PLK4+inhibitors+of+novel+structure+as+potent+anti-proliferative+agents.+241st+ACS+National+Meeting%2C+Anaheim%2C+CA%2C+March+27%E2%80%9331%2C+2011%2C+MEDI+189."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DPLK4%2520inhibitors%2520of%2520novel%2520structure%2520as%2520potent%2520anti-proliferative%2520agents%26spage%3DMEDI%2520189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors: (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as novel anti-proliferative agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6069</span><span class="NLM_x">–</span> <span class="NLM_lpage">6087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400380m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6069-6087&author=R.+Lauferauthor=B.+Forrestauthor=S.-W.+Liauthor=P.+Sampsonauthor=Y.+Liuauthor=L.+Edwardsauthor=Y.+Langauthor=D.+Awreyauthor=V.+Maoauthor=O.+Plotnikovaauthor=G.+Leungauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=J.+Masonauthor=S.+Weiauthor=X.+Luoauthor=V.+Nadeemauthor=M.+Feherauthor=R.+Kiarashauthor=E.+Greenauthor=T.+W.+Makauthor=J.+G.+Panauthor=H.+W.+Pauls&title=The+discovery+of+PLK4+inhibitors%3A+%28E%29-3-%28%281H-indazol-6-yl%29methylene%29indolin-2-ones+as+novel+anti-proliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DAwrey%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DV.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DJ.%2BG.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%253A%2520%2528E%2529-3-%2528%25281H-indazol-6-yl%2529methylene%2529indolin-2-ones%2520as%2520novel%2520anti-proliferative%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6069%26epage%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lj1dhlaLToFdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sebolt-Leopold, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span> </span><span class="NLM_article-title">Mechanisms of drug inhibition of signalling molecules</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=457-462&author=J.+S.+Sebolt-Leopoldauthor=J.+M.+English&title=Mechanisms+of+drug+inhibition+of+signalling+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%2BS.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520drug%2520inhibition%2520of%2520signalling%2520molecules%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D457%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lh3FpbrD1674A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lh3FpbrD1674A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">McInnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Progress in the discovery of polo-like kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.2174%2F1568026053507660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=15853646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=181-197&author=C.+McInnesauthor=M.+Meznaauthor=P.+M.+Fischer&title=Progress+in+the+discovery+of+polo-like+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the discovery of polo-like kinase inhibitors</span></div><div class="casAuthors">McInnes, Campbell; Mezna, Mokdad; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-197</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (PLKs) are key enzymes that control mitotic entry of proliferating cells and regulate many aspects of mitosis necessary for successful cytokinesis.  Of the 4 known human PLKs, PLK1 is the best characterized and is overexpressed in many tumor types with aberrant elevation frequently constituting a prognostic indicator of poor disease outcome.  Despite the fact that PLK1 was regarded as a validated mitotic cancer target for a no. of years, very few reports of small-mol. PLK inhibitors have appeared to date.  In order to provide a starting point for the discovery and development of selective PLK inhibitors, the authors have characterized a no. of known generic kinase inhibitors with hitherto unknown activity against PLK1, as well as discovering novel inhibitors through structure-guided design.  Previously, the only characterized biochem. PLK1 inhibitor was scytonemin, a sym. indolic marine natural product that is a micromolar non-specific ATP competitor.  In addn. to the progress in the development of ATP-competitive small-mol. PLK inhibitors, recent reports on the use of antisense oligonucleotides (ASONs) and small interfering RNAs (siRNAs) directed against PLK1 have shown selective antiproliferative effects on cancer cells both in vitro and in vivo, producing phenotypes consistent with known PLK functions, and confirming that targeting PLKs with conventional small-mol. agents may be a valid and effective anticancer strategy.  Here the authors present a progress update on the approaches taken so far in developing PLK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR3BwTS0270bVg90H21EOLACvtfcHk0lh3FpbrD1674A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksb0%253D&md5=4d0df58d06f076e1f6ba7e5f2671d779</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1568026053507660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507660%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DProgress%2520in%2520the%2520discovery%2520of%2520polo-like%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D181%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Reindl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein–protein interactions</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2Fj.chembiol.2008.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=18482698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=459-466&author=W.+Reindlauthor=J.+Yuanauthor=A.+Kramerauthor=K.+Strebhardtauthor=T.+Berg&title=Inhibition+of+polo-like+kinase+1+by+blocking+polo-box+domain-dependent+protein%E2%80%93protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Polo-like Kinase 1 by Blocking Polo-Box Domain-Dependent Protein-Protein Interactions</span></div><div class="casAuthors">Reindl, Wolfgang; Yuan, Juping; Kraemer, Andrea; Strebhardt, Klaus; Berg, Thorsten</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Ser/Thr kinase Polo-like kinase 1 (Plk1) is overexpressed in many types of human cancers, and was implicated as an adverse prognostic marker for cancer patients.  Plk1 localizes to its intracellular anchoring sites via its polo-box domain (PBD).  Here we show that Plk1 can be inhibited by small mols. which interfere with its intracellular localization by inhibiting the function of the PBD.  We report the natural product thymoquinone and, esp., the synthetic thymoquinone deriv. Poloxin as inhibitors of the Plk1 PBD.  Both compds. inhibit the function of the Plk1 PBD in vitro, and cause Plk1 mislocalization, chromosome congression defects, mitotic arrest, and apoptosis in HeLa cells.  These data validate the Plk1 PBD as an anticancer target and provide a rationale for developing thymoquinone derivs. as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVCWgVzGi04rVg90H21EOLACvtfcHk0lhhdfrEiUc3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVSjsL8%253D&md5=cb8a592799b8ac1a1d08868d1f0b7033</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DReindl%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DStrebhardt%26aufirst%3DK.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520polo-like%2520kinase%25201%2520by%2520blocking%2520polo-box%2520domain-dependent%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Sampson, P. B.; Liu, Y.; Patel, N. K.; Feher, M.; Forrest, B.; Li, S.-W.; Edwards, L.; Laufer, R.; Lang, Y.; Ban, F.; Awrey, D.; Mao, G.; Plotnikova, O.; Leung, G.; Hodgson, R.; Mason, J.; Wei, X.; Kiarash, R.; Green, E.; Qiu, W.; Chirgadze, N. Y.; Mak, T. W.; Pan, G.; Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors: design and optimization of spiro[cyclopropane-1,3′[3<i>H</i>]indol]-2′(1′<i>H</i>)-ones as anti-cancer agents</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI <span class="refDoi"> DOI: 10.1021/jm500537u</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm500537u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sampson%2C+P.+B.%3B+Liu%2C+Y.%3B+Patel%2C+N.+K.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Li%2C+S.-W.%3B+Edwards%2C+L.%3B+Laufer%2C+R.%3B+Lang%2C+Y.%3B+Ban%2C+F.%3B+Awrey%2C+D.%3B+Mao%2C+G.%3B+Plotnikova%2C+O.%3B+Leung%2C+G.%3B+Hodgson%2C+R.%3B+Mason%2C+J.%3B+Wei%2C+X.%3B+Kiarash%2C+R.%3B+Green%2C+E.%3B+Qiu%2C+W.%3B+Chirgadze%2C+N.+Y.%3B+Mak%2C+T.+W.%3B+Pan%2C+G.%3B+Pauls%2C+H.+W.+The+discovery+of+PLK4+inhibitors%3A+design+and+optimization+of+spiro%5Bcyclopropane-1%2C3%E2%80%B2%5B3H%5Dindol%5D-2%E2%80%B2%281%E2%80%B2H%29-ones+as+anti-cancer+agents.+J.+Med.+Chem.+DOI+10.1021%2Fjm500537u."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm500537u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500537u%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DP.%2BB.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%253A%2520design%2520and%2520optimization%2520of%2520spiro%255Bcyclopropane-1%252C3%25E2%2580%25B2%255B3H%255Dindol%255D-2%25E2%2580%25B2%25281%25E2%2580%25B2H%2529-ones%2520as%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm500537u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Li, A.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, V. K.</span><span> </span><span class="NLM_article-title">Asymmetric ylide reactions: epoxidation, cyclo-propanation, aziridination, olefination, and rearrangement</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2341</span><span class="NLM_x">–</span> <span class="NLM_lpage">2372</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr960411r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=2341-2372&author=A.-H.+Liauthor=L.-X.+Daiauthor=V.+K.+Aggarwal&title=Asymmetric+ylide+reactions%3A+epoxidation%2C+cyclo-propanation%2C+aziridination%2C+olefination%2C+and+rearrangement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcr960411r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr960411r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.-H.%26aulast%3DDai%26aufirst%3DL.-X.%26aulast%3DAggarwal%26aufirst%3DV.%2BK.%26atitle%3DAsymmetric%2520ylide%2520reactions%253A%2520epoxidation%252C%2520cyclo-propanation%252C%2520aziridination%252C%2520olefination%252C%2520and%2520rearrangement%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D2341%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Aggarwal, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynd, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcelloni, M.</span><span> </span><span class="NLM_article-title">Application of chiral sulfides to catalytic asymmetric aziridination and cyclopropanation with in situ generation of the diazo compound</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1002%2F1521-3773%2820010417%2940%3A8%3C1433%3A%3AAID-ANIE1433%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFyrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=1433-1436&author=V.+K.+Aggarwalauthor=E.+Alonsoauthor=G.+Fangauthor=M.+Ferraraauthor=G.+Hyndauthor=M.+Porcelloni&title=Application+of+chiral+sulfides+to+catalytic+asymmetric+aziridination+and+cyclopropanation+with+in+situ+generation+of+the+diazo+compound"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Application of chiral sulfides to catalytic asymmetric aziridination and cyclopropanation with in situ generation of the diazo compound</span></div><div class="casAuthors">Aggarwal, Varinder K.; Alonso, Emma; Fang, Guangyu; Ferrara, Marco; Hynd, George; Porcelloni, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1433-1436</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The chiral sulfide I [n = 1] effectively catalyzed the reaction of imines with PhCH:NNNaTs in presence of Rh2(OAc)4 to give aziridines with high stereoselectivity.  N-protection with the SO2CH2CH2SiMe3 group was particularly effective.  I [n = 2] was more effective in the cyclopropanation of alkenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQrLMlbJNJtrVg90H21EOLACvtfcHk0lhhdfrEiUc3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFyrsrY%253D&md5=88812b40e8f86ed6ec910d205e3cfca6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010417%2940%3A8%3C1433%3A%3AAID-ANIE1433%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010417%252940%253A8%253C1433%253A%253AAID-ANIE1433%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DV.%2BK.%26aulast%3DAlonso%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DHynd%26aufirst%3DG.%26aulast%3DPorcelloni%26aufirst%3DM.%26atitle%3DApplication%2520of%2520chiral%2520sulfides%2520to%2520catalytic%2520asymmetric%2520aziridination%2520and%2520cyclopropanation%2520with%2520in%2520situ%2520generation%2520of%2520the%2520diazo%2520compound%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D1433%26epage%3D1436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Marti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span> </span><span class="NLM_article-title">Total synthesis of (−)-spirotryprostatin B: synthesis and related studies</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">11505</span><span class="NLM_x">–</span> <span class="NLM_lpage">11515</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0518880" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=11505-11515&author=C.+Martiauthor=E.+M.+Carreira&title=Total+synthesis+of+%28%E2%88%92%29-spirotryprostatin+B%3A+synthesis+and+related+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja0518880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0518880%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DC.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-spirotryprostatin%2520B%253A%2520synthesis%2520and%2520related%2520studies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D11505%26epage%3D11515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Vicinal diol cyclic sulfates. Like epoxides only more reactive</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7538</span><span class="NLM_x">–</span> <span class="NLM_lpage">7539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=7538-7539&author=G.+Yunauthor=K.+B.+Sharpless&title=Vicinal+diol+cyclic+sulfates.+Like+epoxides+only+more+reactive"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DVicinal%2520diol%2520cyclic%2520sulfates.%2520Like%2520epoxides%2520only%2520more%2520reactive%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D7538%26epage%3D7539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors as novel anti-proliferative agents</span>. <span class="NLM_conf-name">Canadian Chemistry Conference & Exhibition</span>, <span class="NLM_conf-loc">Quebec City, QC</span>, <span class="NLM_conf-date">May 26–29, 2013</span>,  <span class="NLM_fpage">BM7-00029</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+The+discovery+of+PLK4+inhibitors+as+novel+anti-proliferative+agents.+Canadian+Chemistry+Conference+%26+Exhibition%2C+Quebec+City%2C+QC%2C+May+26%E2%80%9329%2C+2013%2C+BM7-00029."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%2520as%2520novel%2520anti-proliferative%2520agents%26spage%3DBM7-00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Haddach, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton-Rewolinski, M. V.</span><span> </span><span class="NLM_article-title">An efficient method for the <i>N</i>-debenzylation of aromatic heterocycles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1016%2FS0040-4039%2801%2902192-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=399-402&author=A.+A.+Haddachauthor=A.+Kellemanauthor=M.+V.+Deaton-Rewolinski&title=An+efficient+method+for+the+N-debenzylation+of+aromatic+heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient method for the N-debenzylation of aromatic heterocycles</span></div><div class="casAuthors">Haddach, Aubrey A.; Kelleman, Audrey; Deaton-Rewolinski, Melissa V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-402</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The treatment of N-benzylated heterocycles with K tert-butoxide/DMSO and O at room temp. cleanly affords N-debenzylated products in high yield.  This procedure can be used on a variety of functionalized N-contg. heterocycles such as imidazoles, benzimidazoles, pyrazoles, indazoles, carbazoles, and indoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxH_1cyKPnwLVg90H21EOLACvtfcHk0liwxpmdR-L7CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlSg&md5=d58503d132cc29a1d75ba44ab13040c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902192-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902192-X%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DA.%2BA.%26aulast%3DKelleman%26aufirst%3DA.%26aulast%3DDeaton-Rewolinski%26aufirst%3DM.%2BV.%26atitle%3DAn%2520efficient%2520method%2520for%2520the%2520N-debenzylation%2520of%2520aromatic%2520heterocycles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D399%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Williams, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwast, E.</span><span> </span><span class="NLM_article-title">Carbanion-mediated oxidative deprotection of non-enolizable benzylated amides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1989&pages=451-454&author=R.+M.+Williamsauthor=E.+Kwast&title=Carbanion-mediated+oxidative+deprotection+of+non-enolizable+benzylated+amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26aulast%3DKwast%26aufirst%3DE.%26atitle%3DCarbanion-mediated%2520oxidative%2520deprotection%2520of%2520non-enolizable%2520benzylated%2520amides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1989%26volume%3D30%26spage%3D451%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">Performed by Lotus Separations, Princeton NJ.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanNiewenhze, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Catalytic assymmetric dihydroxylation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2483</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00032a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1994&pages=2483-2547&author=H.+C.+Kolbauthor=M.+S.+VanNiewenhzeauthor=K.+B.+Sharpless&title=Catalytic+assymmetric+dihydroxylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr00032a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00032a009%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DVanNiewenhze%26aufirst%3DM.%2BS.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DCatalytic%2520assymmetric%2520dihydroxylation%26jtitle%3DChem.%2520Rev.%26date%3D1994%26volume%3D94%26spage%3D2483%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hunter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. K. M.</span><span> </span><span class="NLM_article-title">The nature of π–π interactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5525</span><span class="NLM_x">–</span> <span class="NLM_lpage">5534</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00170a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1990&pages=5525-5534&author=C.+A.+Hunterauthor=J.+K.+M.+Sanders&title=The+nature+of+%CF%80%E2%80%93%CF%80+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja00170a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00170a016%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DC.%2BA.%26aulast%3DSanders%26aufirst%3DJ.%2BK.%2BM.%26atitle%3DThe%2520nature%2520of%2520%25CF%2580%25E2%2580%2593%25CF%2580%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1990%26volume%3D112%26spage%3D5525%26epage%3D5534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Bhosale, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, A. S.</span><span> </span><span class="NLM_article-title">A convenient procedure for the preparation of 2-bromo-1-phenylethanol</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1080%2F00304949209356251" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=695-696&author=S.+S.+Bhosaleauthor=P.+L.+Joshiauthor=A.+S.+Rae&title=A+convenient+procedure+for+the+preparation+of+2-bromo-1-phenylethanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F00304949209356251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304949209356251%26sid%3Dliteratum%253Aachs%26aulast%3DBhosale%26aufirst%3DS.%2BS.%26aulast%3DJoshi%26aufirst%3DP.%2BL.%26aulast%3DRae%26aufirst%3DA.%2BS.%26atitle%3DA%2520convenient%2520procedure%2520for%2520the%2520preparation%2520of%25202-bromo-1-phenylethanol%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2009%26volume%3D24%26spage%3D695%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Weinstock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brush, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, N.C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarau, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaim, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setler, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobia, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahns, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and renal vasodilator activity of some dopamine agonist l-aryl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2325</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00161a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=2315-2325&author=J.+Weinstockauthor=D.+L.+Laddauthor=J.+W.+Wilsonauthor=C.+K.+Brushauthor=N.C.+F.+Yimauthor=G.+Gallagherauthor=M.+E.+McCarthyauthor=J.+Silvestriauthor=H.+M.+Sarauauthor=K.+E.+Flaimauthor=D.+M.+Ackermanauthor=P.+E.+Setlerauthor=A.+J.+Tobiaauthor=R.+A.+Hahns&title=Synthesis+and+renal+vasodilator+activity+of+some+dopamine+agonist+l-aryl-2%2C3%2C4%2C5-tetrahydro-1H-3-benzazepine-7%2C8-diols%3A+halogen+and+methyl+analogues+of+fenoldopam"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm00161a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00161a029%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DLadd%26aufirst%3DD.%2BL.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DBrush%26aufirst%3DC.%2BK.%26aulast%3DYim%26aufirst%3DN.C.%2BF.%26aulast%3DGallagher%26aufirst%3DG.%26aulast%3DMcCarthy%26aufirst%3DM.%2BE.%26aulast%3DSilvestri%26aufirst%3DJ.%26aulast%3DSarau%26aufirst%3DH.%2BM.%26aulast%3DFlaim%26aufirst%3DK.%2BE.%26aulast%3DAckerman%26aufirst%3DD.%2BM.%26aulast%3DSetler%26aufirst%3DP.%2BE.%26aulast%3DTobia%26aufirst%3DA.%2BJ.%26aulast%3DHahns%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520renal%2520vasodilator%2520activity%2520of%2520some%2520dopamine%2520agonist%2520l-aryl-2%252C3%252C4%252C5-tetrahydro-1H-3-benzazepine-7%252C8-diols%253A%2520halogen%2520and%2520methyl%2520analogues%2520of%2520fenoldopam%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D2315%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Smolinsky, G.</span><span> </span><span class="NLM_article-title">Formation of azacyclopropenes by pyrolysis of vinyl azides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3557</span><span class="NLM_x">–</span> <span class="NLM_lpage">3559</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01057a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1962&pages=3557-3559&author=G.+Smolinsky&title=Formation+of+azacyclopropenes+by+pyrolysis+of+vinyl+azides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo01057a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01057a037%26sid%3Dliteratum%253Aachs%26aulast%3DSmolinsky%26aufirst%3DG.%26atitle%3DFormation%2520of%2520azacyclopropenes%2520by%2520pyrolysis%2520of%2520vinyl%2520azides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1962%26volume%3D27%26spage%3D3557%26epage%3D3559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Manfredi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecsedy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meetze, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burenkova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoar, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huck, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRoy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysong, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span> </span><span class="NLM_article-title">Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4106</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4106-4111&author=M.+G.+Manfrediauthor=J.+A.+Ecsedyauthor=K.+A.+Meetzeauthor=S.+K.+Balaniauthor=O.+Burenkovaauthor=W.+Chenauthor=K.+M.+Galvinauthor=K.+M.+Hoarauthor=J.+J.+Huckauthor=P.+J.+LeRoyauthor=E.+T.+Rayauthor=T.+B.+Sellsauthor=B.+Stringerauthor=S.+G.+Stroudauthor=T.+J.+Vosauthor=G.+S.+Weatherheadauthor=D.+R.+Wysongauthor=M.+Zhangauthor=J.+B.+Bolenauthor=C.+F.+Claiborne&title=Antitumor+activity+of+MLN8054%2C+an+orally+active+small-molecule+inhibitor+of+Aurora+A+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManfredi%26aufirst%3DM.%2BG.%26aulast%3DEcsedy%26aufirst%3DJ.%2BA.%26aulast%3DMeetze%26aufirst%3DK.%2BA.%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DBurenkova%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26aulast%3DHoar%26aufirst%3DK.%2BM.%26aulast%3DHuck%26aufirst%3DJ.%2BJ.%26aulast%3DLeRoy%26aufirst%3DP.%2BJ.%26aulast%3DRay%26aufirst%3DE.%2BT.%26aulast%3DSells%26aufirst%3DT.%2BB.%26aulast%3DStringer%26aufirst%3DB.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DWeatherhead%26aufirst%3DG.%2BS.%26aulast%3DWysong%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26atitle%3DAntitumor%2520activity%2520of%2520MLN8054%252C%2520an%2520orally%2520active%2520small-molecule%2520inhibitor%2520of%2520Aurora%2520A%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D4106%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Innocenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K-M.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas-Droux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: SAR, structural biology and cellular activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3228</span><span class="NLM_x">–</span> <span class="NLM_lpage">3241</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201683b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3228-3241&author=P.+Innocentiauthor=K-M.J.+Cheungauthor=S.+Solankiauthor=C.+Mas-Drouxauthor=F.+Rowanauthor=S.+Yeohauthor=K.+Boxallauthor=M.+Westlakeauthor=L.+Pickardauthor=T.+Hardyauthor=J.+E.+Baxterauthor=G.+W.+Aherneauthor=R.+Baylissauthor=A.+M.+Fryauthor=S.+Hoelder&title=Design+of+potent+and+selective+hybrid+inhibitors+of+the+mitotic+kinase+Nek2%3A+SAR%2C+structural+biology+and+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm201683b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201683b%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DK-M.J.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DRowan%26aufirst%3DF.%26aulast%3DYeoh%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DWestlake%26aufirst%3DM.%26aulast%3DPickard%26aufirst%3DL.%26aulast%3DHardy%26aufirst%3DT.%26aulast%3DBaxter%26aufirst%3DJ.%2BE.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DFry%26aufirst%3DA.%2BM.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520hybrid%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520Nek2%253A%2520SAR%252C%2520structural%2520biology%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3228%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mason, J. M.; Lin, D.C-C.; Wei, X.; Che, Y.; Yao, Y.; Kiarash, R.; Fletcher, G. C.; Bray, M. R.; Pan, G. J.; Mak, T. W.</span><span> </span><span class="NLM_article-title">Inhibition of PLK4 as a therapeutic strategy for genomically unstable cancers deficient for PTEN</span>. <span class="NLM_conf-name">AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Therapeutics</span>, <span class="NLM_conf-loc">Boston, MA</span>, <span class="NLM_conf-date">October 19–23, 2013</span>,  <span class="NLM_fpage">B267</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.+M.%3B+Lin%2C+D.C-C.%3B+Wei%2C+X.%3B+Che%2C+Y.%3B+Yao%2C+Y.%3B+Kiarash%2C+R.%3B+Fletcher%2C+G.+C.%3B+Bray%2C+M.+R.%3B+Pan%2C+G.+J.%3B+Mak%2C+T.+W.+Inhibition+of+PLK4+as+a+therapeutic+strategy+for+genomically+unstable+cancers+deficient+for+PTEN.+AACR-NCI-EORTC+International+Conference+on+Molecular+Targets+%26+Cancer+Therapeutics%2C+Boston%2C+MA%2C+October+19%E2%80%9323%2C+2013%2C+B267."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520PLK4%2520as%2520a%2520therapeutic%2520strategy%2520for%2520genomically%2520unstable%2520cancers%2520deficient%2520for%2520PTEN%26spage%3DB267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Mason, J. M.; Lin, D.C-C.; Wei, X.; Che, Y.; Yao, Y.; Kiarash, R.; Cescon, D. W.; Fletcher, G. C.; Awrey, D. E.; Bray, M. R.; Pan, G.; Mak, T. W.</span><span> </span><span class="NLM_article-title">Functional characterization of CFI-400945, an inhibitor of PLK4, as a potential anticancer agent</span>. Cancer Cell<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">, </span>in press</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+M.+Mason&author=D.C-C.+Lin&author=X.+Wei&author=Y.+Che&author=Y.+Yao&author=R.+Kiarash&author=D.+W.+Cescon&author=G.+C.+Fletcher&author=D.+E.+Awrey&author=M.+R.+Bray&author=G.+Pan&author=T.+W.+Mak&title=Functional+characterization+of+CFI-400945%2C+an+inhibitor+of+PLK4%2C+as+a+potential+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26atitle%3DFunctional%2520characterization%2520of%2520CFI-400945%252C%2520an%2520inhibitor%2520of%2520PLK4%252C%2520as%2520a%2520potential%2520anticancer%2520agent%26jtitle%3DCancer%2520Cell%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span>ACD/Structure Designer, <span class="NLM_edition">version 12.01</span>; <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Toronto, ON, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACD%2FStructure+Designer%2C+version+12.01%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Toronto%2C+ON%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FStructure%2520Designer%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scavarda, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span> </span><span class="NLM_article-title">Expression and function of TRK-B and BDNF in human neuroblastomas</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=8264643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVemtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=759-767&author=A.+Nakagawaraauthor=C.+G.+Azarauthor=N.+J.+Scavardaauthor=G.+M.+Brodeur&title=Expression+and+function+of+TRK-B+and+BDNF+in+human+neuroblastomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of TRK-B and BDNF in human neuroblastomas</span></div><div class="casAuthors">Nakagawara, Akira; Azar, Christopher G.; Scavarda, Nancy J.; Brodeur, Garrett M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">759-67</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">There is considerable interest in the role of the TRK family of neurotrophin receptors in regulating growth and differentiation in normal and neoplastic nerve cells.  A neuroblastoma is a common pediatric tumor derived from the neural crest, and the majority of favorable neuroblastomas express a high level of TRK-A mRNA.  However, little is known about the expression or function of TRK-B in these tumors.  TRK-B encodes a tyrosine kinase that binds to brain-derived neurotrophic factor (BDNF), as well as neurotrophin-3 (NT-3) and NT-4/5.  The authors have studied the N-myc-amplified human neuroblastoma cell line, SMS-KCN, which expresses both TRK-B and BDNF.  Exogenous BDNF induces tyrosine phosphorylation of TRK-B as well as phosphorylation of phospholipase C-γ1, the extracellular signal-regulated kinases 1 and 2, and phosphatidylinositol-3 kinase.  BDNF also induces expression of the immediate-early genes c-FOS and NGFI-A but not NGFI-B or NGFI-C.  In addn., BDNF appears to promote cell survival and neurite outgrowth.  SMS-KCN cells also express TRK-A, which is phosphorylated in response to nerve growth factor.  However, the downstream TRK-A signaling is apparently defective.  Finally, the authors detd. that in a series of 74 primary neuroblastomas, 36% express TRK-B mRNA, 68% express BDNF mRNA, and 31% express both.  Truncated TRK-B appears to be preferentially expressed in more-differentiated tumors (ganglioneuromas and ganglioneuroblastomas), whereas full-length TRK-B is expressed almost exclusively in immature neuroblastomas with N-myc amplification.  The authors' findings suggest that in TRK-B-expressing human neuroblastomas, BDNF promotes survival and induces neurite outgrowth in an autocrine or paracrine manner.  The BDNF/TRK-B pathway may be particularly important for growth and differentiation of neuroblastomas with N-myc amplification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFRcpiAn-I7Vg90H21EOLACvtfcHk0liZv3BcsGLXMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVemtLY%253D&md5=4624d1dc084091171f9ccb94017b8eec</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DAzar%26aufirst%3DC.%2BG.%26aulast%3DScavarda%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26atitle%3DExpression%2520and%2520function%2520of%2520TRK-B%2520and%2520BDNF%2520in%2520human%2520neuroblastomas%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D759%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Peters, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coogan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iglehart, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontos, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trogan, E.</span><span> </span><span class="NLM_article-title">Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumour angiogenesis</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1038%2Fbjc.1998.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=9459145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADyaK1cXoslersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=51-56&author=K.+G.+Petersauthor=A.+Cooganauthor=D.+Berryauthor=J.+Marksauthor=J.+D.+Iglehartauthor=C.+D.+Kontosauthor=P.+Raoauthor=S.+Sankarauthor=E.+Trogan&title=Expression+of+Tie2%2FTek+in+breast+tumor+vasculature+provides+a+new+marker+for+evaluation+of+tumour+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis</span></div><div class="casAuthors">Peters, K. G.; Coogan, A.; Berry, D.; Marks, J.; Iglehart, J. D.; Kontos, C. D.; Rao, P.; Sankar, S.; Trogan, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Endothelial receptor tyrosine kinases may play important roles in pathol. vascular growth, particularly in tumors.  In this study, immunohistochem. was used to evaluate the expression of a novel endothelial receptor tyrosine kinase, Tie2/Tek, in the endothelium of vascular "hotspots" in normal breast tissue (n = 10), benign breast lesions (n = 10) and in breast tumors (n = 123).  Tie2 expression was detected in the endothelium of all breast tissues examd.  However, the strongest expression of Tie-2 was seen in vascular "hot spots" within the inflammatory infiltrate at the periphery of invasive tumors.  Moreover, the proportion of Tie2-pos. vessels (Tie2 counts/CD31 counts) was significantly higher in breast tumors than the proportion of Tie2-pos. vessels in either normal breast tissue or benign breast lesions (P = 0.004 and 0.0001 resp.).  These data are consistent with a role for Tie2 in tumor angiogenesis and demonstrate the potential use of Tie2 expression as a novel marker of the tumor vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrajg5HegFblbVg90H21EOLACvtfcHk0lgHbSAyRxzAIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXoslersw%253D%253D&md5=1e6d0e96050dbcf308fc472f75c0cb70</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.8%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DK.%2BG.%26aulast%3DCoogan%26aufirst%3DA.%26aulast%3DBerry%26aufirst%3DD.%26aulast%3DMarks%26aufirst%3DJ.%26aulast%3DIglehart%26aufirst%3DJ.%2BD.%26aulast%3DKontos%26aufirst%3DC.%2BD.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DSankar%26aufirst%3DS.%26aulast%3DTrogan%26aufirst%3DE.%26atitle%3DExpression%2520of%2520Tie2%252FTek%2520in%2520breast%2520tumor%2520vasculature%2520provides%2520a%2520new%2520marker%2520for%2520evaluation%2520of%2520tumour%2520angiogenesis%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26spage%3D51%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Fister, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span> </span><span class="NLM_article-title">Optimal control applied to cell-cycle-specific cancer chemotherapy</span> <span class="citation_source-journal">SIAM J. Appl. Math.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=1059-1072&author=R.+Fisterauthor=J.+C.+Panetta&title=Optimal+control+applied+to+cell-cycle-specific+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFister%26aufirst%3DR.%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26atitle%3DOptimal%2520control%2520applied%2520to%2520cell-cycle-specific%2520cancer%2520chemotherapy%26jtitle%3DSIAM%2520J.%2520Appl.%2520Math.%26date%3D2000%26volume%3D60%26spage%3D1059%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Venugopal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristeleit, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourneau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellemans, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsayed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcclue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forslund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, T. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerji, U.</span><span> </span><span class="NLM_article-title">A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4262</span><span class="NLM_x">–</span> <span class="NLM_lpage">4272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1158%2F1078-0432.CCR-13-0312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=23741066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4262-4272&author=B.+Venugopalauthor=R.+Bairdauthor=R.+S.+Kristeleitauthor=R.+Plummerauthor=R.+Cowanauthor=A.+Stewartauthor=N.+Fourneauauthor=P.+Hellemansauthor=Y.+Elsayedauthor=S.+Mcclueauthor=J.+W.+Smitauthor=A.+Forslundauthor=C.+Phelpsauthor=J.+Cammauthor=T.+R.+J.+Evansauthor=J.+S.+de+Bonoauthor=U.+Banerji&title=A+phase+I+study+of+quisinostat+%28JNJ-26481585%29%2C+an+oral+hydroxamate+histone+deacetylase+inhibitor+with+evidence+of+target+modulation+and+antitumor+activity%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Venugopal, Balaji; Baird, Richard; Kristeleit, Rebecca S.; Plummer, Ruth; Cowan, Richard; Stewart, Adam; Fourneau, Nele; Hellemans, Peter; Elsayed, Yusri; McClue, Steve; Smit, Johan W.; Forslund, Ann; Phelps, Charles; Camm, John; Evans, T. R. Jeffry; de Bono, Johann S.; Banerji, Udai</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4262-4272</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD), dose-limiting toxicities (DLT), and pharmacokinetic and pharmacodynamic profile of quisinostat, a novel hydroxamate, pan-histone deacetylase inhibitor (HDACi).  Exptl. Design: In this first-in-human phase I study, quisinostat was administered orally, once daily in three weekly cycles to patients with advanced malignancies, using a two-stage accelerated titrn. design.  Three intermittent schedules were subsequently explored: four days on/three days off; every Monday, Wednesday, Friday (MWF); and every Monday and Thursday (M-Th).  Toxicity, pharmacokinetics, pharmacodynamics, and clin. efficacy were evaluated at each schedule.  Results: Ninety-two patients were treated in continuous daily (2-12 mg) and three intermittent dosing schedules (6-19 mg).  Treatment-emergent adverse events included: fatigue, nausea, decreased appetite, lethargy, and vomiting.  DLTs obsd. were predominantly cardiovascular, including nonsustained ventricular tachycardia, ST/T-wave abnormalities, and other tachyarhythmias.  Noncardiac DLTs were fatigue and abnormal liver function tests.  The max. plasma concn. (Cmax) and area under the plasma concn.-time curve (AUC) of quisinostat increased proportionally with dose.  Pharmacodynamic evaluation showed increased acetylated histone 3 in hair follicles, skin and tumor biopsies, and in peripheral blood mononuclear cells as well as decreased Ki67 in skin and tumor biopsies.  A partial response lasting five months was seen in one patient with melanoma.  Stable disease was seen in eight patients (duration 4-10.5 mo).  Conclusions: The adverse event profile of quisinostat was comparable with that of other HDACi.  Intermittent schedules were better tolerated than continuous schedules.  On the basis of tolerability, pharmacokinetic predictions, and pharmacodynamic effects, the recommended dose for phase II studies is 12 mg on the MWF schedule.  Clin Cancer Res; 19(15); 4262-72. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhELE0VMCPbVg90H21EOLACvtfcHk0lgHbSAyRxzAIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amt7zP&md5=f4db895a7878fddce61ea9640e427d4d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0312%26sid%3Dliteratum%253Aachs%26aulast%3DVenugopal%26aufirst%3DB.%26aulast%3DBaird%26aufirst%3DR.%26aulast%3DKristeleit%26aufirst%3DR.%2BS.%26aulast%3DPlummer%26aufirst%3DR.%26aulast%3DCowan%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DFourneau%26aufirst%3DN.%26aulast%3DHellemans%26aufirst%3DP.%26aulast%3DElsayed%26aufirst%3DY.%26aulast%3DMcclue%26aufirst%3DS.%26aulast%3DSmit%26aufirst%3DJ.%2BW.%26aulast%3DForslund%26aufirst%3DA.%26aulast%3DPhelps%26aufirst%3DC.%26aulast%3DCamm%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DT.%2BR.%2BJ.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DBanerji%26aufirst%3DU.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520quisinostat%2520%2528JNJ-26481585%2529%252C%2520an%2520oral%2520hydroxamate%2520histone%2520deacetylase%2520inhibitor%2520with%2520evidence%2520of%2520target%2520modulation%2520and%2520antitumor%2520activity%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4262%26epage%3D4272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Wei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denlinger, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsaparikos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jani, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span> </span><span class="NLM_article-title">Evaluation of selective γ-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1618</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5005336&amp;key=10.1158%2F1535-7163.MCT-10-0034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5005336&amp;key=20530712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5005336&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1618-1628&author=P.+Weiauthor=M.+Wallsauthor=M.+Qiuauthor=R.+Dingauthor=R.+H.+Denlingerauthor=A.+Wongauthor=K.+Tsaparikosauthor=J.+P.+Janiauthor=N.+Hoseaauthor=M.+Sandsauthor=S.+Randolphauthor=T.+Smeal&title=Evaluation+of+selective+%CE%B3-secretase+inhibitor+PF-03084014+for+its+antitumor+efficacy+and+gastrointestinal+safety+to+guide+optimal+clinical+trial+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design</span></div><div class="casAuthors">Wei, Ping; Walls, Marlena; Qiu, Ming; Ding, Richard; Denlinger, Robert H.; Wong, Anthony; Tsaparikos, Kosta; Jani, Jitesh P.; Hosea, Natilie; Sands, Michelle; Randolph, Sophia; Smeal, Tod</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1618-1628</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant regulation of Notch signaling has been implicated in tumorigenesis.  Proteolytic release of the Notch intracellular domain (NICD) by γ-secretase plays a key role in Notch-dependent nuclear signaling. γ-Secretase is an attractive pharmaceutical target for therapeutic intervention in cancer.  We describe the potent antitumor effects of PF-03084014, a small mol. that is a reversible, noncompetitive, and selective γ-secretase inhibitor.  The ability of PF-03084014 to inhibit γ-secretase activity was shown by the redn. of endogenous NICD levels and by the downregulation of Notch target genes Hes-1 and cMyc in the T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL.  PF-03084014 caused cell growth inhibition of several T-ALL cell lines via cell cycle arrest and induction of apoptosis.  PF-03084014 treatment also resulted in robust NICD redn. in HBP-ALL xenograft models.  Broad antitumor efficacy at well-tolerated dose levels was obsd. in six Notch-dependent models.  Addnl. mechanism-of-action studies showed inhibition of tumor cell proliferation and induction of apoptosis in HPB-ALL tumors, suggesting that the antitumor activity of PF-03084014 may be mediated by its direct effects on tumor cell growth or survival.  Further studies on PF-03084014-induced gastrointestinal toxicity identified an intermittent dosing schedule that displayed reduced body wt. loss and sustained antitumor efficacy.  We also showed that glucocorticoids abrogated PF-03084014-induced gastrointestinal toxicity and delayed administration of glucocorticoids did not compromise its protection effect.  Collectively, the results show that inhibition of Notch signaling by PF-03084014 while minimizing gastrointestinal toxicity presents a promising approach for development of therapies for Notch receptor-dependent cancers.  This compd. is being investigated for the treatment of T-ALL and advanced solid tumors in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGDbqFGE2aDbVg90H21EOLACvtfcHk0lijMyXAiJdgQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbY%253D&md5=b997504049b97258cc54016424ee7405</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0034%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DP.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DR.%26aulast%3DDenlinger%26aufirst%3DR.%2BH.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DTsaparikos%26aufirst%3DK.%26aulast%3DJani%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DSands%26aufirst%3DM.%26aulast%3DRandolph%26aufirst%3DS.%26aulast%3DSmeal%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520selective%2520%25CE%25B3-secretase%2520inhibitor%2520PF-03084014%2520for%2520its%2520antitumor%2520efficacy%2520and%2520gastrointestinal%2520safety%2520to%2520guide%2520optimal%2520clinical%2520trial%2520design%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1618%26epage%3D1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Awar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvic, M.</span><span> </span><span class="NLM_article-title">Treatment of transformed mycosis fungoides with intermittent low-dose Gemcitabine</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=130-135&author=O.+Awarauthor=M.+Duvic&title=Treatment+of+transformed+mycosis+fungoides+with+intermittent+low-dose+Gemcitabine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAwar%26aufirst%3DO.%26aulast%3DDuvic%26aufirst%3DM.%26atitle%3DTreatment%2520of%2520transformed%2520mycosis%2520fungoides%2520with%2520intermittent%2520low-dose%2520Gemcitabine%26jtitle%3DOncology%26date%3D2007%26volume%3D73%26spage%3D130%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2005.06</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec, H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2005.06%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec%2C+H3A+2R7%2C+Canada%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span><span> </span><span class="NLM_article-title">PK Functions for Microsoft Excel</span>. Pharmacokinetic Software; <span class="NLM_publisher-name">David W. A. Bourne</span>,<span class="NLM_x"> </span><span class="NLM_year">2001–2003</span><span class="NLM_x">; </span><a href="http://www.boomer.org/pkin/soft.html" class="extLink">http://www.boomer.org/pkin/soft.html</a>, Accessed November,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001%E2%80%932003&author=J.+I.+Usansky&author=A.+Desai&author=D.+Tang-Liu&title=PK+Functions+for+Microsoft+Excel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26atitle%3DPK%2520Functions%2520for%2520Microsoft%2520Excel%26jtitle%3DPharmacokinetic%2520Software%26pub%3DDavid%2520W.%2520A.%2520Bourne%26date%3D2001%25E2%2580%25932003%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF','PDB','4JXF'); return false;">PDB: 4JXF</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i94"><a href="/doi/suppl/10.1021/jm5005336">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32654"></div></div></div></div></div><hr /></hr><p class="last">Double reciprocal plot of PLK4 inhibition by compound <b>48</b>; synthesis of compound intermediates; atomic coordinates, bond lengths and angles, and anisotropic displacement parameters for an X-ray structure of compound <b>33</b>; inhibition data for the shortlisted compounds (<b>46</b>, <b>47</b>, and <b>48</b>) at 0.1 μM against a 274 member kinase panel.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5005336/suppl_file/jm5005336_si_001.pdf">jm5005336_si_001.pdf (838.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5005336&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm5005336%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5005336" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999586f8573cb2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
